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ABSTRACT 
 
Purpose – The purpose of this project was to extrapolate knowledge of successful leadership 
practices, determine what led to and nurtured what became an integrated organizational culture and 
identify any decisions and/or transformational events that re-defined Moffitt Cancer Center’s (MCC) 
course or helped propel it to levels far beyond what was originally imagined. The aims of this study were 
discovery of the foundational factors and events that significantly impacted the creation, growth and 
evolution of the center, making MCC an institution of transformational change that had achieved state 
and national prominence.  
Design – This was an exploratory study guided by a qualitative phenomenological research 
methodology using an interpretivist approach. Data was derived from twenty one-on-one interviews 
with people who had the specific knowledge and expertise necessary to obtain a better understanding 
of the leadership, culture and transformational events that transformed MCC into the institution that it 
is today. Interviewees included former and current MCC executive leaders, board members and key 
program directors, as well as the founder and two other former Speakers of the Florida House of 
Representatives. A literature review was conducted to explore founders, visionary leadership, 
organizational culture, and transformational organizations. 
Findings – Key findings included discovery of the factors and events that impacted MCC’s 
growth and success. The interview process revealed three foundational factors pertaining to visionary 
leadership qualities of the founder and others, a mission-based culture and four transformational events 
that set MCC on a course of independence and self-governance. The literature review, with an emphasis 
vi 
 
on founders, visionary leadership, culture and transformational institutions, revealed useful information 
to draw comparisons and differences in the historical context of MCC’s growth and impact. 
Value – MCC, created in Florida statute, existed as a private not-for-profit entity that, 
statutorily, served as an instrumentality of the state. As such, it had an interestingly distinct role as a 
hybrid organization that served a public and private sector need; while, very specifically, serving the 
cancer research and care needs of patients throughout the state and beyond. While the previously 
mentioned business literary research works are plentiful in the private and public sectors, a gap exists 
for hybrid organizations such as MCC. Future research could focus on organization founders who did not 
become part of the executive leadership structure.  
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CHAPTER 1: INTRODUCTION AND MOTIVATION 
 
Discovery and invention are deeply rooted in the history and progression of humankind. From 
the manipulation of stone creating weapons for hunting, innovations changed societies and laid the 
groundwork for new or better solutions. Likewise, business organizations have been created out of 
necessity, new and innovative ideas, creativity or passion. Many businesses existed to meet a public 
need; food supply, materials, tools or specialized services. Innovation created utility companies, public 
and private, to provide electrical power and indoor plumbing, contributing to the evolution of societal 
norms. Additionally, telephone and cable created instant communication and information flow.  It was 
not always necessary for businesses created out of necessity to be much, if at all different from those in 
other communities or even across town. They served a purpose and delivered the goods and/or services 
to meet demand.  
Transformational business organizations broke from the status quo and created solutions that 
changed or redefined markets, while creating societal benefit. Henry Ford didn’t create the automobile 
industry, but he disrupted and refined it through the innovation of mass production, making 
automobiles more readily available and affordable. Steve Jobs didn’t invent the computer, but through 
innovation and vision Apple changed the landscape and made computers available to households 
everywhere.  
The basis of Innovation is an idea. Ideas, coupled with drive, ambition, perseverance and vision 
have led to the creation of remarkable enterprises that became engines of social change for societal 
benefit. Former Speaker of the House of Representatives in the Florida Legislature, H. Lee Moffitt 
(Moffitt) authored legislation to create the H. Lee Moffitt Cancer Center and Research Institute (MCC). 
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Moffitt envisioned building a cancer center, on the University of South Florida campus in Tampa, FL, to 
serve the needs of Florida’s cancer patients and as a cancer research resource. Originally called the 
University of South Florida Cancer and Chronic Disease Research and Treatment Center and designated 
in statute as a direct-support organization (DSO), the institute was statutorily renamed for the founder 
by his colleagues in the legislature.   
In the 32 years since opening its doors in 1986, MCC grew from a modest cancer hospital with 
409 employees to a workforce of over 6,100 employees serving more than 64,000 patients annually. By 
2018, Florida had more cases of cancer diagnosed each year than all other states except California.  MCC 
occupied 17 acres on the University of South Florida (USF) campus but had its own governing board and 
an annual reporting responsibility to the Board of Governors, which oversaw the state university system.  
The founder played a predominant role in the creation of MCC and in the molding of culture and 
mission. As a lawyer, Moffitt had no training in medicine or research, and he acknowledged the need to 
rely on the expertise of others to guide the fledgling center. Many founders in business assume 
leadership roles of Chief Executive Officer (CEO) or board chairman to maintain control of their 
organization. Moffitt did not. For more than three decades, he served as a board member but did not 
allow MCC to devote office space for him and never received compensation for his continued efforts as 
a lawyer-lobbyist in the decades following his legislative tenure. While Moffitt dedicated a great portion 
of his life to MCC, his legacy included visionary leadership and recruitment of mission-driven individuals; 
the creation of an enduring culture. 
Moffitt had an idea. Due to the death of three close friends, Moffitt envisioned a cancer center 
in Florida to serve the needs of the state. Over a three-decade period, Moffitt’s vision grew into a 
nationally renowned cancer center that achieved numerous recognitions, recruited some of the best 
and brightest minds from around the globe and led cancer care and research in Florida and beyond. The 
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institution that started with an idea became not only an economic engine for the community and state 
but also served as a center for societal benefit.     
 
Table 1. MCC Awards and Recognition  
 
• Ranked No. 8 on U.S. News & World Report’s Best Hospitals for Cancer rankings in 2018, making 
Moffitt the best cancer hospital in Florida and top-ranked in the Southeast. 
• Ranked No. 40 out of 319 eligible hospitals in the Best Hospital for Gynecology category by U.S. News & 
World Report in 2018. 
• Named LGBTQ Healthcare Equality Leader by the Human Rights Campaign Foundation in 2018. 
• Achieved exemplar status for its Nurses Improving Care for Healthsystem Elders (NICHE) program, the 
highest designation in an international nurse-driven initiative designed to help hospitals improve the 
care of older adults. Moffitt is one of only 38 medical centers in the nation to have achieved this status. 
• Ranked No. 4 health care facility on DiversityInc’s 2018 Top Hospitals & Health Systems list. Moffitt is 
the only cancer center and the only Florida health institution on the specialty list. 
• Ranked in Computerworld’s 100 Best Places to Work in IT in 2018. 
• Named one of the 2018 Top 10 Nonprofit Companies for Executive Women by the National Association 
for Female Executives (NAFE). 
• Ranked on the Tampa Bay Times Top Workplaces. The Top Workplaces lists are based solely on an 
employee feedback survey administered by WorkplaceDynamics, LLC, a leading research firm that 
specializes in organizational health and workplace improvement. Several aspects of workplace culture 
were measured. 
• Received Gold Standard Accreditation for the 10th consecutive year in 2018. 
• Named 2017 Nonprofit of the Year by the Tampa Bay Business Journal. Moffitt was also recognized as 
the category winner in the Health & Human Services category. 
• Named a 2017 Business of Pride honoree by the Tampa Bay Business Journal and recognized for its 
commitment to LGBTQ diversity and non-discrimination policies. 
• Best and Brightest winner recognized by the National Association for Business Resources. The cancer 
center has been named one of the Best and Brightest Companies To Work For®, as well as one of the 
Best and Brightest Companies in Wellness. 
• Magnet® designation in recognition of nursing excellence. Magnet recognition is granted by the 
American Nurses Credentialing Center (ANCC), the credentialing body of the American Nurses 
Association, to honor outstanding health care organizations for nursing professionalism, teamwork, 
quality patient care and innovations in nursing practices. 
• Named a Working Mother Best Company. 
• Recognized as a winner of the 2015 Press Ganey Guardian of Excellence Award for commitment to 
offering an exceptional patient experience. 
• Recognized by the Institute for Patient- and Family-Centered Care. 
• Named a Fertile Hope Center of Excellence, an award presented to "cancer centers for proactively 
addressing cancer-related fertility". 
• Becker’s Hospital Review, 100 Accountable Care Organizations to Know. 
• Becker's Hospital Review, 150 Great Places to Work in Healthcare – 2016. 
• Ranked No. 6 on the 2016 Top 10 Hospitals and Healthcare Systems list. 
Source: Moffitt Cancer Center, Awards and Recognition 
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Significance of Study 
MCC became more than one person’s personal mission. The institute grew in size and stature, 
earning the coveted Comprehensive Cancer Center (CCC) Designation from the National Cancer Institute 
(NCI) and other awards, including numerous top ten ratings for cancer centers by U.S. News and World 
Report. In fact, MCC earned an abundance of local, state and national awards and recognitions over the 
years. These acknowledgements, shown in Table 1 above, demonstrated MCC’s commitment to serving 
patients, families, employees and the community. The uniqueness of MCC, however, extended well 
beyond these impressive recognitions. In the beginning, MCC operated as a DSO, defined in chapter 
240.299 of Florida Statute, to USF. These statutory requirements, shown in Appendix A, meant that MCC 
lacked independence in its governance and utilization of space.  
 
Table 2. Selected States Population, Cancer Incidence and Mortality, and CCCs 
 
 Population Cancer  CCCs 
State 
Population 
(2017) Rank 
% of 
US 
Total 
Annual 
Growth 
New 
Cases 
(2015) 
New 
Cases 
Rank 
Deaths 
(2015) 
Deaths 
Rank CCCs 
All States 325,719,178  100% 0.72% 1,607,321  595,919  49 
California 39,536,653 1 12.14% 0.61% 163,946 1 59,629 1 8 
Texas 28,304,596 2 8.69% 1.43% 105,108 4 39,120 3 3 
Florida 20,984,400 3 6.44% 1.59% 110,045 2 44,027 2 1 
New York 19,849,399 4 6.09% 0.07% 109,495 3 35,088 4 3 
North Carolina 10,273,419 9 3.15% 1.15% 53,526 8 19,321 9 3 
Maryland 6,052,177 19 1.86% 0.46% 30,480 19 10,567 20 2 
Sources:  
U.S. Census Bureau, Population Division, Annual Estimates of the Resident Population: April 1, 2010 to July 1, 2017. 
National Cancer Institute, State Cancer Profiles, 2015. 
National Cancer Institute, NCI-Designated Cancer Centers, 2018.  
 
As of 2018, MCC was one of the 49 NCI-Designated CCCs in the U.S., and the only CCC based in 
Florida. Table 2 shows the number of CCCs in states selected for comparison, along with population and 
cancer incidence and mortality information. Population was based on U.S. Census Bureau estimates for 
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2017. Cancer incidence and mortality numbers were from the NCI State Cancer Profiles (2015 was the 
latest year for which these data are available).  
Notably, Florida had the third largest population, second highest cancer burden and least 
number of NCI-designated CCCs. Florida’s estimated population growth was also higher than these 
states with at least two or more CCCs. From its humble beginnings as a DSO, MCC grew into one of the 
nation’s premier cancer centers, and the only CCC in Florida, a state in which nearly 6.5% of the US 
population resides. 
Aims of Study 
This project was designed to extrapolate knowledge of successful leadership practices, 
determine what led to and nurtured what became an integrated organizational culture and identify any 
decisions and/or transformational events that re-defined MCC’s course or helped propel it to levels far 
beyond what was originally imagined. The aims of this study were discovery of the foundational factors 
and events that significantly impacted the creation, growth and evolution of the center, making MCC an 
institution of transformational change that had achieved state and national prominence. Ultimately, the 
information derived from addressing these inquiries would help determine what course MCC should 
take moving forward. 
To achieve these goals, twenty-one individual interviews were conducted. Interviews were 
transcribed, and the data was assessed using thematic analysis and sensemaking. An extensive review of 
existing literature regarding founders, visionary leadership, culture and transformational organizations 
in business was conducted to help inform this study by identifying key theoretical concepts and 
elucidating the potential contributions of this work in adding to the current knowledge base.  
This study was intended to uncover not only why but also how MCC came to be the intuition 
that it was after three decades of existence. The research design employed in this work allowed for the 
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discovery of information about factors and events based on interpretations of individuals with historical 
knowledge and key expertise. Following analysis of data from individual interviews, the greater focus 
became the evolution of MCC to an institution of transformational change and the impact of the 
transformed institution on the region and state that invested in it and the patient population it served.  
The following research questions were developed to specifically address the goals of this study:  
1. Can we ascertain factors that were critical to the foundation of MCC as a transformational 
institution?  
2. Can we determine events that set MCC on a course to become and institution of 
transformational change? 
3. What does MCC need to do to continue to be an institution of transformational change with 
societal benefit? 
Findings from this study surfaced the factors and events that led to MCC’s evolution from a DSO 
to an institution of transformational change. The founder and other visionary leaders impacted the 
organization in a number of ways, leading to a mission-driven culture and bold actions that triggered the 
occurrence of transformational events.  The transformed institution went on to expand into ventures 
and partnerships beyond what the founder could have imagined. The business literature reviewed for 
this study was plentiful, yet gaps were identified.  This study’s findings led to the discovery of potential 
areas for future research, as well as the development of a model that could be applicable for other 
businesses.  
Organization of Chapters 
Chapter 2 describes the methodological approach used for this study. The chapter provides a 
discussion of the data collection method of individual interviews, including the strategy employed for 
selecting participants, conducting interviews and extrapolating key themes from the data. Chapter 3 
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provides a review of the relevant literature and discussion of these studies in relation to MCC. Chapter 4 
offers an in-depth picture of who the founder, Moffitt, was as a person, a professional, a politician, a 
founder and a driving force for MCC. Chapter 5 describes the instrumental leadership and four 
transformational events that this research determined had a significant impact on MCC’s first 30 years. 
The final chapter, Chapter 6, includes a discussion of the major study findings, limitations and 
contributions of this work, recommendations for future research, and concluding thoughts.   
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CHAPTER 2: RESEARCH METHODOLOGY 
 
Research Design 
This was an exploratory study guided by a qualitative phenomenological research methodology 
using an interpretivist approach designed to achieve the study aims and address the three research 
questions. Data was collected from individual interviews with people who had the specific knowledge 
and expertise necessary to obtain a better understanding of the leadership, culture and events that 
transformed Moffitt Cancer Center (MCC) into the institution that it is today. To assess the data, 
thematic analysis was used to identify patterns and relationships.  
The strategy of inquiry and methods employed to gather and analyze data were deemed to be 
an appropriate fit based on the overarching goals of this study. Phenomenological research aims to 
describe the common meaning for study participants who have experienced a particular phenomenon 
or concept (Creswell, 2013, p. 76). A focus of this project was understanding what situations, actions and 
events meant to the individuals who were involved with them. Such focus on not only the occurrence of 
events but also individuals’ perspectives and the actions shaped by such perspectives is central to the 
interpretivist approach (Maxwell, 2005, p. 22). Furthermore, interpretivism accepts that a social reality 
may change according to multiple perspectives based on individuals’ unique backgrounds and 
experiences; data collected by having a dialogue with participants of a study can lead to a better 
understanding of the social world by uncovering the not only the people’s experiences but also the 
subjective meanings they have attribute to it (Wahyuni, 2012, p. 71). 
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Data Collection 
This project utilized the qualitative data collection method of individual interviews. Individuals 
were purposefully selected for this research based on their areas of experience and personal 
experiences. The purposeful selection strategy was useful in addressing the study’s research questions, 
as individuals were deliberately selected to derive information that other possible choices could not 
have provided (Maxwell, 2005, p. 88).  
One-on-one interviews were conducted with twenty-one individuals. Interviewees included 
MCC board chairs and members, chief executive officers (CEO) and executive leaders, and program 
leaders. Two interviewees served in the in Florida House of Representatives. Like Moffitt, these former 
legislators ascended to the role of Speaker of the House. Interviewee bios are shown in Appendix B. 
Interviews were scheduled with individuals in advance and conducted either in-person or by phone. 
Each interview was recorded and transcribed using a transcription service. Signed consent was received 
from each interview participant. Interviews varied in length from as little as eighteen minutes to more 
than 59 minutes.  
A quasi-structured approach was used to conduct interviews. All but two of the participants 
were asked fifteen identical questions that were developed specifically for this study. The exceptions 
included Moffitt’s closest friend, Ralph Haben, Esq. who served as Speaker of the House in the term 
prior to Moffitt’s tenure. Haben knew Moffitt from law school and the two maintained a close 
relationship. Haben, having no affiliation with MCC, was asked to describe Moffitt as a person, his 
manner, style and personality. Additionally, Moffitt’s daughter, Jenny, was asked to add additional 
insight. Jenny Moffitt served on the Moffitt Hospital Board and, therefore, was also asked many of the 
prepared questions. Interview questions are shown in Appendix C.  
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The fifteen interview questions were developed to help facilitate the understanding needed to 
address the research questions. Several of the interview questions were designed to illicit responses in 
specific areas: current or previous role at MCC; length of affiliation with MCC; description of MCC; and 
one direct question about Moffitt. Participants were directly asked about the people, leadership and 
decisions that impacted MCC’s success. The intentionally open-ended questions were designed to allow 
for personal opinion and/or recollection. The aim was to allow for free-flowing discussion in the words 
of those involved, facilitating the format for much of the discussion in this work. Those questions led to 
the most fruitful input regarding the differentiators between MCC and other care centers.   
Methods of Analysis 
This exploratory study sought to ascertain what happened as well as how these events occurred, 
as perceived by individuals with distinct knowledge and expertise, in order to address the research 
questions. Thematic coding and sensemaking were used to assess and interpret the interview data.  
Phenomenological data analysis involved the review of interview transcripts to identify 
statements, quotes and/or sentences that offer an understanding of how a phenomenon was 
experienced by individuals. From these significant statements, clusters of meaning were developed into 
themes, which were then used to describe what individuals experienced and the influence of context on 
experiences (Creswell, 2013, p. 83). According to Lin (1998), “Interpretivist questions remind the 
researcher to look not only for the presence or absence of a relationship, but also the specific ways in 
which it is manifested and in the context in which it occurs” (p. 169). Weick, Sutcliffe and Obstfeld 
(2005) state that sensemaking is about the questions of how something came to be an event for 
members of an organization, and what the event means. Sensemaking involves the relationship of 
action and interpretation instead of the influence of evaluation on choice, recognizes that large 
consequences can come from short moments (pp. 409-410). 
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It should be noted that a few of the program directors who were interviewed provided a 
detailed description of their specific work and responsibilities. With the goal to maintain focus on the 
people and decisions, the excluded responses were deemed beyond the scope of the current project. 
These contributions will be used to help inform future research. 
Discovery of the factors that impacted MCC and the decisions made to propel the institution to 
become an institution of transformational change were the primary areas of interest. The design 
enabled input on numerous topics. The results of question #10, “Who or what has impacted Moffitt 
greatly?” became a focal point of this work. The foundational factors identified through this analysis are 
discussed in Chapter 3. Chapter 4 includes an in-depth look at the founder, as perceived by several key 
participants with personal and professional insights. Chapter 5 provides an in-depth look at the pivotal 
events, including the leadership and decisions that made MCC an institution of transformational change.  
A detailed summary and discussion of study findings are included in Chapter 6. 
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CHAPTER 3: LITERATURE REVIEW 
 
Introduction to Literature Review 
Review of the literature focused on three key themes brought forth through analysis of the 
interview data; founder, visionary leadership and culture. Each were explored to discover existing 
findings and to add to existing knowledge. Additionally, a fourth subject, transformational companies 
and societal benefit, was included in the literature review. Many transformational businesses have 
impacted local, regional, state, national or international communities. Moffitt Cancer Center (MCC) 
exemplified transformational change in cancer patient care and research in Florida and beyond. 
Relevant literature on this topic was examined to assess what is contained in the current body of 
knowledge regarding impactful, transformational businesses. 
 
 
Figure 1. Conceptual Model of Foundational Factors of the Transformational Institution 
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The research produced three key factors: founder, visionary leadership and culture. Further, 
four transformational events occurred that caused MCC to evolve into an institution of transformational 
change.  A model, shown in Figure 1, was created utilizing the factors and events to describe an 
evolutionary construction of an organization that, utilizing the model, could learn from and repeat the 
process for continued growth and impact. Breaking the model into its individual components and 
describing its causality explain the significance of the events and outcomes.  
A highly skilled, trained, impassioned leader, the first box, signified a leader who had an idea or 
motivation to create an entity to serve a specific purpose or address a specific need. That committed 
leader created an organization, the second box, with drive and determination and had a vision for how it 
would succeed. Additionally, the leader also impacted the corporate culture which emanated from the 
leaders’ style, passion or personality (Schein, 1983). Arrows, moving from left to right, indicated 
causality; one component directly impacted the next component.  An arrow led from the leader to the 
created organization. Similarly, arrows led to the top circle, visionary leadership, and to the lower circle, 
integrated culture. Arrows indicated the founder had impact on each.  
Visionary leaders, the founder and/or others recruited to lead the organization, possessed or 
adopted commitment to that vision. Visionary leadership enabled a business thought process to identify 
actions to impact the organization’s future.  
Integrated culture was also impacted directly by the founder. As discussed in literature, 
founders’ history, experiences or personality was imprinted on organization’s executives and 
employees, which created the corporate culture. Integrated culture was a necessary component, like 
visionary leadership, to move the organization forward.  
Visionary leadership and culture, as designated by the arrows, created an environment within 
the organization for transformational events to take place. The organization, with visionary leadership 
14 
 
and integrated culture, identified transformational events. The successful execution of those events, an 
arrow from events to institution of transformational change, created a new, changed, adapted 
organization with potential to impact business and/or society in ways it was not possible to under its 
previous construct.  
A Literature Review Summary Table was developed for this study and is shown in Table 3 at the 
end of this chapter. While numerous other sources were informative and contributed to this review, the 
studies included in Table 3 were found to be most pertinent in this review.  
Founder  
Founder-focused literature was found to focus primarily on founders running the companies 
they founded. In the case of this work, founders who do not take on the CEO role or a board chair role is 
not as prevalent. That said, drawing pertinent information regarding founders’ impact regarding culture, 
mission and values was fruitful.  
Exploring the role of the founder in the literature, Schein (1983) wrote extensively on 
organizational culture. Discussing the creation of culture, Schein described how organizational culture 
begins and the founder’s impact. As with political groups, new religions or social movements, a business 
founder has an idea about the creation of a business and surrounds him/herself with like-minded people 
to create a culture reflective of his/her goals “by force of his or her personality” (p. 13).   
Abebe and Alvero (2013) describe the role of the founder-CEO.  While, in the case of MCC, 
Moffitt did not assume the CEO role, as the founder, he directed much of early stages of the center’s 
foundation. Through their research, a study of 41 founder led and 41 non-founder led companies, they 
found that founder-CEO led organizations have a negative relationship with company performance. 
Contemplating the value of this paper for the review, there were a few interesting components that 
made it notable. The authors concluded that “founder leadership is critical in establishing the identity 
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and architecture of the emerging firm” (p. 354). Founder impact is a recurrent theme in much of the 
literature. Additionally, much of the research concludes that founders don’t always make the best long-
term leaders. What made this area of discovery pertinent was that Moffitt never occupied a leadership 
position at the executive or board levels within the organization. He passionately participated in the 
process from inception through three decades but was aware of his personal and professional 
limitations. He chose to lead by example, recruiting experts and giving them control. Serving on the 
board, he preferred to influence from the bench as opposed to on the field of play.  
Founder-centered research encompasses numerous focus areas with varying studies and 
outcomes. The recurrent theme of the literature is that the founder has an indelible impact on the early 
phase(s) of company development (Conte, Siano, & Vollero, 2017; Ellis, Aharonson, Drori, & Shapira, 
2017). “Founders…transmit this knowledge as they shape the behavior of their organizations and may 
influence the behavior of other individual members of their organizations (Ellis, et al., 2017, p. 500). This 
short passage, as with much of the literature, highlights the role of the founder as it relates to 
organizational culture impact (to follow).   
Conte, Siano, and Vollero (2017) state “personal history and the experiences of the founder are 
actively addressed and kept alive through communication campaigns, aimed at creating a distinctive 
brand heritage….” and “corporate identity and personality of the founders represent a significant 
opportunity for brand building…” (p. 276).  
Crotts, Dickson, and Ford (2005) recognized founder influence as leaders that instill 
commitment in employees. “Too often, the do as I say not as I do mentality interferes with the 
alignment between the mission statement on the wall and actual employee behaviors.” Utilizing J.W. 
Marriott as an example, they point to Marriott’s tradition of visiting his properties and visiting with 
employees at all levels “…reaffirming the Marriott mission and values” (p. 61). For more than 30 years, 
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Moffitt walked the halls at the cancer center, appeared unannounced at doorways and attended 
meetings covering nearly every area of focus at the cancer center.  
As described in numerous interviews in Chapters 4 and 5, Moffitt’s attention to employees at all 
levels and his concern for the center’s patients made a lasting impact that many wanted to emulate. 
Founders who created transformational institutions created vision that emanated from their original 
idea. Passionate leaders don’t stop once the bricks and mortar are complete, they remain involved and 
influence institutions by dedication to continued advancement and success. The literature clearly 
identifies numerous impacts founders have on the institutions they created. Whether management 
style, vision, cultural imprinting or instilling their truths and beliefs, founders have impacted their 
organizations.    
Visionary Leadership 
A recurrent theme that surfaced across multiple interviews was that of visionary leadership. The 
literature reveals an inordinate amount of material on leadership and many wide-ranging aspects. 
Findings included research highlighting the role of leadership (Sarros, Cooper, & Santora, 2011), 
personality (Church & Waclawski, 1998; Howell & Avolio, 1992), traits and attributes (Kishore, 
Majumdar, & Kiran, 2012; Muczyk & Adler, 2002), leadership style (Klein, Wallis, & Cooke, 2013), and 
leadership development (Locander, Hamilton, Ladik, & Stuart, 2002; Manning & Robertson, 2002). This 
review narrowed the focus to “visionary leadership” as it related to business leaders and the institutions 
in which they founded or worked. In its early years, MCC’s leadership evolved as the center expanded. 
Early leadership set the course for how the center was governed and the creation of a corporate culture 
(to follow) that gave MCC its unique identity. There was no particular training as to how to lead the 
young center. However, the leaders recruited to MCC had particular characteristics that blended with or 
augmented the vision and passion of the founder.    
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According to Collins and Porras (1995), “…all leaders, no matter how charismatic or visionary, 
eventually die. But a visionary company does not necessarily die, not if it has the organizational strength 
to transcend any individual leader and remain visionary and vibrant decade after decade and through 
multiple generations” (p. 87). Visionary leadership in literature covers a multitude of subject areas. The 
interviews in this work accentuated not only the leadership qualities of the founder, but also that of 
ensuing leaders. Moffitt accomplished his initial mission of creating a cancer center, but his ultimate 
goal was an enduring institution recognized as transformative in care and research. Visionary leadership 
at the executive and board levels was necessary in order to create a visionary organization that would 
benefit the citizens of Florida.   
Westley and Mintzberg (1989) identified varieties of visionary leadership style; the creator, the 
proselytizer, the idealist, the bricoleur, and the diviner. With each style variation, time and context are 
still critical factors; visionary leaders possess individual gifts and talents but are also products of the 
opportunities and other environmental aspects of the time during which they emerged (pp. 22-30). In 
the case of the proselytizer, Apple founder Steve Jobs was an interesting choice as it relates to the MCC 
founder. Westley and Mintzberg described Jobs as lacking the imagination or creativity that some other 
leadership styles possessed. Apple co-founder Steve Wozniak has been credited for the actual design of 
the computer yet did have the thought to sell the machines. Wozniak stated that computers were not in 
fact something that Jobs understood, but it was Jobs’ idea for the two to ‘hold them up in the air and 
sell a few.’ Thus, Jobs’ attribute and significant contribution was “…his evangelical zeal to show people 
the future potential of the product” (p. 25). Likewise, Moffitt, who knew nothing about running a cancer 
center, served as a proselytizer for a young institution and enabled the experts in areas of scientific 
knowledge to lead through innovation and discovery. As the research showed, the chosen leaders 
adopted visionary attributes and led by affording others the opportunity to discover and advance 
science and medicine.  
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Herb Kelleher, former CEO, President and Chairman of the Board with Southwest Airlines was 
not only a business leader but also a thought leader in industry. In his leadership analysis paper, Cote 
(2018) highlighted Kelleher’s fourteen characteristics of leadership and further discusses those qualities 
in three leadership categories. First, Spiritual & Servant leadership, not in the vain of religious or faith-
based literature (Sendjaya & Sarros, 2002) or comparative research (Smith, Montagno, & Kuzmenko, 
2004), but his inspiration attributed to listening, conceptualization, foresight and building community. 
Second, charismatic leadership qualities including acting as a role model, adherence to ethical beliefs 
and “…created a culture that promotes affiliation among employees that drives productivity.” Lastly, 
Cote believed Kelleher to be both a transactional and a transformational leader; evaluating employees 
while also empowering them (pp. 118-120).    
As MCC’s founder, Moffitt inherently possessed many leadership qualities that, through his 
passion, drove the recruitment process to hire uniquely qualified committed to the cause and vision. 
MCC had a hospital, subsequently built a research enterprise, and was multifaceted in its approach to 
patient care and discovery. Manufacturing facilities trained people to specific jobs. In the medical and 
research fields, those recruited bought their own set of skills and knowledge. Leading through 
empowerment, MCC leadership adopted many of the attributes described in the literature. 
Culture 
“There is a constant interplay between culture and leadership” (Bass & Avolio, 1993, p. 113). 
The founding leadership at MCC created a culture within the organization that blended the leadership 
qualities of the early adopters and the innovative knowledge physicians and scientists possessed. The 
culture, as with most businesses, had a genesis but also an evolution. Based on the vision and values of 
early leadership, MCC sought committed individuals who would not only embrace the MCC mission, but 
also had the acumen to adopt and perpetuate a culture. Business culture literature pertaining to this 
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work centered on organizational culture, leadership and culture, founders and culture, and people 
(employees) and culture.  
“How do the entrepreneur/founders of organizations create organizational cultures?” (Schein, 
1983, p. 13). Pertinent questions about the creation of culture are equal to the evolution and 
perpetuation of culture. In his 1983 work, Schein focused on the role of the founder and the creation of 
organizational culture. He stated organizational culture is dependent on a definable organization and a 
shared goal in the environment in which they work. Through the founder’s personality, a group begins 
to shape a culture. “Organizational culture, then, is the pattern of basic assumptions that a given group 
has invented, discovered, or developed in learning to cope with its problems of external adaptation and 
internal integration” (pp. 13-14). Companies integrated leaders and employees while evolving their 
practices and culture due to outside influences.   
In their paper on organizational cultures Mouton, Just, and Gabrielsen (2012) drew attention to 
founders as early impact participants of culture creation but, in their comparison with Schein (1983), 
made the case that others, “middle managers and experienced employees” have impact on the 
development of culture (p. 316). Likely, both conclusions were accurate. Culture may have begun with a 
founder, founding group, but a matrix of possibilities existed in cultural maturation over time.  
In his short paper regarding Kelleher and Southwest Airlines, Quick (1992), building on (Schein, 
1983), stated that while founders are central to early culture creation, “Organizational cultures do not 
spring full-blown and mature onto the corporate landscape.” He surmised that while new cultures 
emanated from the founders, the adoption of cultural values and beliefs became part of the 
organization over time (pp. 46-47). 
Literature focused on people and business culture added additional insight. Discussing the factor 
of people relating to profitability, Black and La Venture (2017) noted four founding principles of and key 
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elements to people-centered culture (pp. 25-29). Despite a differing research focus, the concepts and 
elements of culture had multiple similarities; leadership, communication, values, mutual success.    
A great deal of the literature focused on the creation and development of culture; some 
founder-focused while other material concentrated on CEO or other leadership impact (Brown, Brown & 
Gallagher, 2008; Giberson, et al., 2009). While focusing their work on market culture, Brown, Brown, 
and Gallagher (2008) pointed to three business leaders, Lou Gerstner (former CEO of IBM), Jack Welsh 
(former CEO of GE) and Jack Taylor (founder of Enterprise Rent-A-Car), who either built, or built on, their 
company’s culture to drive for success in the marketplace. “Continually strengthening a firm’s market 
culture is essential for achieving and sustaining a competitive advantage” (pp. 28-33). 
MCC, created in state statute, served as a private non-profit and also as an instrumentality of 
the state; a hybrid organization. Culture creation and adaptation in non-profit, quasi-public/ 
governmental companies, specifically in healthcare, can have unique challenges. Public scrutiny and 
media focus could alter public opinion of the institution. Failure to adjust organizational culture to 
external business, cultural or environmental evolution could lead to institutional problems. “Failure to 
change…could erode public and private confidence in these organizations” (Schraeder, Tears, & Jordan, 
2005, p. 494). Organizational culture, emanating from a founder, founding group, leadership or 
employees, defined the business. Adaptations and adjusts must be made over time to ensure 
institutional success.    
Transformational Organizations and Societal Benefit 
Transformational enterprises have impacted the business landscape in numerous ways for 
generations. The list of organizations that changed the way businesses operate, consumers respond, and 
markets react is long and distinguished. The auto industry was abruptly altered through Ford’s mass 
production innovation. Apple impacted individual computer ownership and later hand help phones. 
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Netflix disrupted the movie rental industry and changed how consumers access entertainment. Amazon 
changed the way consumer products were purchased and delivered. All successful organizations; all 
impacted people, industry and markets. They all impacted society.  
Research on health care entrepreneurship in the Nashville, TN region by Carr, Topping, 
Woodard, and Burcham (2004), stated “…the study of entrepreneurship should also capture those 
development activities that are more macro-related to include societal impacts on entrepreneurial 
action…” The study’s purpose was to describe the relationship “between health care delivery as a 
societal institution… and the “business of health care” as a form of regional development.” The authors 
stated that Nashville was as an “example of a community of health entrepreneurs who recognize and 
exploit entrepreneurial opportunities during periods of revolutionary social change” (p. 49).  
Entrepreneurial opportunities may or may not lead to positive impact for societal benefit. The 
literature focus in this section sought to discover research regarding business activity, profitability and 
transformational impact coupled with societal impact. MCC started as a small cancer center but grew to 
highly impactful institution. Subsequently, MCC created, though its mission-based business practices, a 
societal benefit to the region, state and beyond.     
According to the 2017 MCC Community Benefit report: “Moffitt Cancer Center’s Community 
Benefit initiative supports patients, families and clinicians through advancing cancer prevention, early 
detection, clinical care and research, especially for those at-risk populations disproportionately 
impacted by cancer.” Figure 2 shows MCC’s community benefit by category for Fiscal Year 2016-2017. 
Total community benefit dollars for this time period were more than $86 million. The MCC Community 
Benefit report describes each category as the following:  
• Research: Clinical and community health research, as well as general health care delivery studies 
shared with the public and funded by the government or a tax-exempt entity.  
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• Charity Care: Total cost of services incurred by Moffitt to provide medical services to patients 
who are unable to pay. 
• Medicaid Shortfalls: The Medicaid program pays Moffitt less than it costs the organization to 
provide care to its Medicaid patients. 
• Health Professions Education: Cost associated with clinical education and training for physicians 
and medical students not including government funding. 
• Community Health Improvement Services: Cost of activities carried out to improve community 
health beyond patient. 
• Community Benefit Operations:  Costs associated with assigned staff and community health 
needs assessment. 
• Community Building Activities: Cost of programs that address the root causes of health 
problems, including expenses for the development of community-building programs and 
partnerships. (Moffitt Cancer Center, Community Benefit Report 2017). 
 
 
Figure 2. MCC Community Benefit by Category, July 1, 2016 – June 30, 2017 
23 
 
 
 
While examples of impactful organizations are plentiful, the focus of this work and the literature 
pertaining, centered on transformational business and the impact/benefit to society from a more 
altruistic perspective. Literature focused on those connected issues produced numerous, not explicitly 
related, but not explicitly unrelated areas of research. Social entrepreneurs, social organizations, social 
innovation, transformative innovation and transformational leadership were all search results in the 
review. While each topic provided material on a particular discipline, numerous points of connectivity 
are presented.  
Social innovation, as described by Mumford (2002) “…refers to the generation and 
implementation of new ideas about how people should organize interpersonal activities, or social 
interaction, to meet one or more common goals.” Mumford’s paper described ten cases of Benjamin 
Franklin’s involvement in creating social organizations including the subscription library, police force, fire 
department, the Philadelphia hospital and paper currency (pp. 253-261). Taken for granted more than 
two centuries later as basic fabrics of society, those decisions/innovations, benefited society. Globally, 
healthcare initiatives and research drove innovation and discovery. Social innovation created 
opportunity for new, cutting edge organizations, or transformational change within existing 
organizations that impacted societal change and benefit.    
“In an effort to create societal value, many companies engage in important corporate social 
responsibility (CRS) initiatives (Zimmerman, Gomez, Probst, & Raisch, 2014). In this work, entitled 
“Creating Societal Benefits and Corporate Profits,” the authors examine how businesses embraced 
ventures that served society while earning profits. “…CSR programs depend on the commitment of 
current management and the profitability of the core business” (pp. 18-21). MCC undertook numerous 
initiatives that generated benefit including an annual Men’s Forum, providing physical examinations 
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targeted uninsured or underinsured men, a Mole Patrol mobile unit conducting skin cancer exams at 
different public locations.  While the programs had targeted impact, they were part of a larger 
community benefit initiative to promote early detection and healthier lifestyles.  
Drews (2010) combined qualitative and quantitative research regarding business and the social 
benefits of CSR. Stating that research was usually conducted in one approach or the other, the study was 
intended to use a combined approach to evaluate CSR “from a business as well as a societal perspective. 
The case study concluded that businesses can use theoretical models to analyze the cost and societal 
impact on initiatives (p. 428-429). Not every CSR initiative is successful, and businesses need to be aware 
of the fiscal impact as it relates to benefit. Sustainable businesses could create more initiatives 
impacting societal benefit by utilizing methods of evaluation, assessing business viability/ profitability, 
and corporate ability to engage in additional endeavors.  
Transformative innovation (TI) exists when companies “…embrace social, environmental, ethical 
or similar initiatives as an integral part of their strategic missions” (Bright, et al., 2006, p. 17). “TI plays 
out in at least one of three ways: (1) it capitalizes on and extends mutually beneficial interdependencies 
of business, and society or the environment, (2) it invokes a deep shift in values, assumptions and 
behaviors, or (3) it increases the scope of enacted human strengths.” TI, when successfully executed, 
created mutually beneficial results where corporate profitability and the creation of societal benefit 
were not mutually exclusive events (pp. 17-20).  
The founder’s intent, to provide cancer care to Floridians, and four institutional events 
(decisions) created a transformational institution through transformative means. As discussed in 
Chapter 5, four key events took place that aligned MCC’s business goals to benefit cancer patients. One 
transformational decision, a multidisciplinary approach, transformed antiquated methods of care 
delivery and benefited patients through a streamlined process and, more importantly, statistically better 
treatment as measured by patient satisfaction and health outcomes.   
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Social entrepreneurship and social innovation in business are growing areas of interest in 
research. Much of the existing literature describes the topics as businesses either created for, or 
adapted to, impacting the greater good through their mission and culture of societal betterment (Barki, 
Comini, Hart, & Rai, 2015; Ebrashi, 2011; Martinez, O'Sullivan, Smith, & Esposito, 2016; Steiner & 
Teasdale, 2016; Wilson & Post, 2013). The creation organizations designed to serve a specific market 
sector, while benefitting a geographical and/or societal need is pertinent.  
Social entrepreneurs created organizations with a particular social initiative as the centerpiece 
of the organization (Nicholls, 2006) or via for profit ventures (Cleveland & Anderson, 2001), or though 
cross partnerships with commercial companies (Ebrashi, 2011; Nicholls, 2006). Social entrepreneurialism 
at MCC took on many forms. From its founding, MCC was created to provide services, with superior 
results, to a state that did not have a nationally recognized institution at the time.  
Linking to Ebrashi’s research, MCC partnered with many commercial enterprises, Merck as an 
example, to engage in clinical research trails with the intent to find pharmaceutical treatments for 
cancer patients. In order to augment that partnership, MCC created a for-profit subsidiary, M2Gen, to 
partner with pharmaceutical companies seeking clinical annotated data and tissue samples. As a for-
profit subsidiary, any profit from that venture was to be rolled back into the research enterprise at the 
non-profit organization.  MCC sought to capitalize on potential from a new market venture, with the 
overarching goal of enhancing the research arm of the institution. MCC also partnered with other 
institutions in Florida, other states and nations including a personalized medicine partnership with Tiajin 
Taishan Cancer Hospital in China. With the goal of sharing discovery and treating patients closer to 
home, these partnerships enabled a high level of care without having to travel to Tampa for all 
treatments.  
The only cancer center created by the state, MCC’s immediate impact was regional. As the 
center grew and the research enterprise was founded, MCC’s reach extended far beyond the Tampa Bay 
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area. Previously, many Floridians were forced to seek treatment options out of state at other 
institutions with renowned reputations; MD Anderson in Texas, Mayo Clinic in Minnesota or Memorial 
Sloan Kettering in New York. As MCC progressed through key transformational events, it served patients 
statewide, nationally and internationally. The benefit MCC provided Florida was not simply the number 
of patients it served, but the innovative care-model it created. Prior to the center’s inception, Moffitt’s 
goal was to impact the lives of Floridians with superior care. After more than three decades and nearly 
400,000 patients later, MCC exceeded the expectations of its founder.    
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Table 3. Literature Review Summary Table  
 
Source Sample/Study Description Purpose/Topic Results 
Conte, F., et al. 
CEO communication: engagement, longevity and founder 
centrality. 
Corporate Communications: An International Journal. 
2017; 22(3), 273-291. 
Communication development 
relating to longevity of tenure. 
Exploratory survey of 93 CEOs of 
large companies in Italy. 
Founder 
Founder, CEO, 
communication in 
business 
Corporate communication, CEO communication 
influence. Founder centrality. 
Schein, E. H. 
The Role of the Founder in Creating Organizational 
Culture. 
Organizational Dynamics, 1983, 13-28. 
Paper 
Cultural embedding of founders. 
Founder types and elements of 
involvement and commitment. 
Founder/Culture 
Founder impact on 
development of 
business culture. 
Qualities of differing founder skill sets. Comparative 
discussion of founders and professional managers. 
Generational challenges moving from founder to 
next generation leadership.  
Ellis, S., et al. 
Imprinting through inheritance: A multi-genealogical study 
of Entrepreneurial Proclivity. 
Academy of Management Journal. 2017, 60(2), 500-522. 
Data collection in Israeli ITC 
industry. 65 CEO interviews 
regarding genealogical origin and 
impact.  
Founder/Culture 
Stages of Imprinting 
Founders as conduits. Imprinted elements may be 
transferred to new business organizations. Lineage 
of genealogy between businesses.  
Cote, R. 
Leadership Analysis: Southwest Airlines- Herb Kelleher, 
CEO 
Journal of Leadership, Accountability and Ethics, 2018, 
15(1), 118-122.  
Leadership/Kelleher attributes 
Leadership styles. 
Analysis and analyzation paper.  
Visionary 
leadership 
Leadership styles. Global leadership. Leadership 
approaches. Kelleher/Southwest Airlines  
Westley, F. & Mintzberg, H. 
Visionary Leadership and Strategic Management 
Strategic Management Journal, 1989, 10, 17-32. 
Concept of visionary leadership 
drawing on the theme of 
theater/visionary leadership as 
drama. 
Visionary 
leadership 
 Visionary leadership vary in leaders 
Strategic vs. visionary leadership 
Carr, J., et al. 
Health Care Entrepreneurship in the Nashville Region: 
Societal Linkages, Change Dynamics, and Entrepreneurial 
Responses 
The Journal of Applied Management and 
Entrepreneurship, 2004, 9(1), 49-63. 
Study of Nashville, TN healthcare 
industry and entrepreneurial 
involvement. 
Societal benefit  Environment suitable for entrepreneurial 
investment for the benefit of the Nashville region.   
Transformational change presents opportunities for 
entrepreneurial investment. 
Ebrashi, R. 
Social entrepreneurship theory and sustainable social 
impact 
Social Responsibility Journal, 2013, 9(2).188-209.   
Grounded theory study of social 
entrepreneurial activity and 
entrepreneurial literature. 
Societal benefit 
Entrepreneurial 
theory 
Add to the study of motivation, condition and social 
enterprise 
Management, outcomes and impacts 
Sustainable change 
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CHAPTER 4: THE FOUNDER 
 
Introduction: The Founder 
Identifying and describing any leader’s personality, drive, ambition, goals and core values can, 
on the surface, seem fairly easy. What did they stand for? Did their record reflect their words or actions? 
What did they talk about? How were they viewed by their family, friends and colleagues? What were 
their accomplishments? However, understanding the core of an individual and how words and actions 
are translated into lasting results, redeeming qualities and enduring reputation is more sophisticated. 
The benchmark is time. What did they start that was good, continue to do and did not stop doing for any 
reason?  
A case can be made that H. Lee Moffitt was one of those people who, with fierce passion, made 
a difference. The founder of Moffitt Cancer Center (MCC) never stopped pushing, working, and 
impacting the cancer center for institutional betterment. Moffitt was born and raised in Tampa, FL.  The 
son of a welder and a Holiday Inn desk clerk, Moffitt was the first in his family to graduate from college. 
After graduating from the University of South Florida in 1968, he attended Stetson Law School for one 
year prior to graduating from Cumberland Law School in Alabama. After practicing law in Tampa for five 
years, Moffitt successfully ran for a seat in the Florida House of Representatives; ultimately ascending to 
Speaker of the House from 1982 to 1984. A cancer survivor himself, Moffitt had three friends diagnosed 
with cancer. The three had to seek medical care outside of Florida and all three died.  Impacted greatly 
by the events, Moffitt made it his legislative, and ultimately his life’s, motivating force to establish a 
state of the art cancer center in Florida. 
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Moffitt’s passion for fighting cancer and the institute he founded can best be described by the 
people who have been around him most or influenced by him greatly, personally or professionally.  
Moffitt served for more than 30 years as a founding board member at MCC. He did not receive 
compensation for that position, his lobbying efforts for continued state investment in the center or any 
other service. He also refused to allow the center to designate an office for him. He practiced law before 
and after his legislative time in elective office. He utilized his legislative experience to obtain clients to 
represent before state government. He made a good living but was not rich. His constant and consistent 
passion was the cancer center that bore his name.  
This research project utilized interviews conducted with more than twenty leaders connected 
with MCC. Board chairs, members of the board, the CEOs, key executive leadership and program 
directors were asked for their opinion on numerous topics, including the founder. The interview 
questions are shown in Appendix B. In this chapter, excerpts from several interviews are used describe 
Moffitt on a personal level and a professional level. 
Personal Insights 
Most interviewees were asked identical questions. There were a few exceptions: his best friend, 
his daughter, the general counsel at MCC who knew the founder for nearly his entire career and one 
other founding board member who was a close confidant of Moffitt. Those individuals were asked to 
expand on Moffitt’s personal traits as well as his professional involvement. To get an in-depth picture of 
who Moffitt was, these individuals contributed extensive thought, opinion and perspective on H. Lee 
Moffitt as a person, a professional, a politician, a founder and a driving force for MCC.   
The Hon. Ralph H. Haben, Jr., Esq. 
Ralph Haben and H. Lee Moffitt met at the Cumberland School of Law in Birmingham, AL, where 
they graduated in 1967. Haben was elected to the Florida House of Representatives in 1972 as a 
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democrat representing the Bradenton, FL, area. He was eventually elected by his colleagues as Speaker 
of the House, serving from 1980 to 1982. Haben was H. Lee Moffitt’s closest friend. Moffitt stayed with 
Haben during the 60-day legislative session in Tallahassee, FL, each year. Haben knew Moffitt better 
than most. 
For the purpose of introduction, and discovering the essence of H. Lee Moffitt, the man, Haben’s 
recollections not only add depth, but also commentary regarding Moffitt as a person, a legislator and 
founder of the H. Lee Moffitt Cancer Center and Research Institute.  
I began law school at Stetson. Had not been involved politically in any way ever before, just 
went to University of Florida. Never was involved in student government, just didn't do it. And 
we got there and as a matter of fact Jim Smith at that time was there, he became the attorney 
general. (Smith served as Florida Attorney General from 1979 to 1987 and Secretary of State 
from 1987 to 1995 and 2002 to 2003). And three or four other people that Lee and I became 
friends with.  
They had freshmen elections. And so we were going put together a slate of people and Lee was 
going to be part of that slate and I kept saying who is Lee Moffitt? I met him, introduced myself 
up on the third floor of the law school. And so we went through the election. Somehow or other 
he was running for like secretary or treasurer. And Lee lost. We started hanging around then 
became friends. 
There came a time my senior year, our senior year, when Wilbur Boyd (D-Palmetto) who was 
our senator from Manatee County, constitutional revision (the Florida Constitution requires an 
appointed body to review the state constitution every twenty years and submit proposed 
adjustments) was up. Claude Kirk (R-Jacksonville, elected in 1966) was the governor. And so 
Senator Boyd said why don't you come and become my aide because you have some law 
experience now and we're going through constitutional revision and you can advise me. And I 
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did.  
Then contemporaneous {sic}, or within about three or four months, Lee had met Senator (Louis) 
de la Parte (D-Tampa) and he became Senator de la Parte’s aide. So now we have transitioned 
from law school politics to both working at the same time in the Florida Senate. So we did that 
for a while and then we both got admitted to the bar. He went back to Tampa and started 
practicing. I went back to Manatee County.  In 1972 there was an opening (for a seat in the 
Florida House of Representatives); I ran successfully. And then in 1974 he ran successfully.  
I had been up here for one term and he was then elected in ‘74. During, and I'm trying to think if 
it was before or after, but I remember he got cancer. And I didn't think much about it at the 
time. And finally somebody called me and said he is up in the hospital, this is fairly serious, you 
probably ought to come up here.  
So, we got in the airplane at night and left Sarasota and landed on Davis Island. And went to see 
him and I realized that this was a serious fricking {sic} deal, he had a damn hole in his leg about 
the size of a damn watermelon. And I realized he's lucky to be alive. And so that was an ordeal 
for a while. 
Ultimately he started healing up by this time we had run for the legislature and so we came up 
here (to Tallahassee, FL) and were friends before we came and it just got closer and closer 
because the service up here. Lee was just coming up as a freshman. I knew Lee had this thing 
because of what he'd gone through with cancer which was not pretty. And he had this idea that 
we should build a cancer center. Now what I did not know at the time, which I now not only 
know but live with each and every day, Lee Moffitt is the most stubborn person that I have ever 
met and I have met a lot of really stubborn people. He's not unreasonable particularly. He can 
be. But he's stubborn. And he got in his mind that we were going to have a cancer place.  
But he doesn't know how to do it and so he comes to me and says “Listen, you know Speaker 
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Brown better than I do. I really would like to get some seed money to begin to plan a cancer 
facility.” And I said well that's not a problem. He said “Well I just I don't know what to do.” I said 
well come with me. And so we went up to the fourth floor (of the State Capitol) and went into 
Hyatt's hall and said Hyatt, Lee needs a little over a million dollars. Well, for what? I said listen. 
He wants to look at the feasibility of a cancer facility. And he'll take a million dollars and nothing 
will ever come of it. But if you do not give it to him, he will wear you out. Just constantly, just 
give him the money. And Hyatt said, okay. So he called the appropriations chairman [to] put 
money in the budget. And there it began. 
For a year, that was his main thing. He did a lot of other things but that was his main influence. 
And then and actually the year he was elected, Hyatt called me over and said listen. I need 
somebody, one of our people to succeed me. You need to talk to a couple guys and decide if 
you're going to do it or not. I wanted to be the United States Attorney for the Middle District I 
thought. But then I finally gave that up and stayed and ran and of course back then you had 
Hyatt and me and then Lee. We were all extremely close. Ultimately he became Speaker and 
was able to complete not what exists today but what existed back then, which was sort of the 
focal point. And I'm going to tell you something I think to be emphasized. He has never made 
one penny off of that cancer center. And he could have. He could have made several million 
dollars. Will not do it, will not talk about it. That's unusual. Lee Moffitt is a good person. I'd like 
to kill him sometime, but he is a good person.  
Lee Moffitt came from middle class but good parents, both of them. But both of them really 
cared about him. And you know he's sort of a typical story, went to Plant High School (in 
Tampa), did not have a butt load {sic} of money, but was involved.  He went to (University of) 
Florida for a short time, was always interested in politics. We were both extremely naïve. Had 
no idea about what the real deal was until we got up here, or actually until we started to 
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campaign. I mentioned earlier he is the most stubborn person that I know. But that's a good 
thing. Lee was sort of on the outside looking in. I mean he was well known, well liked. But the 
name Moffitt was like, ‘is that a plumbing part?’ But I had run and so I had some experience on 
how to do it. 
I remember going door to door in Hillsborough County. It was close but he won. And, of course, 
once he won then very quickly moved into a leadership position. What's funny is he's stubborn, 
but his nickname in law school… was Mother Moffitt. Very “let's keep everything under control.” 
But that's him, it's just “I don't want anything bad to happen, don't want anything bad to 
happen.” 
Lee's very steady number one. Number two, I didn't do so much of this, he did, he would reach 
out to the Hillsborough people, “what do you need, how can I help you?” I mean I sort of knew 
but you don’t have to reach out. Believe me they'll be right up here. Don't worry about it. But he 
did that, and he was interested in all things Hillsborough, he really was. Because his circle of 
friends was Hyatt, speaker, me, next speaker, (Rep. Steve) Pajick (D-Jacksonville), (Rep.) James 
Harold Thompson (D-Quincy), all of the leadership people during that period of time, Lee was 
close friends with. He was liked and well respected. You ask any one of them though, they will 
tell you he was stubborn. 
The Lee way is the kind of ... he wants to be right. Not in a bad way, he wants to be right 
because he thinks about things, he sometimes studies them to a fault. He does not want to 
make a mistake. He doesn't want to do something wrong. He doesn't like controversy. He just 
doesn't. He wants everything to work out, he wants everything to be good. And for the most 
part he was able to do that. As Speaker, he was able to accomplish it, not through force of will. I 
think most of the House of Representatives thought this guy is a good guy. He means well, how 
can you refuse him?  
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Let me tell you the classic comment. (Rep.) Elvin Martinez (D-Tampa) one night had had many 
high balls. And Elvin said you know what? I've looked at the total state budget, I don't know if 
we can afford all the Jenny's (Moffitt’s daughter) of the world. Because that was Lee's opening 
address, he said he wanted to take care of the children and education, and he means it. The last 
line of that opening statement was we need to take care of all the little Jenny's of the world. 
And he meant it, of course Elvin was drunk, says we can't afford all the little Jenny's in the 
world.’ Which if you think about it really makes the point that he wanted to do the right thing 
and he wanted to be right. 
He and I are so different. And yet we are the best of friends and have been that way for a long, 
long time. The House (of Representatives) really respected (Speaker) Hyatt (Brown) because of 
what he was able to do, that he was able to turn it around so that the young guys were now 
running the rodeo. And they were a little fearful of me because I knew the rules, I was pretty 
good in debate and, I have a quick tongue. But him they loved him. It's like if Lee wants it let's 
just do it.  
There is nothing wrong with being an advocate. But up here you have to be an advocate within 
certain bandwidths. Sometime Lee does not recognize those bandwidths. And let me tell you 
why. That cancer center is so much, it's part of who he is, it is a major part. I would like to know 
the number of total working hours in a year that he devotes to the cancer center. I guarantee 
you, I guarantee you it's more than 70% of his time.  
The cure is there. 10, 15 years from now all these people that we lose, they're not going to be 
lost. In other words, my momma my daddy my brother, all could have been saved and he knows 
that. So it's the best of the best but sometimes when the mission becomes really important, you 
still have to work in the system. Let me tell you what the system is. It is frustrating. It frustrates 
him on a fairly regular basis.  
35 
 
I guarantee you, you all are going to have to make a fricken {sic} motorized walker where he can 
go to the damn board meetings when he gets about 90 years old. Because he’s not going to quit 
until he dies. Just not. I don't know anybody that is as committed to an institution or an idea as 
he is.  
I don't know any other person that spends the unpaid time that he does, I wouldn't do it. I 
couldn't do it. But he does it. And not only does he do it, he loves it when something good 
happens.  
Do you want me to tell you what is a realistic expectation (about the future) he has or an 
unrealistic expectation that he has? Two different things. The unrealistic expectation is to, not 
for everything, but to find an accepted cure before he dies. And if not that, to continue to grow 
and fund so that we will be better positioned to realize the first. That is to ultimately find the 
cure. You're going to find a cure for some of it. You aren’t going to find a cure for all of it. So 
Moffitt, when they find a cure, it's almost their mission doesn't end, it begins. Now we got a 
handle on it, now how can we develop the procedures and the way to go about getting to where 
50 years from now, they used to have cancer back in early 2000's. We don't have that anymore. 
Like trichinosis in pork.  
If you would have told me in the Speaker’s office, when we asked for about a million dollars, 
that I would be talking about a facility that encompassed acres that was famous, not in Florida, 
not in the United States, but throughout the world, that it would be ranked in the very top 
echelon of facilities and it all started with a hole in his leg.  
He had an idea, he had the mental makeup, the stubbornness to just keep on and on and on and 
to continue to fund and it continued to grow beyond anything we ever, ever could have 
imagined.  
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For a lot of people in Tampa, one day there was some bricks and mortar and it seems like it gets 
bigger and bigger and bigger and now it's a part of the fabric of Hillsborough County, that whole 
area. The jobs, the economic engine that it is, but for me I just remember Hyatt giving him a 
million dollars where we can just get the frick {sic} out of here.  
Who would have thought, they started building it like it'll be an 80-bed facility and he'll be 
happy and we'll name it Moffitt and go on down the road. And that's not what it is now; it's a 
world-class program. If any one of those factors would have been different it wouldn't have 
happened probably, but the most important was him persevering.  
Out of all the questions asked of those interviewed, there was only a single question about the 
founder. Interestingly, all but one person mentioned H. Lee Moffitt before the question was asked. That 
fact was not completely shocking considering his name was on the door. However, the frequency of 
responses and the depth to which the respondents went was enlightening.  
Jennifer (Jenny) L. Moffitt, PhD 
Adding a bit more flavor to the founder himself, Moffitt’s daughter, Jenny, had insight from a 
number of perspectives. She served as a member of the hospital board at MCC. A PhD professor, Jenny 
was not politically active like her father and was focused on her career and her interests. She was 
“recruited’ to serve on an MCC board in similar fashion to general “encouraging” a child to pursue a 
military career by going to West Point. Jenny had grown up with MCC as part of her life.  
I don't really remember a time in my life when it (MCC) wasn't part of the conversation or part 
of my dad's focus or reason for being. There were discussions about his dream for the center. I 
remember it, when the hospital was under construction. Of course, the growth that we've seen 
occur in my lifetime from just an idea to something on paper to something that started to 
emerge from the ground here in Tampa, just the hospital building at the beginning, and then 
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adding on the Research Center and that kind of growth happening. 
My earliest memories are the classroom here, the Cynthia King classroom in the hospital. That 
was my first introduction to cancer. The first time my dad had cancer was before I was born. 
Cynthia would allow me to come and volunteer in the classroom where I got to spend time with, 
this was when we were still doing pediatric care, and I would come and spend time with the kids 
in the classroom. Those were my first lessons about cancer and cancer treatment, learning from 
a young girl being treated for leukemia. I remember her taking me to her room after we left the 
classroom and showing me the IV and talking about how she received her treatment and the 
effect that it had on her. 
Those were really my earliest memories of coming to understand what this place was and the 
impact that it had on the lives of the patients that were coming in.  
Jenny’s early memories and her father’s eternal drive to propel MCC to the forefront of cancer 
care and research were always present. However, she pursued her own path and was not actively 
involved with the daily operations at MCC until after she had established herself professionally. Her 
board affiliation and her own growth as an adult established her own views on her father’s interest and 
drive regarding the cancer center. Her father’s personal experiences with cancer are not only part of her 
recollection, but also her awareness of the disease’s impact. 
It's always interesting for me because I'm trying now as an adult, and within the Moffitt 
community, to see him as a man rather than a father. It's always difficult with our own parents 
to imagine them existing in the world outside of their role as parent… I suppose I'm sort of 
grateful for Moffitt because it allows me to see my dad in a different perspective than the father 
perspective. 
He has been an incredible, if not intimidating, role model for me my entire life because he is so 
passionate, so determined, so engaged, so willing to give of himself and of his time and never 
38 
 
resting in his commitment to the cancer center and his pursuits in his goals for this place. It's 
been remarkable watching the center develop over the years as well as watching him grow over 
the years in terms of what he's learning. He was not someone with medical or healthcare 
background. This was a passion project inspired by the loss of friends, and so he had to do a lot 
of self-education in order to be able to make this place a reality and then to remain a 
participant. 
He didn't just say, "Oh, let's get this thing going," and then move on to something else. He will 
be here until the bitter end. He will... this is a lifetime commitment for him, so it's been 
remarkable to watch him in that capacity. 
The friends that he lost, that all happened before I came into the world when he was very 
young, as did his first battle with cancer happened before I existed. For me, my memories are of 
his second encounter with cancer when I was around 12, I suppose.  He hid it from me when he 
got sick because, as a parent, you never know what it means when you get that diagnosis, and 
especially if your children are of a certain age or not quite sure what the future is and what they 
can handle or what they understand. 
A lot of it was hidden from me, and I was sort of unaware of him being sick. Then when I did find 
out, as any family member or caregiver knows, it's really terrifying, the threat of the loss of a 
loved one and the pain of watching someone you love go through the experience, the physical 
pain, the emotion pain for them. 
Jenny believed that her father’s motivation, his experiences with cancer and the death of three 
close friends were always top of mind. But she also grew to understand that there were specific traits 
her father exemplified that drove his ambition for excellence in cancer care and research. 
I would say visionary, and this comes to me because it's something that I admire so much in him 
is to be able to.  I mean, we talk about him as being determined and tireless and forever willing 
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to fight the good fight but he has this incredible capacity to look into the future, if you will.  Or 
to imagine possibilities that I think makes him unusual. This was something I've always both 
admired and perhaps been a little jealous of, is this ability to say, "Let me think, I'm going to 
anticipate needs," and then not just come up with ideas, but actually work to make that a 
reality. It's a really remarkable quality. 
It never stops with him. It never turns off, where he's always thinking, "Five years from now, 10 
years from now, what do we need to be doing, what do we need to be ready for, how is the 
culture going to change or technology going to change, how can we adapt to meet changing 
needs." It's impressive. 
I think he, in part, leads by example in that you see that devotion, you see that commitment, 
and I think it's inspiring. It's sort of infectious to those of us around him. I think the other thing 
that makes him a great leader, or anyone a great leader, is the capacity to listen to others and to 
gather information and know that there are times to be in the driver seat and there are times 
not to be, that you have to trust those around you to contribute that this is a team effort, that 
this cannot happen without everyone involved in the Moffitt community coming together and 
sharing information and helping in the best way that they can. You've probably heard him ask 
people a bazillion times, "Have you found the cure yet?" 
L. David de la Parte, Esq. 
David de la Parte provided an additional look into the history and depth of the founder.  de la 
Parte, who has long considered Moffitt as a mentor, served as outside General Counsel to MCC from 
1990 until moving in house at MCC in 2007 to serve as Executive Vice President (EVP) and General 
Counsel. de la Parte’s father, Louis de la Parte, served in the Florida legislature and ultimately ascended 
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to the role of President of the Florida Senate for a short period. After law school, Moffitt worked as the 
legislative aide for state senator Louis de la Parte. 
Dad is why I am here. You can trace pretty much everything back to dad as far as my legal 
career, professional career. But Lee Moffitt, for a time, worked for Dad when Dad was in the 
legislature. Lee and Ralph Haben were on their way to Tampa having graduated from law school 
and decided they would go through Tallahassee and see if they could get a gig in government. At 
that time, Dad needed an aide. And gave Lee the job. Dad was in the Florida senate at the time 
representing Tampa, Hillsborough County. 
That's where Dad and Lee kind of established their first formal relationship. Lee certainly knew 
Dad because Dad was active in politics and was elected office and was a lawyer in town. He was 
12, 14 years Lee's senior. Lee tells me, and I've heard him tell others, that he kind of caught the 
political bug from dad. I don't know about that because Lee was political before he went to work 
for dad. He was student body president here at USF so he already had the political bug. Maybe 
he just got more refined.  
In 1990 I became Moffitt's outside general counsel by virtue of Dad's early retirement (former 
Sen. de La Parte had served as MCC’s outside general counsel) because of an illness. I did that 
for about 15 years as outside general counsel and private practice. I was recruited to be the 
cancer center's in-house general counsel by H. Lee Moffitt and Bill Dalton, the then CEO of the 
cancer center in 2007. And so I moved. I sold my practice to my partners. 
Over the years of working for MCC in private practice and internally, de la Parte worked closely 
with Moffitt on all aspects off MCC business. de la Parte grew to revere Moffitt and learned much about 
his personality, drive and motivation. 
H. Lee is one of the most extraordinary people I have had the opportunity to interact with. Lee is 
definitely probably, next to dad, the most extraordinary person I've known. No human being is 
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perfect. Lee certainly isn't perfect, but he is able to bring to bear for us, for the cancer center 
traits, talents, energy that is…again, I have not witnessed in any other organization.  
It does oftentimes go back to one person and their unique attributes and traits. And a passion 
that is just... It's an energy, a life force that Lee has been able to channel to the benefit of this 
place in his mind. Working 24/7 on whether it's how do we get the cars through the valet more 
efficiently, more quickly so patients don't have to sit and wait and can get into the place and get 
the care they needed? To how do we talk the legislature into giving us the hundreds of millions 
of dollars we need to build a new research tower or to build a new clinical facility? 
It's from the very smallest thing, operational thing to the very largest strategic things that we 
do. He's got a mind that's capable of that. And he's got a passion for it. And he is willing to put 
himself personally at risk, and he has. If Lee put the energies that he's put to us to his law 
practice or his political career, he'd probably have a lot more money or he'd be the President of 
the United States or something. But he chose to put his energies into us into this place, into the 
Moffitt Cancer Center. And thank goodness we've had someone like Lee who didn't put his own 
personal interests ahead of the patients and our mission. 
He's a tough task master. He's a bear. He is never satisfied. You've got to be prepared when you 
work with him and work for him to be prepared for a grueling experience. But that has a lot of 
rewards at the end of it. For me, it was a personal and professional embracing and a leadership 
towards a purpose higher than self that Lee personified that for me defined Lee and defines 
Lee's and my experience with him and I think the experience of a lot of people here. There's a 
lot of people at the cancer center that are here because of Lee, either directly or indirectly. 
Because of that culture and a lot of those traits that they see or that they want to emulate in 
some small way. 
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Theodore (Ted) J. Couch, Sr.  
There was likely no one closer to Moffitt in all things MCC than Ted Couch. Couch, a former 
Tampa banker and businessman, served as the Chairman of the Board at MCC and subsequently on the 
executive committee and the parent board of directors. A term of endearment often used to describe 
Couch was “salt of the earth.” Couch was a low-profile, quiet, thoughtful and dedicated driving force in 
the growth and success of MCC. He was smart and could process a lot of information, formulate a plan, 
get it moving and accomplish an enormous amount without drawing attention to himself. Moffitt 
trusted him implicitly. Couch reciprocated with commitment and attention to detail. Couch had a 
responsibility to the institute as a whole while, at the same time, he always understood the founder’s 
vision. 
The way I got involved was, of course, Lee Moffitt. I met Lee through a partner that I had that 
owned the Holiday Inn on Fowler Avenue (in Tampa). And so I was introduced to Lee about the 
time that he was a House Member, actually, prior to him becoming Speaker, I got to know him 
much better after he had become Speaker. 
Everybody knows about Lee. He's determined, when he makes up his mind that he's going to do 
something, he doesn't let anything distract him. He pushes until he achieves his goals, and his 
goals are already, always, or for the most part anyhow, right on target as to what the needs are. 
And in addition to that, he's just an amazing person to work with, as long as you understand 
what his position is. 
Moffitt Cancer Center is probably the greatest thing that has been accomplished in Florida in my 
lifetime, and I'm 82 years old. It's all through the genius, I would say, of Lee and his compassion 
for others who he knew at the time were suffering from cancer but had to go out of state in 
order to get superior treatment. He wanted to remedy that, knowing that the state was growing 
at the rate it was growing. The fact that we have as much sun exposure here makes sense I 
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guess even more. What would you say? Eligible for cancers, or at least skin cancers. So that was 
his motivation to attempt to get the funding to build a center.  
Lee had the motivation to see that a center in the state of Florida was built as he was Speaker, 
and he had the influence to be able to push decisions like this. So his inspiration led him to 
secure, through the leadership sponsorship, for I think it was like 60 million dollars at the time, 
to be dedicated to building the cancer center on the campus of the University of South Florida. 
I think what he's accomplished, it speaks for itself. Going all the way back to the time that he 
was in the legislature. The fact that he was probably one of the youngest Speakers of the House 
that Florida has seen, and the fact that he could actually make a Moffitt happen. Because when 
you look at Moffitt, what it's accomplished over 30 short years is just nothing short of incredible. 
Matching up to other NCI centers around the country. As a business person, I think with his style 
and his brain power, his ability to be able to stay focused, he could have been a very successful 
businessman. And fortunately for us, he channeled all this into service for others. 
I've been around (MCC) for 33 years. The one thing that I really am grateful to Lee for, Lee, at a 
very young age for me, taught me that you can give, even if it's a stretch because that's when he 
enticed me into funding a chair in cancer research at the University of South Florida at the time 
that he was attempting to get the funding to build the center. At that time, I had not had a 
record of giving. It never occurred to me that I could or should be giving. And so he taught me 
that I can make a commitment and that I can honor the commitment, and from that time on, 
I've been making commitments in philanthropy ever since. And it's probably the best thing that 
I've ever learned. It's certainly made a good life for me. 
Four people who were close to Moffitt early in his life and career, through their words, give 
insight into the person from both a human and professional perspective. They have known and 
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observed the man from multiple perspectives: his strengths, weaknesses, drive, ambition and purpose. 
Their relationships began before the cancer center existed and they journeyed with him throughout.  
Professional Insights  
The people who have worked with Moffitt in only a professional setting also have unique 
insights into the founder. Their relationships are, for the most part, professional and based on progress, 
discovery, care, treatment and success of a single institution. Many people were involved, associated 
with, or governed MCC for extended periods of time. Since MCC had been treating patients for only 32 
years, a high number of doctors, researchers, clinicians and executives had experience in other 
renowned institutions prior to joining MCC. Thus, an additional asset was the experience brought to 
MCC from previous cancer centers and businesses. That said, it took a bold person to leave the comforts 
of a known, reputable organization and move to MCC. The culture, mission and mindset were ingrained 
by the founder and the people who were entrusted to lead the institution early on.  
Many of these leaders also add insight into the founder and how the culture was solidified. 
Throughout the following section, Moffitt’s vision, determination, passion and commitment were made 
clear.  
The Hon. Connie Mack III 
Former United States Senator Connie Mack (R-FL) served in the US Senate from 1989 to 2001 
and in the United States House of Representatives from 1983 to 1989. A banker by trade, he served as 
president at a small community bank in Lee County, FL, prior to entering public service. Mack was the 
grandson of legendary baseball player and manager, Cornelius McGillicuddy (Connie Mack) of the 
Philadelphia Athletics (then the Oakland A’s).  
When Mack was a young man, his brother Michael was diagnosed with melanoma, which was 
treated and remained in remission for a decade. At age 35, Michael died of melanoma. Mack recalls that 
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defining event as a significant motivation for seeking public office. Over the decades, Mack’s family was 
impacted greatly by cancer.  His father, mother, wife and daughter all experienced the disease. Mack 
himself was diagnosed with and treated for melanoma while serving in the Senate. While serving in the 
Senate, Mack wanted to impact cancer research and treatment. The National Institutes of Health (NIH) 
oversees numerous health related departments/agencies, including the National Cancer Institute (NCI). 
Mack had a vision of doubling research funding at the NCI to enable more scientists to focus on these 
diseases. The Congress is a representative body that acts and reacts to influences in their districts, 
nationally and internationally. Advocates for heart, lung, diabetes, HIV, Alzheimer’s and numerous other 
diseases were interested in increased federal funding as well. Mack realized that increasing/doubling 
funding for NIH, as opposed to just the NCI, would provide collective support to influence the 
congressional budgetary process. That coalition was successful.  
Nearing the end of his second term in the Senate, Mack made the decision not to seek a third 
term. As he was winding down his tenure in public life, Moffitt approached him about serving MCC on 
the board. 
I wouldn't have spent 17 years at the Moffitt Cancer Center if it hadn't been for Lee. Lee and I 
spent some time together not long after I announced that I wasn't go to run for re-election to 
the Senate. We had dinner together. Lee was just wanting to know a little bit more about why I 
was doing what I was doing with respect to cancer research and doubling NIH. I think both of us, 
even though we were representatives that came from two different parties, we had a mutual 
respect from day one.  
At some point, and I don't think it was that night, but at some point Lee said to me, "We'd like 
for you to join the Board at the Moffitt Cancer Center, and because I know you're the type of 
person who doesn't just want to be another member of the Board, we'd like you to be Chairman 
of the Board." So, I jumped at the opportunity because it fit right into the way I kind of saw my 
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future after getting out of politics and being involved more in cancer research and cancer 
treatment was exactly what I was interested in doing. 
The experiences and the drive to impact the fight against cancer bonded the two men. While 
having the stature of a general, Mack was also a soldier in the war. Moffitt realized that and recruited 
him to serve. Moffitt identified and recruited like-minded people, not political but in mission, to serve as 
leaders, to become part of the MCC community and mission. Mack saw in Moffitt the qualities and 
commitment of an individual who enticed free thinkers to lead and advance the cancer center. 
Lee, being the type of person that he is, it was very clear what he was trying to accomplish, what 
role he thought that I could play in helping that come about. His commitment to continue effort 
to expand the resources for the Moffitt Cancer Center. I love the guy. He really has made a 
difference. So, how do you sum him up? Passionate, determined, committed, focused, visionary. 
There's a saying "enthusiasm is contagious." His leadership style is kind of based on that. He's 
not a rah-rah type, but his actions speak louder than words of his commitment. And because of 
that, he can draw others into what he's trying to accomplish. 
Timothy (Tim) J.  Adams 
Tim Adams was the Chairman in 2018, after serving 26 years on the MCC board. Adams was a 
retired executive from Time Warner Customer Service.  
I'd come to town and I'd just assumed a leadership role at Time Customer Service. And my 
predecessor had engaged Lee as a lobbyist, and so we met that way. And an opening came up 
on the board; I was 30 at the time. I think Lee wanted to recruit some young folks, so that's how 
I ended up here. 
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Adams had a front row seat to the rapid growth at the cancer center and had participated on 
the board for a great portion of his career. Adams was a Moffitt disciple and understood the founder’s 
passion, motivations and drive.  
If we didn't have that singular focus, or we let ourselves get distracted, I don't think we'd have 
come this far this fast. It all starts with Lee obviously, and the vision and mission. So particularly 
the vision and mission, I think, which sprung from Lee. Lee had a lot to do with recruiting of 
leadership both on the boards and management that agreed with the vision and mission.  
I think Lee is extremely unique, and I don't know of anybody else who's built something like this 
from scratch. I don't know the Facebook guys and the Google guys. But if you think about what 
Lee's done, it's really been determination and perseverance, but the really cool thing is, he 
pretty clearly early on realized, "This is how I can help the institution." By making sure 
everybody keeps focused on mission and doing his things with the legislature that he does. And 
he also realized, "There are things I can't help with" and surrounded himself with people with 
pretty unique skills.  
Adams appreciated the thought process that Moffitt possessed and learned over his years on 
the board that knowing what you know and knowing what you don’t know is vital to organizational 
success in business. Even at a non-profit, where success is not based on bottom line market share or 
stock value, Adams knew that MCC’s success depended on smart and successful people, working in 
tandem for a singular purpose. 
Look at the founding set of board members. They all complemented one another and had 
different skills, and I think it takes a big person to say, "Here's what I'm good at and I'm going 
pursue that. And here are some other things that I'm willing to cede control to other people to 
benefit the institution."  
I think the recruiting, the keeping the institution focused on mission, and then obviously, the 
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stuff in his wheelhouse that he's done remarkably well over the years, really distinguish him. A 
lot of founders, I think, would be unwilling to cede any control to anybody. Lee did a wonderful 
job of saying, "Here's the kind of talent I need to bring in to push this place along."  
Edward (Ed) C. Droste 
Ed Droste was one of the significant examples of how the adopted mission passed from hand to 
hand. Droste was a successful business man who owned and operated a large real estate management 
company. He also was one of the founding members of the Hooters restaurant enterprise. Droste had 
an accomplished career, acquiring wealth and notoriety.  He didn’t need to work or devote his time to 
philanthropic activities or organizations, but he did both.  
Droste had gotten to know Sen. Connie Mack in the early 1990s and became politically active, 
supporting candidates and causes that piqued his interest. Mack had come to know Droste as a capable 
and personable individual with business acumen accompanied by focus and determination. As Moffitt 
recruited Mack, Mack recruited Droste. Droste served as the Chairman of the Moffitt Foundation Board 
and as a member of the Executive Committee, making him a member of the MCC parent board.  As 
Droste immersed himself in the MCC foundation, his relationship with Moffitt grew. 
Having been around Lee a lot, I'm amazed at some of these visions. We have a lot of restaurant 
concepts that take off, but one vision ended up somewhere else. They're successful but very 
dissimilar from what the original goal was. Moffitt, to me, obviously exceeds Lee's wildest 
dreams and the legislature's wildest dreams, but I think to be the superior resource and 
alternative for Floridians initially and nationwide, they've achieved that in spades. 
When you say visionary, that comes with the thing that he sees what he wants this thing to be, 
that light on the hill. Whether it's in a legislative session on how to present a position, they 
better follow this way because he's got a vision of how that's going to be accomplished. But I 
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think it's good. He's not only the pioneer that led the troops over the hill, but he's also the 
standard.   
He's a pretty demanding leader. But from where I sit, I see him as a tremendous addition to 
meetings, to groups, whether it's a fundraising event or a strategic session where our sleeves 
are rolled up and it's a five-hour meeting and we've got to come to some decisions. He and 
Connie Mack are very similar, I think, (they) bring that statesmanship type of diplomacy, but a 
razor sharp focus on some of the priorities and some of the strategies. It's fascinating to watch 
them work. 
Significant commentary regarding the founder has already been stated, however, MCC’s 
executive leadership added additional perspective.  
Alan F. List, MD 
Dr. Alan List served as CEO of MCC beginning in 2012. Prior to ascending to CEO, List was MCC’s 
Physician in Chief.  A malignant hematology doctor, List had been recruited to MCC from the University 
of Arizona where he led the blood and liver transplant program and leukemia program as Associate 
Center Director for Translational Science. List continued to practice medicine and conduct research 
while serving as CEO. 
List was one of the experts in his field that came to MCC from a university structure, conducting 
treatment much differently than the MCC model. It can be difficult for faculty to adjust to an 
interdisciplinary model of treatment from a departmental structure that the vast majority of university 
medical programs followed at the time. But List was a believer. He was like-minded in that the structure 
and delivery of care as organized by MCC far exceeded the standard of care in other institutions. List 
concurred that the founder was the early, present and continuous driving force. 
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Lee is a guy who's highly motivated, highly focused, and definitely goal-oriented. Initial 
motivation came from losing friends that had cancer and his own experience personally. But to 
lose such close friends over a short period of time really is what struck him. Lee is someone 
{who}, once he gets started with something no one's going to stop him. He pushed and pushed; 
he had a lot of resistance, but he had the fortitude and the vision to see this through, and 
certainly made it a reality. Still, obviously, very much involved and this is his baby, he wants it to 
succeed, and obviously still influences things today. He's the founding father. The good thing 
about Lee is he's still visible, comes in not just in the C suite but he's in through the hospital, the 
clinics, so when staff see him they want to talk to him, they want to meet the founder.  He is the 
inspiration for a lot of the staff here. And the other thing about Lee, thinking back to when I first 
met him, he's truly a statesman.   
William (Bill) S. Dalton, PhD, MD 
Dr. Bill Dalton served as MCC’s second CEO. Dalton is a researched-based physician, which is 
why he placed the PhD before MD in his title. Dalton had served as Associate Center Director for Clinical 
Research from 1997 to 2001. He served as Dean of the University of Arizona School of Medicine for a 
short period before being recruited back to MCC to serve as CEO from 2002 to 2012. In 2012, Dalton 
transitioned to CEO of M2Gen, a for-profit subsidiary of MCC.  
Dalton, like Moffitt was a force to be reckoned with. Not a gentle leader, Dalton had a 
commanding presence and a forceful leadership style. In passion and drive, Dalton and Moffitt had 
equally strong personalities, like two alpha dogs in the same space. While the personality makeup of 
both could, and at times did, lead to the clash of the titans, both men had an appreciation for the 
other’s commitment and sense of purpose. 
51 
 
I remember the first time I met Lee Moffitt. I had not yet decided to join, was visiting and the 
passion in his eyes about why I needed to come here was captivating. And I had never seen 
anybody... I work with a lot of passionate people. There was an intensity with that passion, 
wanting to do the right thing and he is a driven, committed person, who is also transparent 
about what he is trying to do and how he is trying to do it. And I think the whole idea of creating 
an instrumentality of state was masterful, so he's brilliant in that regard. 
When asked about Moffitt’s leadership style, Dalton responded: 
You don't have an option. When he says you're going to do something, we're going to do it, 
which I appreciate. His leadership is, again, captivating. You want to be part of it. And there is no 
other choice. 
G. Douglas (Doug) Letson, MD 
An orthopedic oncology surgeon, Dr. Doug Letson served as EVP of Clinical Affairs, Physician in 
Chief. Letson joined MCC in 1992. Known for his innovative medical thought process and subsequent 
surgical innovations, Letson appreciated and respected the design of medical delivery at MCC. He was 
one of the early physicians who worked to define interdisciplinary care, a model of care based on 
disease site/type and not by individual departments of surgery, radiation etc. Letson also appreciated 
the founder, having worked at MCC for a long period of time and developed a personal and professional 
relationship.  
His internal energy, his drive, and his expectation of perfection, when you begin with H. Lee, and 
once you know him, you know that he wants nothing but the best for patients. Lee is a, first of 
all, a very, very caring human being. He cares about people. He cares about not only the patients 
that are here; he cares about all the employees that work here, and that's not something that 
you can teach. That's not something that is learned. That is his internal heart that comes out. He 
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wants this to be the best cancer center in the world, and he's driven every day to find out ways 
that he can help this cancer center succeed in being one of the best cancer centers in the world. 
He leaves no stone unturned.  
He's driven for the best care, and he never settles for average. I remember when we first 
obtained a US News and World Report (ranking) of (number) 6 (cancer center in the country), 
which is the highest we've ever been rated. I was talking to him over the phone, and being in the 
physician in chief, I was pretty proud of getting up that level. When I talked to him he never 
applauded number 6. Even though down deep inside he was happy, but what came out was how 
do we get to five? How do we get to four? How do we get to three? It's always pushing the 
needle forward, and how does he get to that next level? And that's what I loved about him, and 
that's what I appreciated about him, because you know that, yes, you've accomplished 
something, but you can't stop and wait and say, "Okay, pat yourself on the back." We still have 
so much more we can do, and so you keep pushing forward.  
You don't want to displease him. You don't want him to be unhappy with anything, and so you 
work so hard to help him live his vision and help him accomplish his vision. And even though his 
expectation is so high out there that it's almost impossible to reach, your drive is to continue to 
get there, and it's kind of like the Vince Lombardi approach in the way I look at things. And so, 
Vince Lombardi, in his football, your goal is perfection. You want to have perfection in every 
play.  
Lee doesn't want to be patted on the back, and he doesn't want to be able to be the face of any 
of that. He's all about outcomes, and so he wants to influence the outcome, but he doesn't want 
to be the one taking any credit for anything that's going on.  
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John (Jack) A. Kolosky, CPA, MBA 
Jack Kolosky served as EVP, Chief Operating Officer (COO) and President of the MCC Hospital. A 
CPA by training, Kolosky joined MCC in 1999 from Georgetown Medical Center in Washington, DC. 
Previously he served as Associate Vice President and Chief Financial Officer of the University of Texas 
M.D. Anderson Cancer Center in Houston, TX. 
Kolosky had executive experience through MCC’s rapid growth and worked with leadership and 
the board to ensure a steady bottom line. With his experience from other institutions, Kolosky brought 
significant healthcare, specifically cancer care, experience to the cancer center. In his many roles at 
MCC, he had the opportunity to interact with founder on financial and operational issues.  
The words I always use about Lee is that he's a force of nature. When people said that we didn't 
need a cancer center, Lee persisted and achieved it. 
I think that Lee's leadership…he brought on a good, smart board in the early days. Lee would say 
this himself, I think, that he didn't know everything, but he knew other people who knew a lot of 
things that would really help. I think those board members really put the foundation in for the 
future success of the cancer center. Lee contributes mightily to the mission and growth of the 
cancer center. Even though it's probably infinitely larger than even he thought {it} could be at 
that time. 
When I walk the hallways and sometimes people will see Mr. Moffitt, the first thing is they'll be 
amazed that he's here, and he's around, and he's active in there, because so many places that 
are named after somebody, the person is no longer around.  
Yvette Tremonti, CPA, MBA 
Yvette Tremonti served as EVP/Chief Financial & Administration Officer. She joined MCC in 1996 
and has served in numerous positions including Vice President of Human Resources. Prior to joining 
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MCC, she worked for Earnst & Young. Tremonti’s experience overseeing HR at MCC gave her a front row 
seat to the type of people leadership and the board recruited to the center. Adopting the vision and 
forward-thinking mindset of the founder, the board and executive leadership, Tremonti helped to land 
some of the best and brightest scientists, physicians and staff that would impact MCC’s success.   
The vision of one person is how it started and I think that person's vision has been so big that his 
involvement, Mr. Moffitt, such that he is never satisfied. 
Lee is definitely a visionary. I think to have this place be what it is today, when it was a vision 
and not even out of the ground a little 30 years ago is amazing. So, I definitely think he is a 
visionary, I think he is strong-willed and because of that has just continued to push us as an 
organization to just continue to be better, so that we can be a resource for the organization and 
I think he is passionate about this organization and what it stands for and what it does as far as 
providing cutting edge care for patients. And I think he is a tireless advocate for the 
organization, as well. 
The Hon. William (Will) W. Weatherford 
One final perspective from a former elected official who came to understand and appreciate the 
focus on cancer research and care as well as the mission of MCC, “…to contribute to the prevention and 
cure of cancer.” Former Speaker of the Florida House of Representatives, Will Weatherford (R-Wesley 
Chapel) became a warrior for MCC. Weatherford not only represented a geographical area near MCC, 
but his family had also been touched by cancer, a brother died at a very young age from a brain tumor in 
1995.  
During his tenure as Speaker of the House (at the time, the youngest serving Speaker in the 
country at 33) Weatherford was a bright, energetic legislator with a fondness for innovative and 
entrepreneurial thought. He understood that MCC was a special place, not only in his region but well 
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beyond. He visited the center numerous times and formed relationships with the CEOs (Dalton then List) 
and other senior executives. He had known the founder for a number of years, beginning when 
Weatherford was a staff member in the Florida House. True to form, Moffitt had talked with 
Weatherford often about the cancer center, its growth, innovation and its needs, specifically capital for 
building and expanding to meet patient demand. Weatherford got it. Throughout his tenure, 
Weatherford helped to secure nearly $400 million in cigarette tax revenue for MCC’s expansion needs. 
That revenue source, paid annually over a period of time, allowed MCC to bond to build a new 
outpatient facility. Weatherford was a believer and appreciated the way MCC focused on cancer and 
attracted talent and grant dollars into Florida. 
If you grow up in Tampa Bay, which I did, I moved here when I was, I guess it was 1987. From a 
timeline standpoint, pretty close to the infancy and the beginning and the genesis of the Moffitt 
Cancer Center. If you grow up here, it's kind of hard not to know what Moffitt Cancer Center is. 
Some of that's because just the brand is recognizable. The other part of it is, typically you know 
someone who has had cancer and unfortunately everybody has experienced it in some way, 
shape or form with family member or friend. So just knowing that Florida and more specifically, 
Tampa had a cancer center, I knew people who had been treated there and just living in this 
community [I] had driven by the campus a few times and knew it was there. 
Didn't know who Lee Moffitt was, didn't know the history behind it really until I got involved in 
the political process. It kind of morphed and my first job in politics was working for Allan Bense 
(R-Panama City) who was the Speaker of the House for 2004-2006. I was his legislative aide and 
you are there to kind of field a lot of meetings, some of which you're sitting in with the Speaker 
of the House, some of which you're just taking meetings that he can't attend. So Lee Moffitt, as 
he does, darkened the hallways of many people's doors in Tallahassee, kind of showed up 
unannounced. As the former Speaker, there is a long-standing tradition that you always make 
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time for Speakers, but I believe Allen was on the floor of the House at the time and couldn't 
come off the floor so somebody said, "Hey, could you go meet with Lee Moffitt?" And I said, "Is 
that the Moffitt of the Moffitt Cancer Center in Tampa?" And they said, "Yes". So I said, "Sure, 
I'd be honored to do that." So I walked out and, "Hey, Mr. Speaker."  
And we came in and he was working on the budget for Moffitt Cancer Center and wanted to talk 
about some of the issues that were facing it that year and I just sat there for the first time and 
listened to Lee tell me what was going on at the Cancer Center, what they were doing and really, 
for the first time, getting an understanding of the history. He actually took the time to walk me 
through. He said, "Hey, do you know much about us?" I said, "No." Where you from? I said 
Tampa. He said, "Well, you should know about the history of the Moffitt Cancer Center." And he 
walked me through the history of the cancer center. And that was my first... that was a long way 
of saying that was my first knowledge of the Cancer Center in its truest form and really to 
appreciate what had happened from my childhood to that point when I was 25 years old and 
how this cancer center had grown to be such a preeminent research and treatment facility. 
H. Lee is a person who was a political mentor to me and a friend. His scrappy, never-say-die, 
persevere, grit persona is throughout the DNA of that institution and it would not be what it is 
today if it wasn't for that grit. I think that Lee was the catalyst for it but because it is in the DNA, 
everybody who is there has it to a certain extent. You kind of sense it when you talk to the 
employees. Doesn't matter if it's government relations, or you are talking to the CEO, no matter 
who I talk to, you get a sense of purpose and a sense of grit with the employees and the leaders 
at Moffitt. I think that started with H. Lee and it has worked its way all the way up. 
Weatherford, like others, understood and appreciated that the founder could have a disarming 
demeanor in social settings. However, when focused on a particular outcome, central to the center’s 
future, Moffitt was all business and didn’t particularly tread lightly. Referring to his leadership style: 
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It's not always soft. Lee will never be remembered for perfect bedside manner or his soft-
spokenness or being a shrinking violet. This is a guy that, if he has something on his mind, and 
he feels really strongly about it, you are going to hear it. And it doesn't matter if you are the 
governor of the state of Florida, it doesn't matter if you are Speaker of the House, it doesn't 
matter who you are, he is going to tell you what he thinks. And he's going to fight. I can't 
remember how many times I would tell Lee over the years, "Lee, it's just not going to work this 
year. Let it go." And then he would come back two days later and pulled something out of the 
ditch in some committee in the Senate and it was back on again.  
It was always amazing to me that he had that personality to not cave. I was too young when he 
was Speaker of the House. I wish I could have seen it. I have read about his tenure. It was a very 
successful tenure because he worked well with his counterpart. His ability to lead through sheer 
force. He's smart, he's strategic, he thinks things through, he's playing the angles, he's 
triangulating, but he just won't go away. 
There is something to be said for a guy that just won't go away. It's like a Rocky Balboa 
mentality. You just keep punching me in the face but I am going to keep getting back up and 
eventually, you are going to wear out. Speaker Moffitt has an ability to just keep fighting. When 
everybody else is tired, when everybody else is punched out, his leadership style, it's like he 
makes up for whatever shortcomings you may think of or come up with {of} his and there aren't 
many, he makes up for all of them with just his grit, his desire, his unwillingness to relent and I 
think that is a very rare trait in today's world and in politics. That's what makes him great. 
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CHAPTER 5: TRANSFORMATIONAL EVENTS 
 
Introduction: Transformational Events  
Moffitt Cancer Center (MCC) began as a statutorily-designated direct-support organization 
(DSO) to the University of South Florida (USF). The Florida Legislature first appropriated start-up funds 
for the proposed hospital in 1981, and in 1986 MCC began serving patients. In 2018, MCC was the only 
National Cancer Institute (NCI)-designated Comprehensive Cancer Center (CCC) based in Florida, 
providing interdisciplinary care to annually treat more than 64,000 patients from all 50 states in the U.S. 
and more than 130 countries, and employing more than 6,100 faculty and staff.  
 
 
 
 
 
 
 
 
Figure 3. Depiction of Four Transformational Events  
 
Since its inception, numerous leadership figures and decisions influenced MCC’s culture, growth 
and success. Chapter 5 digests and interprets the interviews to identify their commonalities (and in 
some cases differences) with which to make sense of MCC’s evolution. This chapter begins with a short 
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case study to set the stage. Next, four specific events are addressed: 1) 1990 Legislation, 2) 
Interdisciplinary Care, 3) CCC and 4) Moving Faculty to MCC. These are events that the interviews 
indicated re-directed and/or transformed MCC in material and often unexpected ways (see Figure 3).  
A Brief Case Study 
Monday, April 16, 1990 was a spring day in Tampa, Florida and the H. Lee Moffitt Cancer Center 
and Research Institute Board of Directors meeting was scheduled at 9:00 AM.  Springtime in Florida also 
meant that the Florida legislature was in session in Tallahassee, FL. During the 1990’s, the legislature 
normally conducted its annual legislative session from the first Tuesday after the first Monday in March 
for a period of sixty days, concluding near or in early May.   
H. Lee Moffitt (Moffitt/the founder), the founder of Moffitt Cancer Center (MCC), served on the 
institution’s Board of Directors. Moffitt was a member of the Florida House of Representatives from 
1974 through 1984, ascending to the position of Speaker of the House during his final two years in the 
legislature. It was during his time leading up to and serving as speaker that the legislature passed 
legislation creating a cancer center, codified in state statute, to serve the citizens of Florida.  Originally 
called University of South Florida Cancer and Chronic Diseases Research and Treatment Center, Inc., the 
center was designated in statute as a direct-support organization (DSO) as defined in chapter 240.299 of 
Florida Statute. At that time, MCC had minimal control over its growth, direction and governance. The 
original structure mandated that the president of the University of South Florida (USF) and the chairman 
of the Board of Regents (later the Board of Governors), or designee, serve on the board, and reporting 
requirements were structured through the university. 
Since MCC opened its doors and served its first patient in October of 1986, patient demand 
grew with the state’s accelerating population. The internal leaders and the founder knew that in order 
to achieve the original vision, to serve the cancer needs of the state, the governing structure needed to 
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change.  MCC was actively recruiting a center director who would lead the young institution, 
establishing a significant research operation and working toward the NCI designation as a Designated 
Cancer Center, ultimately seeking designation as a Comprehensive Cancer Center (CCC), the NCI’s 
highest designation for cancer centers. The process of recruiting a nationally-recognized center director 
proved extremely difficult, as the duties and authority of said position were not clearly defined and were 
potentially hindered by the university’s reporting structure.  
Moffitt worked with local legislators to develop legislation outlining, in statute, the duties, 
responsibilities and authority of the center director position. House Bill 2899 (HB 2899) was filed by Rep. 
James Hargrett (D-Tampa) and Senate Bill 1498 (SB 1498) was introduced by Senator John Grant (R-
Tampa). The proposed legislation designed a new structure that would make MCC a self-governing 
institution and shift power away from USF.  
Tensions were high. The faculty submitted a letter in opposition to the legislation but MCC’s 
founder and others pressed forward. A board vote on proceeding with the legislation was on the agenda 
for the morning of April 16th.  According to the minutes, eight members of the board were present, 
including Moffitt (likely via phone).  Six members were absent. After a short meeting approving previous 
minutes and agenda items, it was moved and seconded to adjourn to executive session at 9:15 AM. In 
executive session, a vote to adopt revised Moxley Principles and Policies passed 5 to 1, with H. Lee 
Moffitt abstaining. 
The minutes simply stated, “After discussion, the flowing motion was proffered.” Motion: “Mr. 
Speer moved to recommend the passage of House Bill 2899 related to the governance of Moffitt Cancer 
Center: Mr. Smith seconded the motion. The motion failed with four dissenting votes and three in 
favor.” The university had won a battle.  
What would H. Lee Moffitt do now? The former Speaker of the House and founder of the 
institution was stifled, prohibited by a vote of the board from pursuing the legislation that he knew 
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would set MCC on a path of self-governance, independence and growth. His board had spoken; he was 
on the losing end and it was over for that legislative session…or was it? 
Setting the Course: People and Decisions 
The research conducted for this project centered on twenty-one interviews with people 
involved with the evolution, growth and success of MCC’s first three decades. Interviewee bios are 
included in Appendix C. Chapter 4 illustrated the personal and professional traits of the founder, H. Lee 
Moffitt and the institutional history; creation, early challenges, growth, space constraints and adoption 
and adherence to MCC’s mission. He served as an inspiration throughout the organization’s history. This 
chapter focuses on the findings regarding the transformational events that set MCC on a successful 
trajectory based on influential leadership and landmark decisions. While it was at different times that 
leaders served and that decisions were adopted, all were interrelated and committed to achieving the 
institution’s mission “…to contribute to the prevention and cure of cancer.” 
People 
Leaders at the executive and board levels were instrumental contributors to the advancement 
of MCC. The visionary leadership attributes of MCC chief executive officers (CEO) and board chairs not 
only moved the institution towards growth and success but also developed a mission-driven 
organizational culture that remained a fundamental part of MCC’s DNA.  While a countless number of 
people helped to advance MCC over the years, the innovation and impact of certain leaders were 
notably recognized through the interview process. These groups, CEOs and board chairs, exhibited the 
dynamic visionary leadership that contributed to vital actions at key junctures and made MCC the 
mission-driven institution it became. The imprint that CEOs and board chairs left on MCC helped to set 
the organization on its path to be a highly-regarded institution of transformational change. 
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Decisions 
The interview data collected for this research showed that decisions made regarding four 
transformational events had a great impact on MCC’s first 30 years. Each decision, adopted by the board 
and/or leadership, led to a transformative event that set MCC on a course that has positively impacted 
patient treatment, research in the fight against cancer, reputation and the business bottom line. The 
first event was the pursuit of legislation to enable independent governance over the business, medical 
care, research and education endeavors of the institution. The second was the creation of an innovative 
model of interdisciplinary care, whereby department organization centered on disease site, not 
individualized departments based on training and practice expertise. The third event was the decision to 
design and achieve CCC status, the highest-ranking award by the NCI. The fourth was resolving to bring 
the physicians and researchers, faculty, in house and forming the Moffitt Medical Group (MMG) and 
Moffitt Research Institute (MRI). Chapter 6 later describes that these transformative events were not all 
explicitly noted by interview respondents, but rather were identified as important decisions that 
transpired into transformational events which ultimately became part of the MCC legacy and propelled 
the cancer center forward based on several common themes observed across interviews. 
Leaders, Culture and Imprinted DNA 
Leadership personalities, descriptions and decisions would be incomplete if not incorporated 
with the types of individuals chosen to run the organization. The interview process revealed certain 
common attributes of leadership inherent in the institutional prototype. MCC CEOs and board chairs 
were instrumental actors in the organization’s evolution. They led the organization in the right direction 
at the right time, and showed dedication to advancing the beliefs, values and principles representative 
of MCC’s mission-driven culture.  
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The three CEOs, Ruckdeschel, Dalton and List had individual leadership styles but a similar 
mentality as to moving the institution forward: innovation, commitment, cause and mission. Each 
served crucial roles at critical times in MCC’s evolution. An aviation analogy: prior to Ruckdeschel’s 
hiring under the new governance structure, Nick Porter taxied the plane down the runway, Ruckdeschel 
took it off and ascended to 10,000 feet. Taking the helm, Dalton spirited the plane to a cruising altitude 
of 30,000 feet and List flew it across the country. Each leader made progress in his time, having left 
indelible fingerprints on the progression of institutional growth and success.  
The chairs of the board, in similar fashion, were driven by mission and they led not with iron 
fists, but by appreciation of the team of brilliant innovators who surrounded them. To quote Apple 
founder, Steve Jobs, “It makes no sense to hire smart people and then tell them what to do. We hire 
smart people so they can tell us what to do.” The board’s responsibility was to enable a similar mindset 
at MCC. The board chose leaders who unlocked entrepreneurial spirit and innovative corporate, 
business and care structure. In addition, the board gave executive leadership freedom to hire like-
minded individuals. The board sought not to manage daily operations but to empower those they chose 
to lead. While the board was responsible for advising, setting certain goals and making sure the 
institution was fiscally stable, the leadership choices reflected the passion and commitment initially 
instilled by the founder. 
Nick Porter, former EVP and COO spent nearly two decades at MCC on staff, and later served on 
the MCC Hospital Board. Porter was an institutional icon who observed board and executive leadership 
challenges and successes for nearly 20 years.  
Ruckdeschel clearly played that role early on because of his just unbelievable belief in himself.  
I've never met anybody closer to Trump than Ruckdeschel. Then you get to Bill Dalton who was 
totally driven by science and excellence in science, setting that standard one step higher every 
time he could possibly do it. Then an individual like Alan List who is like a concert pianist, totally 
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accomplished in everything that he can do and he is the kind of people that others can look up 
to.  
Then you have the leadership that came at the chairman of the board level, Ted Couch, who's 
the salt of the earth. Even (Former USF president) Frank Borkowski, you know, bought a certain 
amount. (Former USF president) Betty Castor and others. Frank and Betty were part of the 
university system and the University of South Florida. Ted Couch wasn't, Bob Rothman, Connie 
Mack, and Tim Adams (were not). These are all individuals who just are great leaders…are 
people who are totally dedicated to making sure that the place does what it's supposed to do 
and that makes it a success. Then you got Lee Moffitt who's on every single phone call, every 
single time. 
Porter was the embodiment of instilled mission and regularly spoke of MCC’s phenotype. 
It spent a long time building a culture that was, the way I would describe it is, years ago, you 
would hear the story of the individual at NASA sweeping the loading dock and the reporter 
asked that person, "What are you doing," and that individual said, "I'm putting a man on the 
moon." Well what we tried to do at Moffitt was to have every employee that was walking 
around say, even though I'm pushing a broom, I'm here to cure cancer. That was the focus and 
that's what it was all about. 
You are constantly looking for the right DNA. Not that every person looks alike, thinks alike, or 
talks alike, but just what drives them is what the place is all about. It was a concerted effort both 
on the administrative side, the clinical side and the science side to do that. The scientists were 
picked for their expertise, there was a conscious effort to make sure that these people are good 
people.   
It's kind of like the way NASA was built, it was the way Southwest was built earlier on. 
Companies took the time to make sure that they hired the right people who had the right vision 
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and wanted to be working together. It's like any set of books that are written. In any given time 
people can play a major role in seeing the success of a cancer center happen. 
Very few cancer centers think that way, act that way. Cancer researchers, for the most part, are 
very individualistic. They are not interested in sharing data. They're not interested in 
collaborating. They're interested in being first author on a paper and being the one who stands 
up and announces the new insight into whatever it is. Basic science or clinical investigation on 
their own. Moffitt is exactly the opposite, where it is a group of people trying to get to an end. 
The role of leadership changes with the leader and the leader's philosophy. It's adopting a focus 
and a culture of servant leadership and allowing that servant leadership to spread throughout 
the organization with the understanding of establishing a very strong mission orientation, very 
strong values and you have to support those values and live those values. Make sure that people 
believe in those things, and they believe in them the most when they see the leader doing that 
stuff. The leader absolutely believes in them.  
L. David de la Parte, Esq. served as MCC’s General Counsel externally and then as an employee 
for nearly 30 years. Working from both external and internal perspectives, de la Parte observed nearly 
every success and every challenge. His close association and mentorship under the founder ingrained in 
him the adoption and adherence to the culture set forth by Moffitt and carried on by early adopters of 
MCC’s mission.   
I think you can think about organizations like Microsoft or Google or Apple or Ford Motor 
company and these founders of these institutions, these large, successful historic times 
institutions, businesses, companies, enterprises. There's some very good decisions, choices have 
been made over the years by Lee and others. This place, over 30 years, has had at least a half a 
dozen inflection points where our trajectory could've ended up being flat or downward versus 
up. And the selection by the board of some key management, key executives, key scientific 
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leaders have just been critical. And those inflection points again being inflection points to 
continue a growth and success versus stagnation or decline. 
I'll throw out some names early on, Jack Ruckdeschel, really our first center director. The kind of 
talents that Jack had, his boldness, his passion and compassion for patients. His fearlessness, his 
leadership. Bill Dalton, a different CEO, a different person with talents but the right person, the 
right CEO for the time to lead us, to lead this place from a management standpoint, from an 
executive standpoint, a scientific standpoint. And now Alan List, just some crucial decisions that 
the board has made collectively.  
A lot of the culture that we have here certainly from an employee/employer standpoint, from a 
patient standpoint, from a management team standpoint is Nick. Nick Porter's transparency, his 
honesty, his sponsorship, mentorship, nurturing of employees, and of his reports.  
There are hundreds of people that have been in leadership, or not in leadership, that somebody 
has chosen well. On the board's side, some early recruits that Lee brought to the board and 
brought to the trailblazing that was done in early years in the battles, the fights, political and 
otherwise.  
Senator Mack was appointed board chair while Ruckdeschel was the CEO and Center Director. 
Mack played a vital role in recruiting Dalton back to MCC, after a brief stint as dean of the University of 
Arizona Medical School, to serve as President, CEO and Center Director. Mack served on the board into 
List’s tenure as well. He had keen insight into the types of leaders necessary for key periods of growth.  
Jack Ruckdeschel was exactly the right person for Moffitt at the time he came. His job was to 
make sure we received the designation of a national comprehensive cancer institute. He did 
that. And as I've said about others before, like with (former) Speaker (of the U.S. House of 
Representatives) Newt Gingrich. Newt is the kind of guy that if the objective was to take the hill, 
he came up with the strategy or the tactics to take the hill. 
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Bill Dalton, was center director for probably 10, 12 years. I think you would have to give Bill a 
tremendous amount of credit for what has happened at the Moffitt Cancer Center. Alan List and 
Tom Sellers following on. These are really top flight leaders.  
You had leadership at every level. You had the board level, the inspiration from Lee Moffitt who 
created the cancer center, and the leaders at the corporate level. Clearly, the leadership team 
that Moffitt (MCC) has been able to develop over the years is a major component of the success 
that has taken place. 
Another long-term participant was Adams. His lengthy tenure on the board, subsequently as 
chair, came with staunch adherence to the code that MCC leadership lived by. He understood the 
decisions that charted MCC’s path and was committed to the formula of ingenuity and mission while 
giving executives, physicians and researchers the space to innovate, create and question existing norms, 
traits learned from his mentor.  
It all starts with Lee obviously, and the vision and mission. Particularly the vision and mission, 
which sprung from Lee. Lee had a lot to do with recruiting of leadership both on the boards and 
management that agree with the vision and mission. Recruiting, keeping the institution focused 
on mission. A lot of founders, I think, would be unwilling to cede any control at all to anybody. I 
really think Lee did a wonderful job of saying, "Here's the kind of talent I need to bring in to 
push this place along."  
All of our CEOs have done something unique. I think they've all been really well suited for our 
point in time when we were where we were. The first CEO (Ruckdeschel) was a very aggressive 
person. It really took that to push us forward, to get the original NCI designation. He may not 
have been such a good post-person, and so Dr. Dalton came in and had the big vision. Now we 
have Alan with a ton of credibility and probably a much better ability to run an organization as 
big as this. Because he's got to cede control.  
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On the board side, you can't leave out people like Ted Couch who, to this day, continues to do 
the hardest lifting we've got here in terms of board work. So there were some giants on those 
original boards, and we just need to keep the talent coming.  
An entrepreneur, business and philanthropic leader, Droste understood how founders and 
leaders can leave an indelible mark on an institution.  
I see mirrors of other businesses I'm in where the founders are sometimes some of the hardest 
people to deal with, because they do have their vision and its tenacity that got them where they 
are. I see that all the time with Lee that he is compassionate, caring, genuine, social, personable.  
It's fun to dream about developing this thing that's going to fight cancer, but when the mission is 
so substantial, you're not walking into a restaurant where you want to make sure your ticket 
times are down and everybody gets a good meal, there’re people going in there, and those four 
valet stations are packed, early in the morning to late at night, every one of them needing help 
and hope. The patients, above all, really set a tone and an urgency whether it's an appointment 
or a lab or anything. Ruckdeschel was a scary guy but I think, at that time, a rebel once in a while 
knocks a few doors down. But a lot of organizations at that stage need that or you sit around 
and plan all the time.  
I was amazed with all the chairman. Bob Rothman had the temperament yet the business 
acumen. Allen List is a fantastic CEO as was Bill Dalton. They all have tremendous skill sets and I 
think that that's a credit to the quality of the talent that the cream does rise to the top because 
it's already such a highly intellectual personable type of management group. If you rise in that 
group, you've got that blend that's so fascinating. You can tell that there's a sincereness there of 
everyone, but a commonality too that's not in every organization.  
Having served as CEO, List had responsibilities of running the day-to-day operations, coupled 
with reporting responsibility to the board of directors. Following other trailblazers, List recognized and 
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understood the complexities of the organization. As a results-oriented physician, List appreciated the 
institutional culture and the committed people around him, starting with the founder.  
Lee is the top and he's the one that made it a reality. But Jack Ruckdeschel and Jack Pledger, in 
that first 10 years or so, they were critical, they moved mountains, they created. They got some 
of the best talent here and provided the support and laboratory space and clinic space that was 
needed. That, I think, was groundbreaking so I'm very impressed with what they were able to 
accomplish.  
Then Bill (Dalton) was here and CEO 10 years. I think when Bill took over, I'm not sure of the 
size, I don't know if it was 1,800 employees or in the 2,000 range, but it's grown dramatically 
ever since to over 6,000. The other people that are key in all of this, Ted Couch is critical. Bill 
Dalton brought a new vision for cancer care. Ted Couch has been quietly behind the scenes not 
only supporting us financially with endowed shares and in other ways as well but has always 
been there as one of the key board leaders. Even to this day he's influencing people, he's 
incredibly effective in influencing other board members, and they all respect him. He's a quietly 
honest individual and with that respect he can obviously influence others. He's been critical. Any 
of our board chairs have been very important throughout the years. Connie Mack, after Ted, and 
remains very influential in helping us. He's been critical as well.  
Bob Rothman has been. He served for eight years and he's been incredibly helpful, he's giving a 
lot of money but also helped us with connections and remains very active. Tim (Adams) has just 
been in his role for the last year and a half or two years, but I think our board has now evolved 
so that it's contributing in new ways. We have a much more diverse board as it relates to real 
world business experience, particularly in biotech and investment, which is something that we 
really needed.  
70 
 
C. Douglas Letson, M.D., Physician-In-Chief and EVP, began his career at MCC in 1992. Dr. Letson 
worked with each of the CEOs and was instrumental in creating an environment enticing physicians 
recruited by MCC. He specifically understood and appreciated the roles of MCC leadership and specific 
junctures. 
I think that there's not one accomplishment that set us off on that course. I think it was a 
progression over time. I think certain things had to occur at certain time periods for us to 
continue to move forward, to get to the level where we are today. We needed different 
leadership at different times, with different styles. I think that if Alan List would have started in 
1990 when Ruckdeschel started, he would not have been able to move that needle to get us off 
the ground because he didn't have that strong personality, and that leadership approach to take 
the risks and chances that Ruckdeschel did. Alan is a very thoughtful individual, that is not a risk 
taker, and that he has to have data for every decision that's made. Early on, we didn't have to 
have that. You needed to have a risk taker, and so I think having Ruckdeschel early on was 
important to move us off that local county approach.  
Then we needed to have somebody that really began to get the research involved. We've been 
so successful because of innovation, and Ruckdeschel was an operation guy. He was not an 
innovator. Although he started us with research and then began the campaign to the 
comprehensive cancer center, that was the leadership of Jack Pledger and the research, and 
that he was able to install the research. But Ruckdeschel didn't have the vision of the research 
and those novel technologies. That's what really set us apart when Bill Dalton came in, that he 
was able to be the visionary, and had this great vision. In fact, we were leading the country in 
some of this vision on how we were going change cancer care, but he couldn't operationalize it, 
and it was really before it's time.  
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All of that was important, because the leadership of the board, between H. Lee Moffitt and the 
other institutional board leaders, were able to see what the institution needed to get to that 
next level. It was the institutional board that realized a change needed to happen every so 
often. I don't think that many institutions would be bold enough to do that. When you've gone 
from nothing to a high level, changing that personnel that's a hard decision. That is something 
that only a very strong board like we've had here is able to see through all that and be able to 
make those changes. 
1990 Legislative Initiative 
The first transformative event, the 1990 legislative initiative, is explained in greater detail than 
the others given that it was somewhat of a starting point that allowed for subsequent key decisions that 
transformed MCC. This legislation enabled independent governance over the business, medical care, 
research and education endeavors of the institution. Had this event not occurred, the course of MCC’s 
growth would likely have been much different.  
The Legislative Process 
The Florida Constitution mandates the structure of state government, including the design and 
length of each year’s annual legislative session. (A Constitutional Revision Commission is appointed 
every 20 years to review the state’s constitution and articles, make recommendations for change and 
write amendments that must be approved by the voters in the November elections.) As of 2018, the 
governing structure of the state (as defined in Article III of the Florida Constitution, contained in 
Appendix D) reflected the federal governing makeup, including the separation of powers: a bicameral 
legislature, House and Senate, an Executive Branch led by the Governor and a Supreme Court. 
The House of Representatives consisted of 120 members representing districts; serving two-year 
terms. The Senate was comprised of 40 members representing distinct districts and serving four-year 
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terms. (In 1992, the legislature passed term limits in Florida, limiting House members to four 
consecutive terms of two years each and Senators to two consecutive terms of four years each. The 
provision did allow for members to seek office in the other chamber or sit out a term and the process 
would renew.) 
The legislature was designed as an elective body of citizen legislators who served each year 
during the legislative session, then returned to their districts and jobs/businesses for the remainder of 
the year. Additionally, by design, legislators received limited compensation for their service. (In 2018 
compensation was less than $30,000 annually.) 
Article III of the constitution called for a 60-day annual legislative session in the state capital, 
Tallahassee, FL.  Section 3. (b) states that the session will begin the first Tuesday after the first Monday 
in March in odd-numbered years, and the same rule applied for even numbered years unless the 
legislature passes legislation stating otherwise (The Florida Legislature, Florida Constitution, Article III).  
While each legislative session is limited to 60 days, unless extension or a special session is required, 
leaders of each chamber, Speaker of the House and the Senate President, designate “Committee 
Weeks” for purposes of organizing committees and subcommittees, hearing proposed legislation (bills) 
in those committees and advancing policy and budget initiatives prior to the beginning of session. The 
number of weeks designated for committees were the discretion of the presiding officer. While normally 
the House and Senate would meet in the same weeks, that was not always the case nor was that 
required by any statute. In accordance with the constitution, the legislature must meet 14 days after 
election for an organizational session wherein the bodies elect their presiding officers and prepare for 
upcoming committee weeks and the legislative session. In an election year, this occurred two weeks 
after the November election. Committee weeks would follow as prescribed by the Speaker and/or the 
President. Often, five to seven weeks were designated for committee meetings prior to the annual 
session. 
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That succinct description of the process was necessary for the purposes of understanding that 
the legislative process was actually longer than the simple 60-day legislative session as prescribed by the 
constitution.  
Moffitt traveled to Tallahassee for nearly every committee week and the legislative session. He 
knew what had to be done in order to pass his legislative initiative. In his opinion, it was vital to the 
growth, independence and success of MCC.  
Each chamber of the legislature designed their own committee structure and appointed 
members to serve on those committees. Committees appointed chairs who ran the committees, set 
agendas and calendared bills to be heard by the committee. Passing nearly any legislative initiative 
required a tremendous amount of work. Committee membership varied in size, depending on 
jurisdiction. Committees and subcommittees could range from a few members on a narrowly-focused 
policy committee to the much larger budget committee. Each member, representing one vote, was 
equally important as the next. Staff too played a prominent role in the process. 
Passing of a Bill  
In order to successfully pass a bill in the legislative process, numerous components had to be 
meticulously executed. First, legislation had to be designed and written in adherence to House and 
Senate rules. The proposed content had to be clearly defined and linked to the proper statues, or 
propose a new statute, and serve a single subject purpose. Each individual bill required a sponsor, who 
submitted the proposal to bill drafting where it was refined/written to conform to the chamber’s rules. 
Once the bill was drafted and accepted by the sponsor, leadership referred the bill to a committee or 
series of committees. (The more committees a bill was assigned to, the more difficult is was to pass. The 
lobbyist terminology for multiple committee assignments was “putting more ‘love’ on the bill,” which 
was not advantageous.) Once a bill was referred to committee(s), staff conducted a bill analysis. The 
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analysis would determine whether the bill met certain criteria, including any fiscal impact to the state 
budget (cost to the state) and/or policy initiatives that were either in line with or counter to the 
chamber’s ideology at the time. Further, the analysis would describe, in detail, what the specific piece of 
legislation intended to do. The staff analysis could enhance the bill’s chance of passage or negatively 
impact it.  
After committee referrals and staff analysis, the bill could be placed on the agenda of the first 
committee of referral. In any legislative session, hundreds or thousands of bills were filed annually. (As 
of 2018, House members were limited to six bills each in any given session while there was no limit for 
senators. In the 1990’s there was no such limitation in the House.) With so many proposed changes to 
Florida law annually, it was impossible to hear every bill in committee, let alone pass them.  
The passage of legislation was a delicate balance of both internal and external pressure. In his 
stump speeches as a United States Senator, Chair Emeritus of the MCC Board of Directors, Connie Mack, 
told his audiences that “government is not a neutral entity” and responded to influences from inside 
and outside the elective body. In essence, Newton’s theory of motion simplified; an object in motion will 
remain in motion until acted on by an equal and opposite force. Legislation, by design, was action. That 
action was supported or opposed depending on policy, ideology, fiscal restraint or any other influences 
such as business competition.  
Lobbyists acted as an external force within the legislative process, representing businesses 
and/or individuals to impact the passage or defeat of certain legislative initiatives. Over the years, 
lobbyists had developed a reputation as trying to influence, or buy through political donations, elected 
official support. As with other professions, such as law, medicine and business, some of the reputation 
was warranted by the “bad apples” who may have stepped outside the bounds of decency. However, 
the lobbying community at the state and federal government levels had become a part of the legislative 
process, representing their client interests and influencing by regular participation in political and 
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legislative activities. There was an old adage the “government can cure you or kill you,” and lobbyists 
worked to make sure the latter was not the case.  
Moffitt, having transitioned from lawmaker to founding board member of MCC and lobbyist, 
knew how the system worked. While Moffitt never received compensation from MCC, and therefore 
was not required to register with the state as a lobbyist for the center, he was MCC’s most prominent, 
present and focused influencer. Moffitt, at the time, was a lawyer-lobbyist representing paying clients 
before the legislature and the Executive Branch. His passion and drive for the center he created was 
always at the forefront of his mind, and he spent a significant portion of his time working on MCC issues, 
including a very important piece of legislation in the 1990 session. 
Once placed on a committee agenda, the bill was heard before the committee of reference, 
discussed, debated and put to a vote. If the sponsor and lobbying entity did their job(s) prior to the 
hearing, the discussion was minimal and the vote was successful. Lengthy debate and numerous 
questions could place a cloud over the bill and diminish the likeliness of passage. The key to good 
lobbying was knowing the vote count prior to the committee hearing, not having to present before the 
committee and engineering a smooth process. While a bill was before a committee, it was also available, 
vulnerable, to the amendatory process. Once a statute was “opened” by a bill, any member could offer 
an amendment that might have been contrary to the initial intent of the bill, making passage difficult or 
negating the original purpose. Awareness of pending amendment proposals and developing strategies 
to contend or counter them was equally as important as the early-stage education and support 
requests.  
Once a bill passed its initial committee, it would move forward to the next committee of 
reference where the same process would repeat. The higher up the committee chain, the more rigorous 
the process. As the session progressed, timing was limited to get bills heard in committee. Additionally, 
76 
 
the higher committees were tasked with passing necessary legislation and budget allocations in order to 
end the session within the 60-day prescribed time.  
At the end of committee meetings, there were always bills that did not make it through the 
process. Even if bills had support and numerous co-sponsors, there was not enough time or support to 
pass everything, even worthy legislation. There was a provision that a bill could be “withdrawn from 
committees of reference” and brought to the floor for debate and vote if it had not worked its way 
through the committee structure. That task, while not impossible, required additional tactical expertise 
and, quite often, agreement from the presiding officer.  
Regardless of how the bill passed through committees and the floor in one chamber, it had to be 
agreed upon by the other. Bills were constructed by the bill drafting staff in each chamber, so while the 
House and Senate versions of the bill were similar, they were not always identical. Once a bill passed 
one chamber, it was “placed in messages” to the other, meaning it was available for consideration in the 
second chamber. If the bill was placed on the calendar, it was brought up for discussion, potential 
amendment, debate and passage. If the bill was amended in the second chamber, it was sent back to 
the first for additional consideration. That back-and-forth process was dangerous in that, in the final 
days of session, the chaotic pace could lead to the bill’s demise due to disagreement between the two 
bodies. If the second chamber agreed on final passage of the bill, after certain parliamentary procedures 
were followed to align the differing bills into one final version, the chamber would vote and pass the bill.  
Once an identical bill passed the House and Senate, it was sent to the governor for approval. 
The governor, within a specified period of time, had the right to approve the legislation and sign it into 
law or to disapprove and veto the bill. Most bills had implementation dates in the legislation or specified 
“upon becoming law.” Florida’s fiscal year was from July 1st through June 30th and a majority of 
legislation passed became law on July 1st of the next fiscal year.  
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The vast majority of bills were passed in the waning days of each year’s session. Therefore, the 
governor did not receive the bills until the legislature had adjourned for the year. If the governor vetoed 
a bill at that point, the sponsor and/or supporting entity would have to wait until the following year to 
bring a new bill before the legislature. There was a provision for special sessions to deal with budgetary 
or other matters wherein, if a vetoed bill was “within the call” of the special session, it could be brought 
back up for an override vote of the governor’s veto. 
A Defining Moment 
Moffitt had served in the Florida House of Representatives, ultimately achieving the prominent 
position of Speaker of the House and was an attorney. He knew the process. Additionally, as a staunch 
advocate for MCC, Moffitt was focused on protecting and developing the institution. He and his allies on 
the board had become concerned and frustrated with the connectivity to the university where the 
cancer center resided. The university controlled the campus, had membership on the board, employed 
the faculty and, in Moffitt’s mind, had a different set of priorities and a different perspective regarding 
MCC’s position and future. 
In its early days as a small hospital, MCC hired the Hospital Corporation of America (HCA) to 
serve as the administrative structure; supplying a CEO, a Chief Financial Officer (CFO) and a COO. After 
three years, MCC hired Nick Porter, EVP and COO at Johns Hopkins in Baltimore, MD, to serve as 
Executive Director. Porter was charged with recruiting an internal, MCC-employed CEO. There were a 
number of obstacles in that endeavor: the short time in existence, lack of reputation, space for 
expansion and new programs and, a huge hindrance, the lack of defined authority that the new CEO 
would have in running the center. The search ended in frustration while pursuing early possible 
contenders. 
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Moffitt had a vision for something far greater than a small cancer center on a university campus 
in Tampa, FL. He wanted the center to serve as a resource for the state, a leading research institution 
and a trusted and respected cancer facility for patients in Florida and beyond. He had an indelible 
memory of his conversations with R. Lee Clark, former Director and Surgeon-in-Chief of M.D. Anderson 
Cancer Center in Houston, TX. 
R. Lee Clarke, years ago, told me of the mistakes he made at M.D. Anderson.  He said that one 
things that you have to do if you’re going to be a successful institution is that you have to 
remove the shackles of the medical school. And the organization of medical schools is not 
conducive to the concept of NCI comprehensive centers where the center director has the 
control he needs to be able to run it.   
If you’re looking at early on, the critical event in my mind … I’m a lawyer, what in the hell do I 
know about cancer centers, hospitals, doctors all of this? … was when I formed a friendship with 
R. Lee Clark at M.D. Anderson.  He was a surgeon.  He wrote the National Cancer Act for Richard 
Nixon.  He created M.D. Anderson which was 40 years ahead us. He had been down that path 
before and out of his sheer generosity and kindness, he took me under his wing and he gave me 
a roadmap that I strictly followed that helped, to a large extent, to get us to where we are 
today. He truly was a visionary.   
Clark told me that we needed to follow the NCI guidelines. We couldn't hire a center director 
because of the fact that the center director had no power. The center director would have to go 
by chance. The center director here at the cancer center would have to go to each one of the 
department chairman and beg for a surgeon or a pathologist or whatever, and didn't have 
control over the space, didn't have any control over the hiring, didn't have any control over the 
money.  
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Others in the founder’s inner circle shared his frustrations with the existing relationship with the 
university. Moffitt knew he had to pass his bill to ensure a clear path forward for the institution he 
created. The interview answers associated with defining decisions for MCC’s first three decades revealed 
that self-governance was paramount. Interestingly, only a few respondents, including the the founder 
and general counsel, referred to the 1990 legislation by name or title. Numerous people, however, 
stated that MCC needed to create self-identity and control, or recalled legislative changes that led to 
MCC’s later state of self-governance. Sen. Mack stated: 
Somewhere along the line, someone told Lee how important it was for the institution to be 
independent, free-standing, which allowed for decisions to be made and actions taken place in a 
very short period of time. Very little bureaucracy.  
MCC’s Center Director and EVP, Thomas A. Sellers, PhD, MPH, added: 
One of the things that he learned from M.D. Anderson was you have to associate with a 
university but don't be married into a single institution. So, M.D. Anderson will always be part of 
the University of Texas system. We don't have that restriction and there was a time in our 
history where that was very helpful in giving us a little more flexibility to achieve our mission. I 
think that was probably the most important one. 
The former Executive Director, retired COO and EVP Nick Porter, was involved with nearly every 
decision in the early years and had his finger on the pulse of internal and university tensions. When 
asked about MCC’s relationship with USF, Porter was not shy. 
A little bit like in the 20 years ago with Ireland and Northern Ireland, nobody liked each other. 
Well, let me put it this way, since the majority of the faculty were USF and the majority of the 
board of directors were non-university related, the board of directors and the chief 
administrative people were relatively steadfast Moffittites and the University of South Florida 
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was, “Hey, this is our cancer center.” You know, “You people are were supposed to do what we 
tell you to do, when are you going to figure that out?” Of course we never figured it out. 
When asked about separating from the university Porter explained: 
Part of it had to do with the requirements that the NCI had in place to become a comprehensive 
cancer center. In order to do that, the center director had to show, in a very formal way, that 
the institution they are involved with would give them the space, the money, you could hire 
people, to accomplish certain goals. The University of South Florida at that time didn't get it. 
They were not willing to make those kinds of guarantees or even begin talks around those 
guarantees. So it became a much more viable way of thinking to think how could we, ourselves 
empower the center director with those attributes and Lee Moffitt being a (former) legislator 
said, well, I think we'll pass a law and we'll put in that law, all those things that are necessary to 
allow a center director to have the authority to actually run a cancer center to the ends of 
meeting the mission of curing cancer. 
As the founder’s frustration grew, he recalled, once again, the advice that R. Lee Clark had 
shared with him. In order to be a successful, stand-alone institution, MCC would need to alter existing 
state statute. 
Nobody wanted to come and be center director of a brand new, wet behind the ears, unproven 
cancer center. So Clark said, "You got to do something." So I got the NCI guidelines. And I got my 
manual typewriter. And I typed out the statute, the original statute, it's been changed several 
times over the years, giving the center director the power to control the space.  
Moffitt wrote the legislation and found two hometown legislators to sponsor it for him: Rep. 
James Hargrett (D-Tampa) and Sen. John Grant (R-Tampa).  
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The Bill(s) 
The passage of HB 2899 and SB 1498 became the founder’s focus. It was the most significant 
legislative initiative that MCC had pursued since its inception. It decoupled MCC from USF in many 
governing, financial and managerial ways. It established, in statute, the powers of the center director 
and reorganized the board structure that enabled MCC to begin self-governance in earnest.  It was lofty 
legislation. By no means would the path be simple. Little did the founder know at the time that the fight 
at home was going to be more difficult than the legislative session in Tallahassee.  
The proposed legislation made very specific and significant changes to the existing USF-MCC 
relationship. The major initiatives in the bill(s) included wide-ranging topics. The bills specified that the 
governing structure of the center would be vested in a board of directors, serving without 
compensation, would include the president of USF, the chair of the Board of Regents (the precursor to 
the Board of Governors that oversaw the state university structure later) or their designee, five 
representatives of the university system and not more than fourteen nor less than ten persons who 
were not medical doctors or state employees. It further specified that the directors would be elected by 
majority vote of the Board of Regents, with the chairman elected by majority vote of the board. The 
legislation removed direct control from the university. 
The legislation added language that enabled other medical schools, not just USF, utilization of 
the hospital resources. Thus, creating separation from sole linkage to USF. 
A vital component created, in statute, the role and responsibilities of the center director, complying with 
the standards the NCI prescribed to attain Designated Cancer Center and Comprehensive Cancer Center 
(CCC) status. This provision gave the center director powers to establish mission-focused programs, 
control of the budget and investment from private or public sources. It also granted control of the 
facilities, space and equipment. 
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Reporting responsibilities were adjusted to include the Chancellor of the Board of Regents, the 
president of USF and the president of affiliated universities. Also included in the language, a 
requirement that an annual report be submitted to the governor, cabinet and presiding officers of each 
chamber of the legislature.  
Three amendments to the legislation were filed to further clarify responsibilities. One included a 
statement of intent of the legislature that MCC strive to become a CCC. Another amendment directed 
the board to create a council of scientific advisors. The final amendment granted the center director the 
authority to create departments, hire staff, conduct research, care for patients and engage in 
educational training and activities. The last amendment also made staff members eligible for joint 
appointments at affiliated institutions.  The three amendments are included in Appendix E.  
In summation, the legislation clearly defined roles and separated MCC from direct control of the 
university. It was a bold and substantive initiative. Moffitt had his work cut out, the university was 
clearly not in favor. As Moffitt explained: 
The university was up in arms. Clint Brown was on the board of regents at the time. They went 
to Clint. Clint came to me. Clint was one of my mentors at the time. And I said, "No." And he 
went back and said, "Stubborn little bastard isn't going to move."  
Conflict  
The moment of truth was upon the founder and his friends at the April 16, 1990, MCC Board of 
Directors meeting. The agenda stated that, after the approval of the previous minutes, a report from the 
Professional Affairs Committee, the Board Self-Evaluation Summary and a presentation of the financials, 
the next agenda item was Senate Bill 1498 and House Bill 2899. The agenda and minutes from this 
meeting are included in Appendix F.  
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According to the minutes of the meeting on April 16, 1990, eight board members attended, 
including the Honorable H. Lee Moffitt. (It is likely, from the interview recollections of general counsel 
David de la Parte, Esq., Moffitt attended via phone for a portion of the meeting. He recalls talking with 
Moffitt on the phone after the meeting concluded, which de la Parte describes in a later section of this 
paper.) Additionally, there were six members of the board absent from the meeting, including some of 
Moffitt’s closest confidants.  
Included on the board packet was a copy of the bill, a side-by-side analysis of the two bills, a 
proposal extended to Jerome W. Yates, M.D., Associate Director for Clinical Affairs at Roswell Park 
Memorial Institute in Buffalo, NY, whom MCC was attempting to recruit as center director, and his 
subsequent withdrawal letter stating “the lack of strength in the medical school has proved a major 
stumbling block in attracting program leaders…” (Likely included to press the point for passage of the 
legislative initiative). A University of South Florida College of Medicine Faculty Statement document in 
adamant opposition to the legislation was also included in the packet. These materials from the board 
packet are included in Appendix F.  
The statement document from the faculty identified the university’s opposition to supporting 
the legislation. The faculty felt that a mutually interdependent relationship would avoid costly 
replication of facilities, equipment, personnel and faculty.  
Apparently, at present, there is a body of opinion that believes that the two institutions should 
be totally separated with the only common feature being their location on the campus of the 
University of South Florida. It would seem, too, that the individuals who propose such 
separation are somehow disappointed in what has transpired to date. However, at no point 
have we as a faculty been made aware of how or where we have failed. The proposed legislation 
has created a great deal of confusion and anxiety among members of the faculty working at the 
hospital as to their academic futures. 
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The letter continued with a number of points regarding training programs, concern about two 
specific departments (Radiology and Pathology), and potential loss of state investment. There was 
linkage to the relationship that the Shands Hospital and University of Florida had and a comment that 
the relationship should serve as a model for the relationship between MCC and USF. The letter 
concluded: 
We urge consideration of the points which we have set forth in this document. We protest 
strongly that the proposed complete dissociation of the two institutions will profit no one, least 
of all the people of the State of Florida and the quality of cancer care for them. 
The letter was signed by the chair of the Department of Physiology, chair of Internal Medicine 
and the chair of the Department of Radiology.  
The minutes state that the meeting began at 9:00 AM, previous minutes were approved, the 
Professional Affairs Committee received the semi-annual report on quality assurance and risk 
management and that there was a subsequent motion and second to accept the report, which was 
approved unanimously. The board addressed the board self-evaluation summary and the February 
financials. 
At 9:15 AM, Chairman Borkowski (USF president) “advised the board to adjourn to executive 
session for discussions relative to the Search Committee and House Bill 2899.” There was a motion and a 
second and the meeting ended at 9:15 AM. The minutes reflect that “the revised Moxley Principles and 
Policies document was distributed” and discussed.  After due motion and second, the principles were 
adopted by a 5-1 vote. These principles and policies are shown in Appendix F.  
The following is the entire entry that followed: 
House Bill 2899  After discussion, the following motion was proffered. 
Motion Mr. Speer moved to recommend the passage of House Bill 2899 related to the 
governance of Moffitt Cancer Center; Mr. Smith seconded the motion. The 
motion failed with four dissenting votes and three in favor. 
Adjournment There being no further business, the meeting was adjourned at 10:20 a.m. 
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There was no description about the discussion/debate which took place. It seems unlikely that 
much discussion was necessary for the other item, adoption of the principles. More likely, the majority 
of the 65 minutes was spent on the legislative initiative. A record of the final vote was not included in 
the minutes. There was one person not attending who was a participant at the 9:00 AM meeting. April 
16th would have meant the legislature was in regular session, and Moffitt was always in Tallahassee 
during session. Therefore, Moffitt likely called in and hung up to go to a meeting or left the call as to not 
be part of the debate and vote. A tie is a loss when it comes to legislation. 
The most interesting fact of this discussion is that the board was debating a bill, an existing bill, 
not an idea about a bill. Therefore, Moffitt had already done a lot of work on the bill. He had written a 
bill, found sponsors in the House and Senate, and those bills had been drafted and assigned bill 
numbers. A staff analysis of the House bill (Appendix E) had been released on April 9th and was so 
positive it nearly compelled immediate support. If not for the staff signatures, one might assume the 
founder wrote it himself. In short, it was already active legislation moving through the process. 
Additionally, it was session, not a committee week, so the process had been going on for months.  
Moffitt spent a lot of time educating elected officials on the history, purpose and mission of MCC. He 
talked about the will of the legislature and how things worked, which he knew as well as anyone.  
It is easy to surmise, from the comments of the leaders interviewed for this work, that the founder was 
not about to give up on his vision for independence. His focus, tenacity, will and personality were not 
about to let a little thing like a directive from his board interfere with his goal.  
A few of the early MCC leaders shed light on the time and some of the events. de la Parte was a 
strong advocate for the center and the founder. He recalled issues around a significant board meeting 
during the 1990 legislative session. 
It was at one of a number of inflection points in the cancer center’s maturity and evolution that 
could have gone differently. Could have not been one in a series of inflection points that's led to 
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an extraordinary successful enterprise and fruition of a dream. It could have led to the dream 
not being realized and the cancer center being mediocre, not extraordinary. It was at a time 
when the cancer was struggling to marshal the resources and the focus around cancer and 
around growing the political enterprise and positioning ourselves for the research enterprise 
and untangling ourselves from the larger University of South Florida; the larger health sciences 
center and medical school. At that time, they employed all our physicians. We didn't have that 
many scientists at that time, but they employed all our physicians. We employed the nurses and 
the staff, but all the doctors, and to the extent that there were PAs (Physicians Assistants) were 
employed by USF by the USF practice plan. 
The doctors were spread across all the departments in the College of Medicine. The problem 
with that is the traditional departments in the College of Medicine, they didn't have just cancer 
to deal with, they weren't just training cancer docs. They weren't just treating cancer patients. 
That, on top of the fact that their enterprise was being used to offset the cost of education and 
the cost of the larger campus. The necessary focus wasn't there, the resources weren't there, 
and H. Lee knew that in order to beat this disease, we had to be laser focused, we could not be 
distracted. All resources, human and otherwise, needed to be focused on cancer, and as part of 
the University of South Florida, that could not be accomplished. H. Lee with a little bit of help 
from me, devised a restructuring of the cancer center from a legal standpoint that would give 
the center director of the cancer center absolute control over all the resources needed to do the 
job that we'd been charged with doing. Control over the labs, control over the faculty, control 
over all the money that was generated by virtue of the cancer care, the grants, the research 
grants that were coming in, which at that time went to the University of South Florida. Once the 
university finished subtracting all their fees and tariffs and overheads and administrative 
expenses, and reallocation to other parts of the university that had less resources. We would get 
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what was left over to put to cancer research, put to recruiting physicians, what have you. And it 
wasn't enough, and it wasn't ever going be enough.  
At that time, a significant percentage of the board of directors were university individuals. The 
dean of the College of Medicine, the vice president of Health Sciences, the president of 
university, and when the restructuring that vested really in the chief executive officer of the 
cancer center, all those things needed to do the job, and remove those from the university, 
were voted on by the Moffitt board of directors in the form of a bill, draft legislation to be 
submitted to the legislature to restructure, reform the cancer center so it could better achieve 
its mission. I presented that proposal at the board meeting. We were in the middle of session. H. 
Lee was in Tallahassee running the bill. He wasn't at the board meeting. The board voted not to 
support that legislation. And as I recall, it was one or two votes. What had historically been 
unanimous votes on almost everything, if not everything, and has since then been almost 
unanimous votes on almost everything, almost everything turned into this split, very 
contentious vote, where people voted along the university lines and voted along the Moffitt 
Cancer Center lines. 
I remember calling Lee to report the outcome of the board meeting. No way of knowing that I'd 
failed. Part of my job was to advocate, why it was going to be good for the cancer center. I was 
not able to pull that off, nor were Lee's dear friends that he had brought onto the board who 
were committed to killing for him if they had to. And I'm waiting for Lee to just really hammer 
me over that failure and I'd say, "Lee I have to tell you, unfortunately the board did not vote to 
approve this bill, this legislation. Lee just very, very calmly said, "Well David look, you know, you 
did the best you could. You did a good job, but the legislature's going do want it wants to do. I 
mean they created us, we're a creature of the legislature, and if the legislature chooses to 
reform or restructure the cancer center, I mean really it's out of the board's hands. I mean 
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they're going have to comply with it." And lo and behold the legislature chose to reform and 
restructure the cancer center.  
Putting the exclamation point on the successful outcome of the 1990 legislative session for MCC, 
Nick Porter concluded: 
So years and years ago that negotiation with the legislature began and obviously ended up 
happening and it was also a combination of the, and this is not just the University of South 
Florida, but almost any university in its utter lack of wisdom, not understanding that partnership 
is much better than divisions. So rather than saying, “Look, the university says you do it this way 
or we're going to squish you,” you know, people don't like being threatened and they typically 
can find ways to survive. The university just never got it, and therefore they ended up being 
totally surprised one morning waking up saying, oh my God, this place has actually pulled it off. 
The founder had won. Working through the legislative process, Moffitt had designed a bill, 
found sponsors, worked the bill(s) through the committee process, met with staff, members and 
leadership and did his job lobbying the legislature to pass his bill. The founder and others acknowledge 
that the passage of SB 1498, included in Appendix E, was the most important adjustment to state 
statute for MCC since H. Lee Moffitt created the cancer center while serving as Speaker of the House. 
Interdisciplinary Care 
Universities normally structured their healthcare professional departments by area of training 
and expertise. Surgeons worked in the Department of Surgery, radiologists in the Department of 
Radiology and other professionals in departments that train and practice in specific areas of medicine. 
Practitioners in the community often reflected that organizational structure in private and/or group 
practice. When a person received troubling news from their family doctor, they were often referred to 
multiple doctors in varying locations. Using a tumor as an example, a patient received news that a tumor 
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had been identified. The family physician referred the patient to a surgeon, who was trained to remove 
such things. Additionally, for good measure, they were referred to an oncologist, who treated the 
majority of casework with chemotherapy. And lastly, patients would receive a referral to a radiation 
oncologist, with training and expertise in radiating tumors to shrink and possibly eliminate them. Each 
physician was highly skilled and trained impeccably. However, it is possible that the patient, after 
multiple trips to different parts of town or beyond, may have been advised of three completely different 
treatment regiments. Oftentimes, the patient was frustrated, frightened and confused as to who was 
right and what advice they should follow. 
Consider the old adage of “If you’re a hammer, everything looks like a nail.” In the context of 
cancer care, if a particular treatment option was the center of a given practice, then it was likely to be 
highly utilized. Surgeons were trained to cut out tumors. Radiation oncologists were trained to shrink 
tumors through radiation. Whether trained to deliver chemotherapy or any other area of expertise, 
doctors were trained, performed and practiced in the areas in which they excelled.  
Like many universities, USF was structured by department. The majority of physicians who 
practiced at MCC were part of that structure. At the time, the faculty at MCC were USF employees. MCC 
paid the university for the practices through hospital and clinical care revenue, but the doctors still wore 
white jackets with the USF emblem. Additionally, the practice groups followed the same structure at 
MCC as they did within the university.  
The 1990 legislative initiative not only gave MCC the power of self-governance but also codified 
the duties and powers of the center director in state statute. That legislation made it more possible that 
MCC could find and recruit a superbly qualified candidate to serve as center director. Prior to the 
passage of the legislation, MCC had been frustrated by top candidates turning down, or not even 
showing interest in, discussion on the position (Appendix F includes letters showing correspondence 
with Jerome W. Yates, M.D., Associate Director for Clinical Affairs at Roswell Park Memorial Institute in 
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Buffalo, NY, whom MCC was attempting to recruit as center director). That significant piece of legislation 
enabled MCC to recruit a center director who knew the scope and boundaries prior to hire. 
Dr. John (Jack) C. Ruckdeschel was a medical oncologist who specialized in lung cancer. An 
Albany Medical College graduate, Ruckdeschel interned at John Hopkins School of Medicine, did his 
residency at Beth Israel Deaconess Medical Center and did fellowship programs at the NIH and 
Baltimore Cancer Research Center. Ruckdeschel was recruited and hired as MCC’s first center director 
and first CEO under the governance structure after passage of the 1990 legislation. 
Also a significant impact person identified in the interviews, Ruckdeschel made a transformative 
decision at MCC early in his tenure. With experience from his time in Albany, he focused on the patient 
as the center of treatment, not the area of expertise of a physician. Ruckdeschel designed and 
implemented a model of care called interdisciplinary care, focusing on disease site as opposed to 
departments of like-trained faculty. Some respondents referred to this methodology as multidisciplinary 
care. MCC’s Physician-in-Chief, Letson, clarified: 
They are relatively interchangeable. Moffitt has been a multidisciplinary team, but we have 
been gravitating to an interdisciplinary approach.  
Multidisciplinary: people from different disciplines working together, each drawing on their 
disciplinary knowledge.  
Interdisciplinary: integrating knowledge and methods from different disciplines, using a real 
synthesis of approaches. 
Ruckdeschel described his experience with this methodology and how MCC adopted it as its 
method of diagnosis and treatment: 
When I was in Albany we had a couple of pseudo teams. We had one really good team which 
was the thoracic team. A thoracic surgeon who's a M.D., PhD, came down from Minnesota, and 
he and I were mostly on faculty at the time. We went out to Chicago, and met with the thoracic 
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group there, and it was a medical oncologist, the radiologist, and the surgeon, went down to 
radiology and looked at x-rays together. We thought we could do better than that. We set it up, 
we got everybody involved with it. It worked well in Albany. So when I went to Tampa I knew 
the model, I knew how it worked. I knew that I couldn't let departments like radiology, or the 
thoracic program, or even pathology assign a specialist of the week.  
Ruckdeschel took his base of knowledge from Albany, refined the process and implemented the 
care model to better serve patients. With all the physicians, surgeons, radiologists, medical oncologists 
and others in the same room to review results, an agreed-upon treatment protocol could be more 
readily established. MCC referred to these meetings as tumor boards, where the physicians, all experts 
in their fields, were joined in one room to seek agreement on protocol. Those meetings created an 
environment for healthy debate, and there was sometimes debate, about patient treatment. Was 
surgery first, or radiation or chemo? The professional had to make their case, debate the merits, 
research facts and data and then the group would come to a mutual decision. 
From an ease-of-use perspective, the patient had to visit only one location. They may have seen 
multiple doctors during the diagnoses phase, but the decisions about treatment were made at the 
tumor board and the patient received the agreed-upon protocol at the same location where they went 
for diagnosis.  
From a physician perspective, departments organized by disease site enabled communication, 
idea sharing and discovery information to flow freely between the team. Ruckdeschel stated:  
I made it clear in my offerings to the board before I came that, in order to distinguish the 
institution from the community practice we had to do complete interdisciplinary care. Being a 
lung cancer specialist, I need to go to one conference a week that includes all the thoracic 
surgeons, medical oncologists, radiation therapists, radiologist, pathologist, nurses, dieticians, 
and trainees once a week. And I'm completely up to date with not only what I've learned in my 
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meetings and in my reading, but what all those other individuals bring from the surgical, the 
radiotherapeutics, the biology, the pathology, literature, to it. So, I'm updated every single week 
all the patients with lung cancer in the institution. And there were quite a few.  
A private practitioner in the community doesn't just see lung cancer. He sees breast cancer, lung 
cancer, colon cancer, lymphoma, everything. That's the nature of the job. He doesn't have time 
to go to a dozen different conferences a week. It's extremely rare that they ever talk about the 
cases between them. He might say to a radiotherapist, "Hey I got a patient with this problem. 
Can you take care of that?" And that's about it.  
But after a patient has seen a surgeon, a radiotherapist, a medical oncologist who has a complex 
plan of care outline, then it is not likely as ever to happen that all of those practitioners will get 
together on a conference call out in the community and discuss exactly what to do with the 
patient, while looking at all their x-rays and everything at the same time.  
I think Moffitt was really the first of the cancer centers to really go completely to 
interdisciplinary care. What it meant was doing away with medical oncology clinic, doing away 
with surgery clinic, doing away with hematology clinic, and making sure that all of those were 
done. We were able to do that and divvy up the space differently. As we hired, we hired into 
teams. We never again hired a general oncologist, or general hematologist. They came into 
specialized areas. They were either myeloma experts, or transplanters, or pancreatic specialists, 
whatever, but they went to a team. We never again hired just generalists in the place. 
I think that was really the core of the success clinically of the place. Because we very quickly 
distinguished ourselves as not doing the same thing as the community people. We went from 
under 3,000 patients a year when I got there to 17,000 when I left. And it'd already become 
when I left, the third largest cancer center in America. 
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From the board perspective, leaders understood what the decision meant for patients and the 
culture at MCC. Tim Adams served on the MCC board for nearly three decades and was later named 
chairman. For the board, fiscal stability was very important. However, the instilled culture of the 
organization, the passion for patient care through treatment and research, and living up to the mission 
superseded everything else. As a nonprofit, MCC’s leaders needed to make sure the books were 
balanced, but they didn’t have to worry about stock prices, earnings ratios or dividends; they could 
center everything on the patient and concern themselves with reputation by outcomes. 
Tim Adams, long time board member who served as chairman beginning in 2017, described the 
situation from the internal, not university, viewpoint. 
We were frustrated for a number of years because the faculty sat at USF, and no fault of USF, 
but they're in traditional medical school kind of slots. So the surgeons are in the department of 
surgery; the radiation people are in the department of radiology. At Moffitt, we practice a team-
based approach. You want surgeons working with radiologists working with medical oncologists. 
That just couldn't really work well in the medical school environment. So, the interim step was 
to form a department of interdisciplinary oncology where the people left their functional silos 
and went into a department of interdisciplinary oncology that essentially was the docs who 
worked at Moffitt. That precipitated a little better team-based care, but they still sat in matrixes. 
So, you're in the department of interdisciplinary oncology but you're also in the department of 
surgery, and so there was still friction there, and ultimately USF and Moffitt agreed it'd be best 
to just have the doctors come completely over to Moffitt so that they didn't have that sort of 
friction that was impacting patient care really. (Subject of a following section) 
Dr. Letson began his career at MCC in 1992 and played a part in the transformation of the 
patient care model. A graduate of Louisiana State University, Letson pursued a fellowship in 
musculoskeletal oncology at Massachusetts General Hospital Harvard Medical School. As MCC’s 
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Physician-in-Chief, he was a leading proponent of the multidisciplinary design from both the physician 
and patient perspectives.  
Moffitt cancer center is a specialty cancer center that is a multidisciplinary cancer center that 
takes care of a patient from beginning to end. From diagnosis to novel treatment therapies, to 
either end of life, or for continuing care. The cancer center is special in that it is an institution 
that has its own hospital, and that specialized only in cancer care. Where many institutions have 
a cancer center within a medical system, or hospital system. This is a very rare situation. 
Essentially, all the people that are hired by the Moffitt cancer center are supportive to cancer 
treatment. 
Interdisciplinary care is an opportunity… In order to treat cancer effectively, you have to treat it 
with multiple disciplines, multiple modalities. Moffitt is special in that you can have these 
interdisciplinary care teams that all worked for one institution. We have one goal in mind, and 
that's cancer therapy. Interdisciplinary oncology teams here at Moffitt specialize in cancer care 
for a specific type of cancer, which is rare. In most institutions around the United States, you 
might have a medical oncologist that treats solid tumors, and might treat lung cancers, and GI 
cancers. Here, the interdisciplinary team takes care of a specific type of cancer, such as the lung 
cancer team. You'll have the medical oncologist, surgical oncologist, radiation oncologist, all 
giving therapy for a specific type of lung cancer. But you'll also have pathologists and 
radiologists that are specialists only in lung cancer. And you will have nurses, PA's, and other 
personnel dealing with the overall cancer care. Whether it’s physical therapists, occupational 
therapists, they're all on a specific organ team. So the interdisciplinary care means that you're 
treating cancer in its totality, and here the interdisciplinary care teams are all focused on one 
specific type of cancer. 
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University structure is, for the most part, made up as an academic structure, where you have 
departments of surgery, departments of medicine, departments of pathology. These separate 
departments will have multiple individuals in those departments, of which, they will have some 
sort of sub specialty in a specific disease type.  
Here at Moffitt, we don't have a traditional academic structure. We have clinical programs set 
up as disease specific programs. Your research, your education, your clinical care, everybody is 
focused on one specific disease. So that means that when you're getting your clinical program 
together, and you're doing retreats, clinical meetings, everybody is focused only on one type of 
cancer.  
Former board chair and retired US Senator Connie Mack summed up his assessment of 
interdisciplinary care concisely.  
One of the fundamental things that they came up with was this notion of "get rid of the silos,” 
this interdisciplinary approach to treatment. I think that's number one. 
Multidisciplinary care teams providing patient-centered care were described in the 2017 MMG 
Annual Report as physician teams that included surgical oncologists, medical oncologists, radiation 
oncologists, diagnostic imaging radiologists, experts in anatomic pathology, hematopathology and 
laboratory medicine, anesthesiology, hematology, cancer genomics, internal and hospital medicine, 
cardio-oncology and supportive care. Advanced practice professional teams included advanced 
registered nurse practitioners, physician assistants, certified registered nurse anesthetists, 
anesthesiologist assistants and registered radiologist assistants. The use of multidisciplinary clinics made 
it possible for patients to meet each member of the care team in one day. Rather than making multiple 
trips for multiple appointments, by having one extended appointment patients were able to be 
evaluated by multidisciplinary team members and leave the same day with a treatment plan. Thus, the 
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multidisciplinary clinic visit reduced the time from evaluation to treatment. Table 4 shows the 
impressive list of MCC interdisciplinary departments (Moffitt Medical Group, 2017). 
 
Table 4. MCC Interdisciplinary Departments, 2017 
 
• Adolescent & Young Adult  
• Anatomic Pathology 
• Anesthesiology 
• Blood & Marrow Transplant & Cellular 
Immunotherapy 
• Breast Oncology 
• Cutaneous Oncology 
• Diagnostic Imaging & Interventional Radiology 
• Endocrine Oncology  
• Gastrointestinal Oncology 
• Genitourinary Oncology 
• Gynecologic Oncology 
• Head & Neck Oncology-Endocrine 
• Hematopathology & Laboratory Medicine 
• Individualized Cancer Management Internal 
& Hospital Medicine 
• Malignant Hematology 
• Malignant Hematology & Cellular Therapy at 
Memorial Healthcare System 
• Neuro-Oncology 
• Radiation Oncology 
• Sarcoma 
• Senior Adult Oncology 
• Supportive Care Medicine 
• Thoracic Oncology 
 
Comprehensive Cancer Center (CCC) 
Each of the landmark decisions that became transformational events at MCC over time are 
inextricably linked. Without the passage of the 1990 legislation, the search for a center director would 
have continued to be stymied by structural confusion and blurred lines of authority and decision-making 
ability. If not for that first center director, Jack Ruckdeschel, the interdisciplinary methodology of faculty 
department design and patient treatment may not have come to fruition. Additionally, the passage of 
that legislation attached the powers of the center director while mandating, in statute that the center 
strive to become NCI-designated CCC. Beyond the evolution of the care model, Ruckdeschel was also 
tasked with creating an environment to promote and excel in cancer research. 
The NCI awards designations to specific entities for research achievement in cancer. The first 
designation is that of Designated Cancer Center. The CCC designation is the most prestigious and 
97 
 
sought-after award. As of 2018, there were 49 institutions in the country that carried such distinction.  
CCC designation is based solely on research, not patient care. Many institutions touted the CCC 
designation in marketing as a differentiator, including MCC, which could be interpreted as better patient 
care. The following is the NCI’s description of the impact of cancer centers on cancer care (National 
Cancer Institute, NCI-Designated Cancer Centers, 2018):  
The cancer centers develop and translate scientific knowledge from promising laboratory 
discoveries into new treatments for cancer patients. Many cancer centers are located in 
communities with special needs and specific populations. As a result, these centers not only 
disseminate evidence-based findings into communities that can benefit from these findings, but 
the centers can also, through the experience of working with those patients, help inform 
national research and treatment priorities. 
Each year, approximately 250,000 patients receive their cancer diagnosis at an NCI-Designated 
Cancer Center. An even larger number of patients are treated for cancer at these centers each 
year, and thousands of patients are enrolled in cancer clinical trials at NCI-Designated Cancer 
Centers. The centers also provide public education and outreach programs on cancer prevention 
and screening, with special attention to the needs of underserved populations. 
The rapid pace of discovery and the improved cancer treatments that the NCI-Designated 
Cancer have helped pioneer have contributed substantially to the increase in the number of 
cancer survivors in the United States, as well as to the quality of their lives (NCI, NCI-Designated 
Cancer Centers). 
The NCI had very strict guidelines for awarding the designation. Once awarded, renewal was 
required every five years which was not a perfunctory process. With the designation, research money to 
awarded to each institution over the five-year period. The NCI described why the Cancer Centers 
Program is important to cancer research as follows:  
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The NCI grant funding to the cancer centers supports shared research resources, provides 
developmental funds to advance scientific goals, and fosters cancer programs that draw 
investigators from different disciplines together. In addition, individual cancer center 
investigators are highly successful at obtaining research funding from NCI and other funding 
agencies and organizations. Indeed, research proposals from cancer center investigators 
account for about three-quarters of the successful investigator-initiated grants that are awarded 
by NCI. 
The centers also offer training for scientists, physicians, surgeons, and other professionals 
seeking specialized training or board certification in cancer-related disciplines (NCI, NCI-
Designated Cancer Centers). 
To begin establishing a significant research program, strong leadership was required, someone 
who understood what the process would take. The institution had its center director and Ruckdeschel 
knew the expectations. Nick Porter, who was responsible for the daily operations at the center, was 
involved with recruiting Ruckdeschel to the center and worked diligently on the transformation under 
new leadership. Porter, too, was cognizant of the mandate to create a research entity worthy of 
designation. 
It took an individual like Jack Ruckdeschel, who was the center director, he might not have been 
a PhD, but he certainly understood science to a certain degree. He certainly understood cancer 
and he was very willing to be very aggressive in recruiting. He had the foresight to recruit Jack 
Pledger, who was a basic scientist, who was highly trusted throughout the basic science world, 
which then would allow him to recruit other basic scientists to Moffitt. (That) allowed us to 
bring in many of the earliest basic scientists who were genuinely superb individuals and begin to 
weave that together.  
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It allowed us to present to (the) NCI that we had programs with scientific merit, scientists that 
were competitive, and that the cancer center, administration and board of directors were there 
to make sure that they were successful. When Jack Ruckdeschel was hired in ‘93, it was about 
10 years later that we became an NCI Comprehensive Cancer Center. There was not one living 
individual when I went there who would have even bet a penny that we could become an NCI 
Comprehensive Cancer Center. But we put the dominoes in the right order and worked very 
hard to prove that we could do the science and that we really mirrored what the NCI wanted to 
support with the core grant. Which was to provide resources to allow scientists and others to be 
the most effective they could possibly be in a cancer setting.  
As to why the designation is so important, Porter continued: 
Ruckdeschel knew the importance of the CCC designation: what it meant to MCC, what it meant 
to the center’s reputation and what it meant for the future. Again, while not a PhD scientist with 
an enormous research history, he had the foresight, the vision, and the fortitude to push for 
excellence. He surrounded himself with people of distinction and created a research enterprise. 
The ability to meet challenges was common to other MCC leaders, including the founder. His 
leadership and tenacity willed the institution forward. 
The comprehensive status was ours. That was where the importance was. It's like getting the 
Nobel Peace prize or it's like winning the World Series. I mean, that's what we did to show that 
we were excellent. And we used it heavily in marketing. But in point of fact, the comprehensive 
designation, even the NCI designation, has nothing to do with the quality of your patient care. 
Zero!  
So to me, the comprehensive designation, as I think it was to Lee, was the mark that not only 
had we done this, but we had done it right. We had done it to the highest standards, and we 
were as good as any place in the country.  
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MCC’s first CEO, William S. Dalton, acknowledged the institution’s efforts after being recruited 
from the University of Arizona. Asked about what decision(s) set MCC on a course to build its reputation, 
Dalton commented: 
The first was the commitment to becoming an NCI-designated center. Arizona was one of the 
first NCI-designated centers, and to be honest with you, when we were designated, it was like, 
"Hey, we got it." And that was it. No one talked about it and it wasn't a big deal.  
When I was recruited here (to MCC) and it was real clear that that was the goal, I had never seen 
such a concentration and commitment by everybody to achieve NCI designation. When it was 
achieved, it was a massive celebration. I think it tells you the value that people feel that they can 
create. So, I think gaining NCI designation was the first pivotal and then followed by 
comprehensive status. 
COO and EVP John (Jack) A. Kolosky added commentary about the utilization of 
“comprehensive” by some other institutions: 
There have been places that have used the word comprehensive cancer center in their title, and 
they may be community cancer centers, and I know that they're trying to boost their reputation 
locally. But, the definition of comprehensive as we use it really is to try and differentiate 
ourselves as the only NCI cancer center, National Cancer Institute center that has earned the 
reputation, earned the title of Comprehensive Cancer Center, and the only one that is based in 
the state of Florida. That's something that's unique and clearly above and apart from anybody 
else in the state of Florida. 
Dr. Thomas Sellers, MCC’s Center Director and EVP and a nutrition and genetics scientist, 
oversaw the research endeavors at the center. Sellers was responsible for growing the research 
enterprise and recruiting new scientists. Sellers saw the CCC designation as a necessary tool to recruit 
the best and brightest minds from around the globe.  
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Well there's only 70 (designated centers) in the country. There's only 45 that are comprehensive 
(CCC). It is a difference because, at least for patients, you're going to get tomorrow’s standard of 
care today. To get an opportunity to participate in clinical trials.  
I think in terms of the scientists, being able to recruit a scientist, the cancer center support grant 
provides funding that builds an infrastructure. So get access to the latest and greatest 
technologies and tools, and that matters.  
In 2018, MCC was the only NCI CCC based in Florida. Mayo Clinic had a presence in Jacksonville, 
FL, but its CCC designation was linked to the campus in MN. Since MCC opened its doors in 1986, the 
population of the state of Florida had more than doubled, becoming the third most populous state in 
the nation. Other centers, the University of Florida (UF Health Cancer Center, formerly Shands) and the 
University of Miami (Sylvester Comprehensive Cancer Center), planned to seek designated status from 
the NCI but had not yet been reviewed. (Note: Sylvester had been CCC in the past but had lost the 
designation decades prior). Many saw the concept of multiple centers designated in Florida as a growing 
necessity. With more than 120,000 cases of cancer diagnosed in Florida annually, the burden of cancer 
care was great and continued to grow. While the designation is not directly related to care, the bench-
to-bedside discoveries at CCC’s could enable patient access to clinical trials and new treatments.  
A founding board member and former chair, Ted Couch had served on the board prior to when 
the first building was constructed. He was a participant in all the key decisions and had watched MCC 
grow from nothing to a small hospital with just over 400 employees to a CCC with more than 6,100 
employees. 
So it is the only one in the state of Florida thus far. I think there's the possibility that some other 
medical centers are going to attempt to have an NCI designated status, and I would encourage 
them to do so because the state's becoming a huge population center and it's pretty hard for 
Moffitt to be able to serve everybody the way we'd like to serve. 
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The CCC designation carried with it an institutional reputation as a national leader in research. It 
defined a cancer center and contributed to the ability to recruit innovative researchers who made 
dramatic discoveries. The statute passed in 1990 enabled MCC to advance under self-governance. 
Ruckdeschel became the chief sailor, but he needed a steady hand on the rudder, someone to steer the 
ship to land at the proper destination. For Ruckdeschel, that person was W. Jack Pledger, PhD.  Prior to 
joining MCC in 1995, Pledger had been a professor at Vanderbilt University and the University of North 
Carolina Medical School. He also spent time at the Dana Farber Cancer Center and Harvard Medical 
School. Pledger had credentials and he knew a lot of people in the research community. He was hired to 
build the team of research professionals who would prepare MCC for NCI designation. 
Moffitt Cancer Center had a mission to contribute to the prevention and cure of cancer. In 
addition, the standard by which it would be recognized as reaching its potential, to become a 
Comprehensive Cancer Center at the NCI. To reach that particular standard which is the highest 
the government can give to any cancer center, Moffitt needed to not only have an incredibly 
very good cancer treatment center but they also had to have a research emphasis that would 
put them up in the leaders of the country.  
So the idea would be to develop the research programs that would support a Comprehensive 
Cancer Center which required at least three programs. One of those could be a clinical research 
program. In addition, a population science program so that'd be a total of four. 
In developing cancer centers and to be able to qualify, you have to have at least three programs 
and each of those programs have to have at least three funded investigators and the total 
amount of research will actually be the driving force for the kind of funding you can get from the 
NCI. My job was to develop the basic research programs that could support this Comprehensive 
Cancer Center. To recruit the faculty. To make sure they all became funded with NCI funds so we 
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could prove that we were doing cancer research and to develop the core facilities that would 
support that research. 
A cancer center core grant provides money to the institution. But 80-90% of that money that 
they will provide is given to you to support NCI funded research. So if you don't have any 
research, there's no reason to have a cancer center. What we did over the first three years was 
to develop the programs that allowed us to become NCI-designated cancer center and I'll point 
out that took three years.  
Then the other part was to become comprehensive. In the late '90s you had to become a clinical 
cancer center like we had just become. And then, on your next competing renewal after a three-
year window, you could then seek comprehensive status. Now that since was changed a little bit 
but after we developed the NCI designated cancer center, two years later we went in for our 
competing renewal where we sought comprehensive status and we were awarded 
comprehensive status. From the time that I got there until comprehensive status was reached it 
was a five-year period. 
The cores that we used for the NCI to support have really increased and technical abilities have 
increased in the number of people they serve and are now ranked as some of the best technical 
support facilities in the country. So it continues to grow and continues to be the beacon. 
According to the MCC website, “…as a National Cancer Institute-based Comprehensive Cancer 
Center, Moffitt is committed to continually developing and evaluating new therapies that can improve 
patient outcomes and quality of life. At Moffitt, patients can access the “gold standard” in cancer 
treatment, as well as novel options, such as immunotherapies, targeted treatments, interventional 
radiology services and hormone therapies, through our robust clinical trials program” (MCC, Cancer 
Treatment). 
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Moving Faculty to MCC (MMG and MRI) 
 Building on the institutional advancements after MCC gained self-governance, moving the 
faculty to MCC employ, and the subsequent creation of the MMG and the MRI, was a bold and visionary 
decision. Prior to 2008, the faculty at MCC, physicians and researchers, were employees of USF. MCC 
paid the university from its revenue generated from the hospital and clinical operations, and the 
university, in turn, paid the physician salaries. That system gave the faculty university privileges for 
teaching and research purposes. Additionally, tenure was conferred by the university. The structure, not 
including the multidisciplinary care model for patient care, was similar to other university-connected 
hospitals and practice groups. The majority of faculty had been trained in such an environment and 
were used to the structure.  
For MCC leadership and the board, institutional reputation and recognition was a major focus. 
MCC had just gone through a rebranding effort to clarify its independent identity and simplify its 
marketing identification, including its logo.  Its former logo utilized a lot of information in a small 
amount of space. Further, it included linkage to the university. MCC’s former information, on business 
cards, letterhead, marketing advertising and consumer materials stated: “H. Lee Moffitt Cancer Center 
and Research Institute at the University of South Florida. An NCI designated Comprehensive Center.” 
The former branding colors were comprised of manila and teal. The rebranding effort shortened the 
marketing image to simply, “Moffitt Cancer Center” and updated the brand colors to blue and white.  
While the new branding effort created the image of an independent institution, dropping the university 
connectivity in the material, many faculty walked the halls of MCC donned in white lab coats with the 
green and gold USF insignia while others wore the new MCC logo. While not a subject of critical 
proportion, it did create some confusion, visually and otherwise. 
More importantly, the ideological and individual institutional differences did not dissipate after 
the passage of the 1990 legislation. Tensions still existed between the two entities and the strong 
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personalities of those involved: board members on both sides, the university president, Moffitt CEO, 
lawyers on both sides and internal faculty who adopted differing viewpoints.  The details of all of those 
situations and issues could have been the subject of a lengthy book or, at minimum, a fascinating reality 
TV show. An example, without wading into tabloid description of individual personalities by name, will 
illustrate one instance of the interinstitutional chess maneuvers. 
MCC faulty being paid by the university were accustomed to receiving paychecks on a regular 
schedule. During one heated period, the university did not pay the faculty on a particular Friday and 
waited until the following Monday to submit payments. The faculty, needless to say, were apoplectic. 
Confronting the issue, a MCC executive inquired. The resulting answer from a university representative 
was a simple “Do I have your attention now?” It’s not hard to imagine the ensuing conversation. 
While institutional tensions played a role, for MCC the compelling issue was, once again, 
separation and self-governance. In order to have full authority and guidance of the medical staff and 
research operations, MCC made the decision to bring the faculty in-house. Related to that decision, from 
a managerial and organizational perspective, MCC created the MMG and the MRI. The decision to 
employ the faculty was not taken lightly and required delicate, yet strong, leadership. Faculty, 
accustomed to a university structure, were not unanimous in supporting the decision. Concern over 
tenure, university privileges for teaching and research and lack of connectivity with a university were 
very concerning issues. It took a lot of effort to work through all of the issues. MCC and the university 
negotiated legal terms and, at the conclusion of the negotiation process, the faculty became MCC 
employees rather than university employees. The university granted privileges in return for an annual 
stipend and the cancer center granted tenure. 
Dr. Jack Pledger lamented: 
Back when I was there, Moffitt gave the money to USF to pay all of our salaries and the 
physicians more or less were responsible to department chiefs in the medical school even 
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though the Moffitt was paying their salaries. Moving all the faculty in there finally came to 
fruition when (former CEO) Bill (Dalton) was there. Then later the complete kind of destruction 
of the relationship between USF, where we tried to work out the things like IP ownership and 
pursue the patents and all that stuff. And then all that split up. The first decision to become a 
comprehensive cancer center followed by bringing the faculty into Moffitt and making them 
members of Moffitt and then the breaking down of the old ownership.  The thought of whether 
Moffitt was, yes directly, on its own and not in any way overseen by the university. Sort of the 
total independence. 
And then probably one of the later things that I felt was very good. And all this involves with the 
doctors practice going in (to the) DIO (Department of Interdisciplinary Oncology). So it really 
gives the Moffitt Cancer Center a lot more control on their own employees that they're paying 
for.  
I started pushing to develop a separate entity for the cancer center called a Moffitt Research 
Institute. Which then allowed everybody to have the research part put under this research 
umbrella. And, of course, that's where they put the (NCI core) grant and Dr. Sellers is the 
director of that institution and the grant. So those are the kind of the ones that I was involved 
in. But probably the main thing was just making the separation very clear. 
We were still bringing in money to the institution through USF and were getting like a 40-45% 
indirect and they were only giving us probably 20% of that. With the cost to do research it was 
just ridiculous. We couldn't keep that up very long.  
Former board chair Ted Couch linked the decision to employ the faculty as significant and aided 
physicians and researchers, propelling MCC forward. 
I would say that one of the significant accomplishments is what we've been able to do to build 
our research capacity. What we've been able to do that I think is significant is that research 
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capacity, the NCI status that we earned in a very short period of time, I think that probably is 
one of our main accomplishments. And then, probably the next thing, was to be able to manage 
our medical staff. To be able to hire our medical staff, that was probably another significant 
move that was costly to go into. But I think that probably it's been a very meaningful 
accomplishment in being able to run the hospital. 
James J. Mulé, PhD, EVP and Associate Center Director, recalled the decision to hire the faculty 
and the care and communication required. 
The other is the separation from USF, was the decision to bring all the faculty over here, was the 
right thing to do for all the right reasons and do it in a way that both organizations felt it was 
good and productive and would not necessarily be adverse to each organization. So, I look at 
that as a win-win, and I think it was crucially important to the history of the organization. So, I 
view it as it was necessary. I could understand the angst of the faculty members at the time, 
because they're academics, they're used to having their paycheck come from university and 
have their academic professorships at the university. So this was a period of time where we had 
to settle those concerns and maintain the ability for them to have appointments at USF, which is 
still important to the active faculty here.  
I think it was a testimony to the leadership and the board to allay those concerns and make it 
whole for the employees, for the academics. It was a lot of transparency, a lot of 
communication, a lot of meetings with faculty to ensure them that this was the right thing to do, 
and put together a promotion and tenure system, which we didn't have before, and have the 
faculty involved in every decision that was made, including being members of that committee, 
set up the departments, the academic departments, similar to what's done in the university, and 
I think the results speak for itself.  
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Board chair Tim Adams, having served on the board for more than 26 years, also had a front row 
seat over MCC’s rapid growth period. He was part of the decision-making process during all of the 
landmark decisions that matured and propelled the institution. 
We were the first in the nation, Cancer Center, to employ our clinical faculty. So, if I look at one 
single thing that really impacted us, that's probably the biggest because the faculty, the way we 
care for cancer is pretty unique. It's team-based. You can't do that with a faculty that's off-site 
or not part of the organization, and so pulling that clinical faculty in and having them align with 
mission and with the Moffitt culture probably really set us apart from everybody else.  
And other people, obviously in the last four or five years, lots of clinical enterprises have 
employed physicians, but as far as I know we were the very first Cancer Center to do it and we 
were way ahead of most other people. And I think that really, really positioned us to pursue 
mission. 
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CHAPTER 6: DISCUSSION AND CONCLUSION 
 
This study identified the factors and events that led the Moffitt Cancer Center (MCC) to evolve 
from a direct-support organization (DSO) at the University of South Florida (USF) into a self-governing 
institution of transformational change. The role of the founder, leadership and culture, key factors, led 
to a mission-driving organization that was stymied by cultural, organizational and governance 
differences with the university regarding directional growth. A critical inflection point, MCC’s 
organizational and governance future was indelibly altered by the passage of legislation in 1990. The 
legislative success, coupled with three additional transformative events, evolved MCC into an 
organization with a future of limitless possibilities.  
Individual interviews of MCC board chairs and members, chief executive officers (CEO) and 
executive leaders revealed the three fundamental factors and four transformational events enabled 
MCC’s evolution. The findings were used to address the study’s three research questions. A review of 
the literature regarding founders, visionary leadership, culture and transformative organizations showed 
that while some facets of MCC were similar to those of other large organizations, MCC was also unique, 
as discussed later.  
Summary of Major Findings 
The interview data was analyzed using interpretivist analysis and sensemaking to identify 
common themes across the interviews in order to determine how factors and events transformed MCC. 
Primary areas of interest, based on the study’s research questions, were discovery of who or what 
impacted MCC and the decisions made to propel the institution. The overarching goal was to depict how 
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and why MCC became and institution of transformational change. There were two key findings, which 
are described in this section. Finding 1 pertains to the foundational factors that were critical to MCC’s 
evolution. Assessment of this data led to the identification of three foundational factors that were the 
focus of a comprehensive literature review. Finding 2 pertains to transformational events. This analysis 
led to the identification of four decisions that were most significant in MCC’s advancement. Notably, the 
decision that came first chronologically made possible each of the subsequent decisions. Each of these 
key findings are described in this section.   
Key Findings 
Finding 1 
Iterative analysis of the interview data revealed three key factors that were deemed to be 
important foundational factors: 1) Founder, 2) Visionary Leadership and 3) Culture. These factors, along 
with Transformational Organizations and Societal Benefit were the focus of the literature review 
conducted for this study. The literature supported the role and impact of these factors in relation to 
MCC’s evolution: founder (Conte et al, 2018; Ellis et al, 2017; Leavy, 2016), visionary leadership (Cote, 
2018; Taylor et al, 2013; McLarney, et al, 1999; Westley & Mintzberg, 1989) and culture (Bass & Avolio, 
1993; Giberson, et al, 2009; Sarros, et al, 2011). Transformational organizations and societal benefit, 
included in the literature review (Carr, et al, 2004; Ebrashi, 2013), sought to gain perspective regarding 
organizational creation and adaptation or evolution resulting in high-impact societal enhancement.   
MCC also appeared to be unique in some ways, including the ongoing involvement of the 
founder in a non-executive leadership position. MCC’s societal benefit as an institution of 
transformational change also had a unique quasi-public/private quality in that it was created as an 
instrumentality of the state yet operated as a private non-profit. The perceived similarities and 
differences are further interpreted and described in the discussion section of this chapter. 
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Finding 2 
Analysis of the research led to the discovery four key decisions that were deemed to be 
transformational events: 1) 1990 Legislation, 2) Interdisciplinary Care, 3) Comprehensive Cancer Center 
(CCC) and 4) Moving Faculty to MCC.  These pivotal events, particularly the first event which was the 
most unexpected and informative finding, were determined to be the impactful events that enabled 
MCC to emerge as an institution of transformational change with societal impact.  
The first transformational event, the 1990 legislation, made it possible for the subsequent 
events to occur. While only a few interviewees explicitly mentioned the 1990 legislation specifically, a 
recurrent theme in participant interviews was MCC’s need for self-governance in the years following its 
creation. Familiarity with the political process and the impact of such a statutory change helped identify 
the 1990 legislation as a fundamental decision that allowed for self-governance. Appendix G contains a 
summary of the recurring themes in the interviews that identified the 1990 legislation as a monumental 
event, paving the way for future transformative decisions or events. 
Interdisciplinary or multidisciplinary care were explicitly stated in several interviews; described 
as the way MCC organized patient care by disease site. A differentiator, MCC transformed patient care 
by eliminating a university-style department structure and created teams of specialists focused on a 
particular type of cancer.  
MCC’s status as a CCC was revealed as a monumental achievement in institutional 
transformation. CCC status is the highest-ranking award by the National Cancer Institute (NCI), part of 
the National Institutes of Health (NIH). The decision to pursue, and ultimate success in achieving, the 
coveted NCI-CCC designation was crucial.  
The decision to move faculty to MCC was identified as a key event based on the recurring theme 
of separating from the university and “moving all the faculty in here” or “the next thing was to manage 
our medical staff.” A bold and visionary decision was made to make faculty employees of MCC rather 
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than USF. The Moffitt Medical Group (MMG) and the Moffitt Research Institute (MRI) were important 
organizational additions to accommodate distinct groups, physicians and researchers, in their areas of 
expertise.  
Findings were used to assess the three research questions that were developed to address the 
aims of this study. 
Research Question 1: Can we ascertain factors that were critical to the foundation of MCC as a 
transformational institution?  
MCC CEOs and board chairs were identified as the prominent leaders who made a significant 
and lasting contribution to MCC. While numerous other individuals were mentioned, the majority of 
responses fell into these two categories of leadership.  
The research identified leadership groups which led to the key factors that became a basis of the 
literature review: 1) Founder, 2) Visionary leadership, 3) culture. Additional research regarding specific 
actions, decisions and leadership qualities/traits of those individuals could lead to additional substantive 
findings in future work.  
Research Question 2: Can we determine events that set MCC on a course to become an 
institution of transformational change?  
Four key decisions made at the board and/or executive level were identified as having set MCC 
on a certain trajectory: 1) 1990 Legislation, 2) Interdisciplinary Care, 3) CCC and 4) Moving Faculty to 
MCC. Through this analysis, these four decisions were deemed to be transformational events for MCC, 
yielding the most significant findings in the research. 
Research Question 3: What does MCC need to do to continue to be an institution of 
transformational change with societal benefit? 
The research did not yield concise information to address the question of what MCC needs to do 
to continue to be Florida’s premier cancer center. The need for continuity in funding and commitment 
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to the organizational culture were mentioned in several interviews. However, due to the lack of 
consistency to identify what would have been interpreted as common themes, this question is an area 
for future research.  
Explanation of Model 
Figure 4 below shows the final model of foundational factors and events that impacted MCC’s 
evolution as an institution of transformational change. Findings of this research were used to evaluate 
the relative impact of factors and events. The perceived influence of each is indicated (+) in the model.  
The conceptual model (Figure 1) explained, in broad terms, in essence a roadmap that could be 
utilized by organizations to transform, enabling greater economic and/or societal impact. The 
conceptual model was utilized to describe the factors and events that transformed MCC into an 
institution of transformational change (Figure 4).  
MCC’s three key factors, founder, visionary leadership and culture were overlaid into the model. 
Similarly, the four transformational events; 1990 legislation, interdisciplinary care, CCC and moving the 
faculty from the university to MCC were also placed in the model. Finally, weighting of the factors and 
events, with a (+) designation; denoted on the arrows. The boxes and circles represented the key factors 
and the transformational events that led to the evolved organization; an institutional of 
transformational change. The arrows signified causation, reading from left to right, in the model.  
The first box, highly skilled, trained, impassioned founder was exemplified by MCC founder, H. 
Lee Moffitt. As Speaker of the House in the Florida Legislature, the founder utilized his position of power 
and influence to create MCC in state statute. Moffitt’s founder imprint was significant and his continued 
participation on the board impacted the direction of the institution. H. Lee Moffitt, in box one, was a 
high-impact factor in the creation of the organization, the second box, visionary leadership, upper circle, 
and culture, lower circle. Arrows indicate causation. The creation of the organization was his 
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accomplishment, therefore the founder’s impact on MCC, the organization (+++), visionary leadership 
(++) and culture (+) was substantial. 
The second box, organization, was the cancer center (MCC). The organization, although small 
and a Direct Support Organization (DSO) on the university campus, served its envisioned purpose to 
deliver cancer care to patients in the region and state. Not only did the founder impact its creation 
(+++), visionary leadership (++) of the board and senior executives and the culture (+) they, therefore, 
impacted the organization. Equally the organization was impacted by key factors, visionary leadership 
(++) and culture (+). The organization, MCC (+++), visionary leadership (++) and culture (+) each 
influenced the transformational events.  
The research brought forth four transformational events, the large circle, which evolved MCC 
into a new organization, listed in the circle. Those combined events (++++) created an institution of 
transformational change with societal impact through its new structure under self-governance, a 
(+++++) organization.  Further description is presented in the discussion section.  
Discussion  
This worked was based on interviews of twenty-one individuals involved with the creation, 
growth and evolution of MCC. One question, “Who or what impacted Moffitt greatly?”, presented as the 
defining question of the study, as it yielded responses to help identify the foundational factors and 
transformative events that re-directed MCC’s course. In this section, the major findings of this research 
are discussed in terms of their perceived meaning of MCC’s transformation related to existing literature. 
This chapter 7 includes this study’s limitations, recommendations for future research, and concluding 
remarks. 
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Figure 4. Model of Foundational Factors and Events of a Transformational Institution  
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Foundational Factors 
 MCC’s growth and success were shaped by the role of the founder, successful leadership 
practices and an integrated organizational culture.  The founder, a cancer survivor himself, utilized his 
political position in the state legislature to create the cancer center. The literature showed that founders 
impact the organizations they create through their experiences and their personal history (Conte, et al., 
2017, p. 276). Moffitt did not cease after the building was erected. For more than three decades, he 
served as a founding board member and remained intimately involved in MCC’s directional and policy 
development. More than thirty years after the center opened its doors, the founder still traveled to 
Tallahassee each legislative session to lobby for MCC. The founder’s visionary leadership was imprinted 
on the institution and the leaders, executive and board members, recruited to MCC possessed or 
adopted similar characteristics. Leading by example, founders impacted employee’s commitment 
(Crotts, et al., 2005, p. 61). Moffitt was a visionary leader who sought like-minded professionals to join 
the cause.  
  The visionary leadership of the founder created an environment of opportunity to attract 
additional leaders who shared in his corporate vision. As the “proselytizer,” the founder evangelized his 
creation and drew talent to MCC (Westley & Mintzberg, 1989, p. 25). The cast of leaders created an MCC 
culture of commitment and dedication, coupled with the freedom to pursue creative solutions to the 
scourge of cancer. Schein (1983), mentioned often in culture centered literature, stated that culture was 
not an immediate occurrence, but over time, cultural values became part of the fabric of an organization 
(p. 46-47). The founder and the early adopters created an evolutionary culture that changed and 
adapted throughout the years.   
 Literature on the three foundational factors enriched the content and enhanced understanding 
for this work. MCC, as a private non-profit, while also serving as an instrumentality of the state, had a 
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quasi-private, quasi-public role that was not predominate in the literature. However, material pertaining 
to the basic foundational factors was plentiful.  
 Figure 4 above depicts the final model of factors and events. The model, evolved from Figure 1 
though research and discovery, shows impactful factors leading to events that transformed MCC. Impact 
is signified by a number of (+) signs near each corresponding arrow. The preponderance of the interview 
respondents listed the founder as a significant factor not only in the creation of MCC, but also of his 
continued leadership and impact on the institution decades later. Visionary leadership and culture 
presented as important factors in addition to the founder. Figure 4 shows the causality through arrows 
and the weighted impact that each factor or event had on subsequent boxes or circles. The founder 
impacted the creation of the organization, visionary leadership and culture. Those factors, in turn 
impacted the institution. Once the factors became part of the corporate fabric, the founder, visionary 
leadership and culture created the institutional impetus to purse transformative initiatives that changed 
the institution’s societal impact.  
Transformational Events 
Four specific decisions, as described by the interviewees, elevated MCC as a nationally 
recognized cancer center and established it as an institution of transformational change.  
The 1990 legislative initiative specified and empowered the position of center director. The 
legislation enabled self-governance, control of the board of directors, control of facilities, statutory 
authority to create departments to fulfill the institute’s mission, and control of the budget and research 
grant dollars. Passage of the legislation codified those important changes and made MCC accountable, 
on an annual reporting basis, to the state university system governing board, the Board of Regents (later 
the Board of Governors) in state statute. That was the single most significant transformational event. 
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But for the passage of that legislation, the additional three transformational events would not have 
been possible.  
The creation of an interdisciplinary approach was impossible for MCC pre-1990. MCC’s decision 
to reorganize the patient care model, the second transformational event, designed care around disease 
site as opposed to departmental organization by area of training and expertise. Rather than stand-alone 
departments such as surgery and radiation oncology where physicians treat many types of diseases, 
MCC’s model organized healthcare teams in a defined department that included professionals targeting 
that specific disease. To clarify by example, all care deliverers focused on skin cancers, melanoma, basil 
cell or squamous cell carcinoma, were in a department focused only on cutaneous diseases.   
The decision to pursue CCC status was possible because the institution, via the 1990 success, 
controlled the facilities and had authority to create departments and control grant awards. In order to 
achieve CCC status, a research enterprise was created and MCC recruited researchers from around the 
country and beyond. CCC was based solely on research and was not awarded based on patient care or 
number of patients served. As of 2018, there were 49 CCC’s in the United States and MCC was the only 
Florida-based center in the state.  CCC designation was a differentiator and set MCC apart from other 
centers in the state and region. Without the freedom to create a research enterprise, enabled by the 
1990 legislation, control of grant funding and the freedom to recruit highly qualified individuals focused 
specifically on cancer, MCC’s effort would have been greatly hindered.  
The final transformational event, moving the faculty to MCC was also not possible under the 
previous structure. Under the previous structure most physicians and researchers were employed by the 
university yet worked fulltime at MCC. MCC paid the university and USF granted faculty tenure. The 
2008 initiative moved faculty to MCC. Subsequently, the cancer center paid a stipend to the university 
for faculty campus privileges while MCC granted tenure. The decision was not simple as faculty were 
used to a more direct university structure. However, by creating the Moffitt Medical Group (MMG) and 
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the Moffitt Research Institute (MRI), control of the faculty through that transformational event further 
separated MCC from direct connection to the university and reinforced self-governance. Those 
combined events, pivotal inflection points MCC’s history, transformed in the institution.   
The final box, an institution of transformational change, showed the evolved cancer center as a 
freestanding institution with the authority and ability to guide its own future. The transformed 
institution made decisions, including the creation of new departments, innovative business ventures, 
and strategic research and education collaborations. Three examples are described at the end of this 
work. The institution of transformational change (+++++) evolved into a new organization with societal 
benefit, furthered its mission and achieved the mandate set forth in state statute.       
 
 
 
Figure 5. Final Depiction of Four Transformational Events 
 
 
 Figure 5, evolved from Figure 3, depicted that the 1990 legislation enabled the subsequent three 
transformational events. Lines to the other events signified linkage, enabling the other three events, not 
causation. While the three events that followed the 1990 legislation were made clear through the 
research process, concise identification by the respondents, the legislative event itself required an 
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interpretivist and thematic approach. Creswell (2013) stated “coding involves aggregating the text or 
visual data into small categories of information” where themes “are broad units of information” (pp. 
184-186). The 1990 legislative initiative was only mentioned by title or timeframe by a few participants. 
Other respondents mentioned numerous factors that they interpreted as important to MCC evolution 
and maturation, but not any specific initiative or event.  
The conclusion that the 1990 decision was, indeed, a key transformational event presented itself 
through a process of assessing the key phrases, words or concepts that the respondent shared.  Each of 
these information pieces led to the conclusion that the event or outcome described could have only 
happened due to the passage of the legislation. Specifically, responses such as “we needed to govern 
ourselves,” “we need to control our research awards” or “we needed to be able to hire a center 
director,” thematically were linked to the legislative outcome and were only made possible by its 
passage (Appendix G). 
 As of 2018, MCC was the only CCC based in Florida and had served patients from every county in 
the state, every state in the nation and more than 130 other nations. Many organizations engaged 
initiatives aimed to benefit society while still operating as a successful business (Zimmerman, et al., 
2014, p. 18-21). From a small hospital with 409 employees in 1986, MCC had grown to more than 6,100 
employees serving over 64,000 individual patients annually. It was a mature, transformational 
institution fighting cancer and serving a social benefit. Social innovation has been described as the 
implementation and utilization of new ideas to meet common goals (Mumford, 2002, p. 253-261). MCC, 
as an institution of transformational change, likely exceeded the expectations of even its founder. 
This project was designed to extrapolate knowledge of successful leadership practices, 
determine what led to and cultivated MCC’s mission-driven organizational culture and identify 
transformational events that re-defined the institution. Data was collected from individual interviews 
and assessed using thematic analysis and sensemaking. This process led to the discovery of critical 
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foundational factors and transformative events that contributed to understanding how MCC evolved 
into one of the country’s top cancer centers. While the literature helped to make clear many ways in 
which MCC was similar to other large organizations, there also appeared to be gaps in the current 
knowledge base, particularly in terms of the unique role a founder who does not assume a senior 
leadership role in non-profit organization that serves a societal purpose.  
Limitations 
 Future qualitative and quantitative research projects could focus directly on two distinct areas; 
1) decision making and decision outcomes of non-profits designed to address specific areas of concern 
and 2) non-profit institutions of societal impact.  
This project began with three research questions, yielding fruitful information from two of the 
questions. The third, “What does Moffitt need to do to continue to be Florida’s premier cancer center?” 
did not yield notable data for this research project. Results included reimbursement rates for services, 
research money, culture, leadership and a number of other unrelated responses. A series of more 
targeted questions may provide richer data that could be subdivided into categories or themes for 
review and analysis.  
 Qualitative research projects relying on interview data can present numerous obstacles. 
Answers to questions are drawn from the opinion or recollection of the respondent. Responses are 
derived from the interviewee’s memory regarding an event, conversation or occurrence. Therefore, 
factual accuracy regarding times, places, circumstances or results are subject to the recall of the 
respondent and/or their willingness to be forthcoming. In interview-based research, if possible, a 
greater number of interviewees, logically, should yield a clearer picture with corroborating interview 
data.  
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 Interview questions must be clearly designed in order to answer the research questions. If 
particular data is sought, a narrow line of questioning should be considered. Open-ended questions 
would be useful to elicit responses without targeted outcomes.    
Research regarding founders who did not assume leadership positions such as CEO or board 
chair was not clearly present in the literature. Targeted research regarding company founders who 
participate in, but do not own or run the organization may be useful. Further, non-profit founders who 
are committed to a particular cause could be a topic for future societal impact research.  
Specific topics for research that could be explored in future studies from this work include 
legislatively created institutions and societal benefit. Governments at all levels allocate tax resources for 
a multitude of purposes. Government waste has been the subject of much research and media 
attention. However, research regarding government investment in institutions of societal impact may be 
a valuable tool for transforming organizations with shared benefit.  
This research project included twenty-one interviews with MCC leaders and program directors. 
The majority of the program director data was not included in the scope of this work but may be useful 
in future research endeavors.   
Contributions  
 The aim of this research was two-fold: 1) discovery regarding the creation of MCC via leadership, 
culture and growth, and 2) institutions of transformational change and societal benefit. The findings of 
this project could be utilized in future research for non-profit and for-profit entities regarding 
transformational events that alter the trajectory of an organization. Furthermore, this research adds to 
current knowledge regarding how visionary leadership and culture contribute to transformational 
decisions creating societal benefit. 
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 Through data examination of the research material, this study adds to current knowledge and 
literature pertaining to transformational change and societal impact, while utilizing existing literature 
regarding such factors as visionary leadership, culture and founder research. The findings in this 
research contribute to the current base of knowledge.  
Conclusion 
Drive, personal experience, ambition, perseverance and vision have led to the creation of 
remarkable enterprises that became organizations of societal impact. MCC’s founder had an idea. Due 
to the death of three close friends, he envisioned a cancer center in Florida to serve the needs of the 
state. Over a three-decade period, the founder’s creation grew from a small regional cancer hospital 
into a nationally renowned CCC. MCC earned numerous recognitions, recruited some of the best and 
brightest minds from around the globe, and led cancer care and research in Florida and beyond. The 
institution that started with an idea became not only an economic engine for the community and state 
but also served as an institution of transformational change with societal benefit.     
The research illuminated specific elements that contributed to the growth, success and impact 
of MCC. The concept of the institution started with one person, the founder. His vision, actions, evolving 
role and constant attention were explored through the research process. Regarding the institution, the 
concepts of founder, visionary leadership and culture emerged through the interview process as key 
factors for this study. Recurring results revealed through interview data helped identify the key factors 
that made a significant and lasting contribution to MCC. Additionally, four pivotal transformational 
events that changed the course of the center were identified. The factors led to key events, the events 
led to an institution of transformational change providing societal benefit. 
Three topics exemplify what MCC did with the new freedoms that came with self-governance 
and the subsequent transformational events. 
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In 2007, MCC created a partnership with Merck & Company, a giant in the pharmaceutical 
industry. The partnership, with investment from Merck, enabled MCC to create a for-profit subsidiary 
company. M2Gen, a health informatics company was designed to accelerate personalized medicine. 
Created by then CEO, William S. Dalton, PhD, MD, M2Gen sought to combine annotated clinical data and 
tissue samples for study, clinical trials and drug discovery. Drug development was expensive and clinical 
trials took a lot of time to develop and receive Food and Drug Administration (FDA) approval. One 
component of the early M2Gen business plan was to create a data base that could house millions of 
data points and tissue samples, linked to certain genetic markers, for utilization of pharmaceutical 
companies to fill clinical trials. Clinical trials could take years to fill and complete. M2Gen provided an 
opportunity to change that by establishing a data base that could match patients to trails in a matter of 
days or weeks as opposed to years. In business time is money. For cancer patients time is precious. As of 
2018, personalized medicine was the future; treating each patient based on their own genetic makeup. 
The creation of M2Gen was a direct result of MCC transformational change. 
Previously unheard-of research was also possible due to transformation. MCC created a 
Department of Mathematical Oncology which was designed to explore mathematical study of tumor 
growth prediction. Though that innovative department’s work, findings and clinical trial results showed 
promise in altering treatment. Mathematicians in the department challenged long establish protocols by 
exploring how lower doses of radiation or chemotherapy may have advantage over the most tolerable 
dosages, as had been the norm for decades. Through clinical trials their research showed promising 
signs in numerous cancers that dosing just enough to impact the disease, taking a break and continuing 
only when the statistics elevated positively impacted the quality of life for patients and extended life in 
cases.  
In 2008, MCC formed a partnership with the Personalized Cancer Center in Tianjin, China. MCC 
trained graduate students, post-doctoral fellows, nurses and physician-scientists as part of the exchange 
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between the two cancer centers. Sharing of information and exporting expertise, the two-way 
agreement augmented research and aided both entities in the cutting-edge field of personalized medical 
treatment.  
Freedom to partner with other organizations and/or educational institutions was made possible 
by MCC’s foundational factors and the key events that created an institution of transformational 
change. The societal impact had only just begun. There was no limit to the potential due to the vision of 
one man, the people he surrounded himself with, the visionary leadership they possessed, the 
organizational culture they created and the transformational decisions they made.  
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The 2000 Florida Statutes 
 
 
Title XVI 
EDUCATION 
Chapter 240  
Postsecondary Education 
View Entire Chapter  
 
1240.299  Direct-support organizations; use of property; board of directors; activities; audit; 
facilities.--  
(1)  DEFINITIONS.--For the purposes of this section:  
(a)  "University direct-support organization" means an organization which is:  
1.  A Florida corporation not for profit incorporated under the provisions of chapter 617 and approved by 
the Department of State;  
2.  Organized and operated exclusively to receive, hold, invest, and administer property and to make 
expenditures to or for the benefit of a state university in Florida or for the benefit of a research and 
development park or research and development authority affiliated with a state university and organized 
under part V of chapter 159; and  
3.  An organization which the Board of Regents, after review, has certified to be operating in a manner 
consistent with the goals of the university and in the best interest of the state. Any organization which is 
denied certification by the Board of Regents shall not use the name of the university which it serves.  
(b)  "Personal services" includes full-time or part-time personnel as well as payroll processing.  
(2)  USE OF PROPERTY.--  
(a)  The Board of Regents is authorized to permit the use of property, facilities, and personal services at 
any state university by any university direct-support organization, and, subject to the provisions of this 
section, direct-support organizations may establish accounts with the State Board of Administration for 
investment of funds pursuant to part IV of chapter 218.  
(b)  The Board of Regents shall prescribe by rule conditions with which a university direct-support 
organization must comply in order to use property, facilities, or personal services at any state university. 
Such rules shall provide for budget and audit review and oversight by the Board of Regents.  
(c)  The Board of Regents shall not permit the use of property, facilities, or personal services at any state 
university by any university direct-support organization which does not provide equal employment 
opportunities to all persons regardless of race, color, religion, sex, age, or national origin.  
(3)  BOARD OF DIRECTORS.--The chair of the Board of Regents may appoint a representative to the 
board of directors and the executive committee of any direct-support organization established under this 
section. The president of the university for which the direct-support organization is established, or his or 
her designee, shall also serve on the board of directors and the executive committee of any direct-support 
organization established to benefit that university.  
(4)  ACTIVITIES; RESTRICTION.--A university direct-support organization is prohibited from giving, either 
directly or indirectly, any gift to a political committee or committee of continuous existence as defined in s. 
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106.011 for any purpose other than those certified by a majority roll call vote of the governing board of the 
direct-support organization at a regularly scheduled meeting as being directly related to the educational 
mission of the university.  
(5)  ANNUAL AUDIT.--Each direct-support organization shall make provisions for an annual postaudit of 
its financial accounts to be conducted by an independent certified public accountant in accordance with 
rules to be promulgated by the Board of Regents. The annual audit report shall include a management 
letter and shall be submitted to the Auditor General and the Board of Regents for review. The Board of 
Regents and the Auditor General shall have the authority to require and receive from the organization or 
from its independent auditor any detail or supplemental data relative to the operation of the organization. 
The identity of donors who desire to remain anonymous shall be protected, and that anonymity shall be 
maintained in the auditor's report. All records of the organization other than the auditor's report, 
management letter, and any supplemental data requested by the Board of Regents and the Auditor 
General shall be confidential and exempt from the provisions of s. 119.07(1).  
(6)  FACILITIES.--In addition to issuance of indebtedness pursuant to s. 240.2093(2), each direct-support 
organization is authorized to enter into agreements to finance, design and construct, lease, lease-
purchase, purchase, or operate facilities necessary and desirable to serve the needs and purposes of the 
university, as determined by the systemwide strategic plan adopted by the Board of Regents, upon 
approval of such agreements by the Board of Regents and approval of the project by the Legislature. 
Such agreements are subject to the provisions of s. 243.151.  
(7)  ANNUAL BUDGETS AND REPORTS.--Each direct-support organization shall submit to the university 
president and the Board of Regents its federal Internal Revenue Service Application for Recognition of 
Exemption form (Form 1023) and its federal Internal Revenue Service Return of Organization Exempt 
from Income Tax form (Form 990).  
History.--s. 10, ch. 75-302; s. 21, ch. 79-222; s. 6, ch. 85-313; s. 67, ch. 87-224; s. 1, ch. 88-237; s. 75, ch. 90-360; s. 14, 
ch. 91-55; s. 5, ch. 94-230; s. 819, ch. 95-148; s. 16, ch. 95-243; s. 27, ch. 95-392; s. 96, ch. 96-406; s. 1, ch. 98-99; s. 1, 
ch. 2000-267; s. 3(7), ch. 2000-321.  
1Note.--Repealed January 7, 2003, by s. 3(7), ch. 2000-321, and shall be reviewed by the Legislature prior to that date.  
Note.--Former s. 240.182.  
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Interview Questions 
Wilson Dissertation 
 
1) What is your current role/affiliation with Moffitt? 
 
2) How long have you been affiliated with Moffitt? 
 
3) What is Moffitt Cancer Center? 
 
4) What is your perception about Moffitt’s reputation? 
 
5) What is the role of Moffitt? 
 
6) As the only Florida based CCC, is Moffitt distinguished differently than other cancer centers? If 
so, how? 
 
7) How did Moffitt achieve its position?  
• Policy 
• Leadership 
• People 
 
8) Tell me about Lee Moffitt 
 
9) How about his leadership? 
 
10) Who or what has impacted Moffitt greatly? 
 
11) What is the role of the board? 
 
12) What about leadership? 
 
13) If you could point to one or more decisions, what was important to Moffitt’s success? 
 
14) What are the needs for the future? 
 
15) Looking forward, what are the potential pitfalls/danger areas that Moffitt Cancer Center may 
face? 
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Timothy (Tim) J.  Adams  
 
Tim Adams is former president of Time Customer Service, Inc. (TCS) and was responsible for all TCS 
activities conducted on behalf of Time Inc. TCS employs 700+ people and occupies in excess of 300,000 
square feet of office and light industrial space. TCS’s primary responsibility is the fulfillment of 
subscriptions for the Time Inc. family of magazines, the National Geographic Society, American Express, 
Kiplinger, National Wildlife, Wenner Media, Foreign Affairs, Smithsonian, and The Week. 
 
Tim is from Webster Springs, West Virginia. He received his Bachelor of Science in Industrial Engineering 
from West Virginia University.  
 
Adams has incredible financial acumen that has guided Moffitt’s 1.5 million-square-foot expansion over 
two decades. He was a key negotiator behind a recent $75 million investment in Moffitt subsidiary 
M2Gen that will benefit countless patients nationwide through precision medicine-based clinical trials. 
His support of partnerships has enabled Moffitt to extend its expertise globally, to Tianjin Medical 
University in China, and statewide, including partnerships with Memorial Healthcare System’s Broward 
County hospitals.   
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Theodore (Ted) J. Couch, Sr.  
 
Ted Couch, Sr. graduated from Jesuit High School in 1954, entered a Roman Catholic Seminary for one 
year and thereafter attended the University of Tampa and the Louisiana State University School of 
Banking. 
 
His full time working career began in 1956 with the newly formed First Industrial Savings Bank of Tampa 
where he was employed as a runner. In 1958 First Industrial became the Northside Bank of Tampa and 
moved to a North Tampa location as a full commercial bank. By this time Mr. Couch had worked his way 
up to becoming an officer of the bank and after holding every office position in the bank in 1966 he 
earned the title of President. In 1977 Mr. Couch left the bank to pursue the development of commercial 
real estate in the North Tampa area and to date continues to manage the properties he developed over 
the last 30 years. 
 
In 1981, Mr. Couch and his partner George Cortner agreed to fund a chair in cancer research at the 
University of South Florida. This financial support from the community assisted in the appropriation of 
funding by the Legislature and through the persistence of then House Speaker, H. Lee Moffitt, the 
Moffitt Cancer and Research Center on the campus of USF became a reality. Mr. Couch chaired the 
board of directors of the Moffitt Cancer Center for 7 years. In 2000, he stepped down to chair Moffitt’s 
first capital campaign. This ambitious effort concluded in 2006 after exceeding the $87 million goal. 
 
During his working career, Mr. Couch has chaired the University Community Hospital board and is now 
emeritus after 27 years of service. He has served on numerous boards and foundations in the 
community and has been a consistent donor to countless charities in the Tampa Bay Community. He 
maintains that wealth demands increased responsibility along with personal discipline and that wealth 
does not bring happiness to a person’s life but sharing of wealth does. 
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William (Bill) S. Dalton, PhD, MD 
 
Dr. William Dalton is CEO of M2Gen, a Moffitt Cancer Center biotechnology company.  Additionally, he is 
founding director of Moffitt’s Personalized Medicine Institute, established in 2012 to focus on Moffitt’s 
brand of personalized medicine, Total Cancer Care®. Dr. Dalton served as president and CEO of Moffitt 
from 2002 to 2012 and was instrumental in helping the Cancer Center achieve tremendous growth and 
innovation.  He facilitated the launch of M2Gen and the development of Moffitt Total Cancer Care®. Dr. 
Dalton received his Ph.D. and medical degree from Indiana University School where he completed an 
internship in medicine. He then completed a residency in medicine and fellowships in oncology and 
clinical pharmacology at the University of Arizona in Tucson. He joined the University of Arizona medical 
school faculty, where he became professor and dean of the College of Medicine. He also directed the 
Bone Marrow Transplant Program at the Arizona Cancer Center.  
 
Dr. Dalton joined Moffitt in 1996 and served as associate center director for clinical investigations and 
deputy director of the cancer center.  He also founded and chaired the Department of Interdisciplinary 
Oncology at the University of South Florida where he is a professor of oncology.  Dr. Dalton left Moffitt 
briefly in 2001 to serve as dean of the College of Medicine at the University of Arizona, returning in 2002 
as the cancer center’s president, CEO and center director. A medical oncologist, Dr. Dalton has been a 
principal investigator or co-investigator for numerous research studies in his specialty of malignant 
hematology.  Over his career, Dr. Dalton has published extensively, served on numerous editorial 
advisory boards for professional publications, participated extensively on committees for National 
Institute of Health/National Cancer Institute, American Association of Cancer Research, American 
Society of Hematology and the American Society of Clinical Oncology.  He has also served on many 
university-based scientific advisory boards.   
 
Education & Training: 
Board Certification: 
• Medical Oncology 
Fellowship: 
• University of Arizona - Oncology 
• University of Arizona - Clinical Pharmacology 
Residency: 
• University of Arizona - Medicine 
Medical School: 
• Indiana University - MD 
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L. David de la Parte, Esq. 
 
Mr. de la Parte is Executive Vice President and in-house General Counsel at H. Lee Moffitt Cancer Center 
and Research Institute. He joined Moffitt Cancer Center to establish its in-house General Counsel office 
in March 2007 after leaving de la Parte & Gilbert, P.A. as its managing partner. He received his 
Bachelor’s Degree in political science from Florida State University in 1983 and his Juris Doctor from 
Stetson University College of Law in 1985. While in private practice, Mr. de la Parte concentrated his 
practice in the general representation of clients in the health care industry and the representation of 
governmental and quasi-governmental agencies. He became Moffitt Cancer Center’s outside General 
Counsel in 1990.  
 
He was admitted to The Florida Bar, the United States District Court for the Middle District of Florida 
and the United States Court of Appeals for the Eleventh Circuit in 1986. He is also a member of the Bar 
of the United States Supreme Court. He is a member of the American and Florida Bar Associations and 
was the founding chair of the Hillsborough County Bar Association Health Law Section. He is also a 
member of the American Health Lawyers Association and the Florida Hospital Association Academy of 
Healthcare Attorneys. He is considered an “AV” rated attorney by the Martindale-Hubbell Law Directory, 
which is the highest rating conferred by Martindale-Hubbell for legal skills and ethical conduct. In 2004, 
he was recognized by Florida Trend magazine as one of Florida’s "Legal Elite." 
 
Mr. de la Parte is past chair of the District 6 Health and Human Services Board for Hillsborough and 
Manatee Counties. In 1995, he served as co-chair of the Governor’s Special Panel on Child Protection, 
which investigated the death of Lucas Ciambrone. He is past chair and currently serves on the Board of 
Directors of Youth Environmental Services, Inc., and Tampa Marine Institutes, Inc., nonprofit 
organizations which operate programs for the rehabilitation of delinquent youth. 
 
 
  
143 
 
Edward (Ed) C. Droste 
Ed Droste was appointed in 2014 to Moffitt Cancer Center’s national Board of Advisors, a growing group 
of prominent individuals who serve as Moffitt ambassadors and offer their expertise and counsel on 
issues relating to the cancer center. 
Ed Droste is chairman of Provident Management Corporation.  He also is the co-founder and partner in 
Hooters Restaurants, originating in Clearwater, Fla. in 1983.  Hooter’s currently has more than 400 
restaurants nationwide with sales of nearly a billion annually, as well as locations in 28 countries.  Droste 
was involved in the conceptualization, development and marketing of Hooters Casino Hotel in Las 
Vegas. He graduated from Iowa State University in 1973, with a B.S. degree in Industrial Administration 
and Political Science. He was President of his graduating class and was named National Top Alumnus of 
the Year for his fraternity, Tau Kappa Epsilon. He later dedicated a study hall in his name at Iowa State’s 
business school. 
In conjunction with Hooters Restaurants, Droste formed Provident Advertising and Marketing to 
coordinate the chain’s promotional activities for the brand and other ventures in a number of 
industries.  Through Provident, Droste also co-founded several successful restaurant concepts, including 
Pete & Shorty’s Tavern, Adobe Gila’s and Splitsville, which recently opened a location in Downtown 
Disney. 
Droste has served in leadership positions of multiple societies and boards.  He currently serves as 
chairman of Moffitt’s Foundation Board of Directors.  Droste was appointed by Gov. Rick Scott to the 
Florida Prostate Cancer Advisory Council.  He also was honored by the Florida Council on Economic 
Education for his induction into the 2012 Tampa Bay Business Hall of Fame. 
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Robert (Bob) A. Gatenby, MD 
Robert Gatenby, MD is the Chairman of the Department of Radiology at Moffitt Cancer Center and Co-
Director of the Cancer Biology and Evolution Program. He joined Moffitt in 2008 from the University of 
Arizona where he was Professor, Department Radiology and Professor, Department of Applied 
Mathematics since 2000. He received a B.S.E. in Bioengineering and Mechanical Sciences from Princeton 
University and an M.D. from the University of Pennsylvania in 1977. He completed his residency in 
radiology at the University of Pennsylvania where he served as chief resident. Bob remains an active 
clinical radiologist specializing in body imaging. While working at the Fox Chase Cancer Center after 
residency, Bob perceived that cancer biology and oncology were awash in data but lacked coherent 
frameworks of understanding to organize this information and integrate new results. Since 1990, most 
of Bob's research has focused on exploring mathematical methods to generate theoretical models for 
cancer biology and oncology. His current modeling interests include: the tumor microenvironment and 
its role in tumor biology, evolutionary dynamics in carcinogenesis, tumor progression and therapy, 
information flow in living systems and its role in maintaining thermodynamic stability. 
 
Discipline: 
• Molecular Oncology 
• Integrated Mathematical Oncology 
• Diagnostic Imaging and Interventional Radiology 
• Myeloma 
• Cancer Imaging and Technology 
• Center for Immunization and Infection Research in Cancer 
• Cancer Biology and Evolution Program 
• Evolutionary Therapy 
• Education & Training 
 
 
Board Certification: 
• Diagnostic Radiology 
 
Fellowship: 
• University of Pennsylvania, MD  
• Hospital of U Penn, Chief Resident - Radiology 
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Anna R. Giuliano, PhD 
Anna R. Giuliano, PhD, is the founding director of the Center for Infection Research in Cancer (CIRC) at 
the Moffitt Cancer Center. Her career had its inception in the relationship between human 
papillomavirus (HPV) infections and cervical cancer in women and has evolved over the past several 
decades to encompass HPV and penile, anal, and oral cancers in men, as well as other infectious 
diseases and their causal relationships with various cancers. Her work has contributed significantly to 
our understanding of the rate at which HPV infections are acquired and cleared, the proportion that 
progress to disease, and also to HPV vaccine protection against multiple diseases in women and men.  
An expert in the field of cancer research with a longstanding and successful record of National Institutes 
of Health funding since 1990, she has been actively involved in cancer epidemiology and prevention 
studies conducted among diverse populations in the United States and abroad. In the course of those 
endeavors, Dr Giuliano was a contributor to the 1999 Institute of Medicine (IOM) report titled The 
Unequal Burden of Cancer and the 2005 International Agency for Research on Cancer (IARC) report that 
concluded for the first time that HPV is a cause of multiple cancers in women and men. In 2013, at the 
100th anniversary of the American Cancer Society (ACS), she was the recipient of the ACS Distinguished 
Achievement in Cancer Award. Dr Giuliano has authored more than 330 peer-reviewed publications. 
 
Discipline: 
• Cancer Epidemiology 
• Head and Neck-Endocrine Oncology 
• Cancer Epidemiology Program 
• Center for Immunization and Infection Research in Cancer 
 
Education & Training: 
• Tufts University, School of Nutrition, Medford, MA, MS - Nutrition 
• Tufts University, School of Nutrition, Medford, MA, PhD - Nutritional Biochemistry 
• New England Epidemiology Institute, Fellow - Epidemiology Statistics 
• University of Arizona, NCI Cancer Prevention Fellow - Cancer Prevention Epidemiology 
  
146 
 
The Hon. Ralph H. Haben, Jr., Esq. 
Ralph was raised in Palmetto Florida. He attended Manatee County schools and received his B.A.E. in 
Education from the University of Florida in 1964. He graduated from Cumberland College of Law in 1967 
and began private practice in Manatee County in 1968. He served as an assistant state attorney and as a 
municipal judge. 
In 1972 Ralph was elected to the Florida House of Representatives. He served on every major committee 
and won many legislative awards culminating in his election as Speaker of the House in 1981. While 
serving in the Legislature, Ralph was an integral part of the revisions of the Florida Criminal Code, the 
Evidence Code and the Probate Code. As Chairman of the Committee he had to carefully evaluate the 
existing law, the relevant cases and the public policy questions involved in the revisions. 
Since 1982, Ralph has maintained a successful law practice in Tallahassee, Florida.  
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John (Jack) A. Kolosky, CPA, MBA 
Jack Kolosky is Chief Operating Officer of Moffitt Cancer Center in Tampa, FL, and serves as the 
President of Moffitt Hospital. He joined the Cancer Center in November 1999. 
Mr. Kolosky is responsible for ensuring that high quality care is provided to its many patients and that 
the Cancer Center is compliant with regulatory agencies and accrediting bodies, continually monitoring 
Moffitt's service and delivery systems. Mr. Kolosky also has the role of corporate Executive Vice 
President/Chief Operating Officer, where he oversees Patient Care Services as well as corporate 
functions as Information Technology, Internal Audit and Facilities and Support Services. 
Mr. Kolosky has more than 30 years of health care leadership experience, including multiple hospital 
environments, clinic settings and academic, tertiary health care delivery systems. Prior to coming to 
Moffitt, he served as the Chief Financial Officer for the Georgetown University Medical Center in 
Washington, D.C., and 
Mr. Kolosky is a Fellow in the Healthcare Financial Management Association, a member of the American 
College of Healthcare Executives, and is active in a number of other professional organizations. He 
serves on the board of directors of Moffitt Genetics Corporation (M2Gen), the Tampa Bay Partnership 
and is the past chair of Chapters Health System (the parent corporation of LifePath Hospice). Mr. 
Kolosky is currently the Board Chair of the Alliance of Dedicated Cancer Centers and the Board Chair of 
the Florida Hospital Association. He previously served on the board of the Nevada Cancer Institute. 
as the Associate Vice President and Chief Financial Officer of the University of Texas M. D. Anderson 
Cancer Center in Houston, Texas. 
Mr. Kolosky received his bachelor's degree in Accounting from Western Illinois University and an MBA in 
Finance from Drake University. He holds a Certificate from the Harvard University School of Public 
Health and is a Certified Public Accountant. 
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G. Douglas (Doug) Letson, MD 
Dr.  Douglas Letson is executive vice president of clinical affairs and physician-in-chief at Moffitt Cancer 
Center, as well as prior chair of the Sarcoma Department. In addition, he is a professor of surgery, 
radiology and orthopaedics at the University of South Florida and director of the USF Orthopaedic 
Residency Program. As an orthopaedic oncology surgeon, Dr. Letson’s research and clinical interests 
include: novel therapeutic agents to treat sarcoma; limb salvage for bone and soft tissue tumors; as well 
as segmental prosthesis, new hinge designs and soft tissue attachment for metallic prosthesis. Dr. 
Letson has a keen interest in new techniques and design of instrumentation for minimal invasive 
reconstructive surgery. He collaborated with Stanmore Corporation in England to develop a non-invasive 
leg lengthening implant, and he is the only physician in the United States to implant and lengthen the 
limbs of several children successfully.  
A graduate of Louisiana State University School of Medicine, Dr. Letson completed his residency in 
orthopedics at LSU affiliated hospitals, where he was chief resident at LSU Children’s Hospital. He 
pursued advanced training through a musculoskeletal oncology fellowship at Massachusetts General 
Hospital-Harvard Medical School and was awarded Clinical Oncology Fellow of the American Cancer 
Society. Prior to joining Moffitt in 2000, he was with the Watson Clinic in Lakeland, FL, and with the 
Florida Orthopaedic Institute in Tampa. Dr. Letson is a frequent guest speaker at local and international 
physician conferences and has received numerous awards, including American Orthopaedic Academy 
Honor Society, Professor of the Year at Orlando Regional Healthcare, Teacher of the Year for the USF 
Radiology Department and Best Doctors in America. 
 
 
 
Education & Training: 
Board Certification: 
• Orthopaedic Surgery 
Fellowship: 
• Massachusetts General Hospital – Harvard Medical School - Musculoskeletal Oncology 
Residency: 
• Louisiana State University Medical School Affiliated Hospitals - Orthopaedics 
Medical School: 
• Louisiana State University - MD 
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Alan F. List, MD 
 
Dr. Alan List is the president and CEO of Moffitt Cancer Center. He is a senior member in the 
Department of Malignant Hematology and the Experimental Therapeutics Program. In addition, Dr. List 
is a professor of internal medicine and oncology at the University of South Florida Morsani College of 
Medicine. After earning his medical degree from the University of Pennsylvania, Dr. List completed a 
residency in medicine at Good Samaritan Medical Center in Phoenix, AZ. He pursued fellowships in 
hematology and medical oncology at Vanderbilt University Medical Center in Nashville, Tenn.  
 
Prior to joining Moffitt in 2003, Dr. List was a professor of medicine and director of the Leukemia and 
Bone Marrow Transplant Program at the University of Arizona Tucson, as well as Associated Center 
Director of the Division of Translational/Clinical Research. Dr. List is internationally recognized for his 
many contributions in the development of novel, more effective treatment strategies for 
myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). His pioneering work led to the 
development of lenalidomide (Revlimid®) from the laboratory to clinical trials, which went on to receive 
fast-track designation from the U.S. Food and Drug Administration and approval for the treatment of 
patients with MDS and multiple myeloma.  
 
He is the author of more than 330 peer-reviewed articles and co-editor of Wintrobe’s textbook of 
Hematology. He serves as a member of the Board of Directors of the Myelodysplastic Syndrome 
Foundation and the AA & MDS International Foundation and is the President-Elect (2017-18) for the 
Society of Hematologic Oncology (SOHO). He also is an active member of the American Society of 
Clinical Oncology; American Society of Hematology; American Association for Cancer Research; 
International Society for Experimental Hematology; J.P. McCarthy Foundation Medical Advisory 
Committee; and the Southwestern Oncology Group. 
 
 
 
Education & Training: 
Board Certification: 
• Medical Oncology 
• Hematology 
Fellowship: 
• Vanderbilt University Medical Center, Nashville, TN - Oncology 
• Vanderbilt University Medical Center, Nashville, TN - Hematology 
Residency: 
• Good Samaritan Medical Center, Phoenix, AZ - Internal Medicine 
Medical School: 
• University of Pennsylvania - MD 
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The Hon. Connie Mack III 
Senator Connie Mack represented the State of Florida in the United States Congress for 18 years, 
including 12 years in the United States Senate where he played a leading role in economic and health 
care issues. Senator Mack led a historic bipartisan Congressional effort to double funding over a five-
year period for biomedical research conducted through the National Institutes of Health. At the time of 
his retirement in 2001, Senator Mack served as the Republican Conference Chairman, making him the 
third-ranking member of the Senate Republican leadership. 
Senator Mack became the first Republican in Florida history to be re-elected to the U.S. Senate in 1994 
when he received more than 70 percent of the vote, more than any other Republican candidate in the 
nation. Prior to his election to the Senate, he served three two-year terms as a member of the House of 
Representatives from southwest Florida. In April 1994, Mack was named by Campaign and Elections 
magazine as one of the 20 most popular elected officials in America. As a House member, U.S. News and 
World Report identified him as one of the nation’s most effective “new rising political stars.” 
For the past 10 years, Senator Mack has worked with clients to develop and implement strategies to 
successfully achieve their legislative policy goals. In 2007, he became a founding Partner and Senior 
Policy Advisor with Liberty Partners of Florida, LLC in Tallahassee and continued in these roles as the 
partnership expanded in January 2010 into Liberty Partners Group, LLC in Washington, DC. Appointed by 
President Bush in 2005, Senator Mack served as Chairman of the President’s Advisory Panel for Federal 
Tax Reform. Currently, Senator Mack serves as Chairman Emeritus, serving after years as Chairman of 
the Board of Directors of the H. Lee Moffitt Cancer Center & Research Institute in Tampa, Florida. He 
was a founding trustee of the American Cancer Society Foundation and served as past President. The 
Senator is a member of the Board of Directors of the Mutual of America Life Insurance Company, is Vice 
Chairman of M2Gen, and serves on the Board of the Moffitt Cancer Center, where he is the Chair 
Emeritus. 
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Jennifer (Jenny) L. Moffitt, PhD 
Jenny Moffitt is assistant professor of English at Florida Southern College in Lakeland, Florida. Before 
joining the faculty at Florida Southern, she taught for seven years at Florida State University, first as a 
graduate student and then as a visiting lecturer. Her research and teaching interests include American 
literature, gender theory, and visual culture studies. Jenny is the recipient of the J. Russell Reaver Award 
for Outstanding Dissertation in American Literature or Folklore, and the Bryan Hall Award for Excellence 
in Teaching First-Year Composition. She holds a B.A. in English from Appalachian State University, a M.A. 
in Literature from Humboldt State University, and a Ph.D. in Literature from Florida State University.  
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The Hon. H. Lee Moffitt, Esq. 
 
Moffitt was born in Tampa and attended Henry B. Plant High School in Tampa, graduating in 1959. He 
later obtained his Bachelor of Arts from the University of South Florida in 1964 and his Juris Doctor 
from Cumberland School of Law in 1967. 
Moffitt was elected to the Florida House in 1974, serving Tampa, Florida. He served 
as Democratic member of the Florida House of Representatives, holding various positions throughout 
his ten years of service there. In 1976 he was selected as the Most Effective First-Term House 
member and presented with the Allen Morris Award by the Florida Times-Union. From 1978 to 1980 he 
chaired the Commerce Committee, and the House Reapportionment Committee from 1980 to 1982.He 
was again selected by St. Petersburg Times (now Tampa Bay Times) as the "most Effective Member of 
the House" in 1982, as Chairman of the House Reapportionment Committee. In November 1982, he was 
elected Speaker of the Florida House of Representatives and served in this capacity until 1984. He 
retired from the legislature in 1984 to return to the practice of law. 
While a member of the house of representative, Moffitt spearheaded a project to build a cancer 
treatment center in Florida. Moffitt had been diagnosed with a malignant tumor in his left knee at age 
29, for which he did a tumor resection. It was this experience, along with the death of friends, Joseph 
Lumia, Judy Barnett and George Edgecomb, from cancer, that motivated Moffitt to lobby for a cancer 
treatment center in Tampa. He secured an initial $70-million via the Legislature for the commencement 
of the construction 
The H. Lee Moffitt Cancer Center & Research Institute officially opened on October 27, 1986, three years 
after its groundbreaking. Despite Moffitt's objection, the Florida legislature voted to name the facility in 
his honor. In 2006 he was honored by the Association of Community Cancer Centers' (ACCC) Annual 
Achievement Award for his commitment to combating cancer through the center he founded. Since its 
founding the center has expanded its services and was designated an NCI Comprehensive Cancer Center 
in 2001. 
Also, during his legislative career he passed constitutional resolutions that created a merit selection 
process for the Florida Appellate Judiciary and granting Floridians a right to privacy. Both constitutional 
amendments were approved by Florida voters. He also led the effort to pass the Water Quality and 
Assurance Act of 1983, and the Growth Management Act of 1985. 
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James (Jim) J.  Mulé, PhD 
 
Dr. Mulé joined Moffitt in 2003 as the associate center director for Translational Science. His research 
focuses on characterizing and validating genomic signatures of immunotherapy response, as well as 
designing and translating novel vaccine and adoptive T-cell transfer strategies to patients with advanced 
solid tumors. s been named a Master of Immunology by the American Association for Cancer Research 
(AACR) publication Cancer Immunology Research. The distinction recognizes his life’s contributions to 
cancer research; in particular, his work to better understand how anti-tumor immune responses develop 
and are regulated by the body. The results of his life’s work have helped shape the future of cancer 
therapy through the development of personalized immunotherapies that use a patient’s own immune 
system to fight his or her disease. 
 
The clinical application of immunotherapy for cancer is rapidly moving forward in multiple areas, which 
incorporate the adoptive transfer of antitumor-reactive T cells and the use of 'therapeutic' vaccines. 
Both clinical and immunologic endpoints have shown new promise to the field. Novel dendritic cell-
based vaccine strategies designed in the laboratory and proven in preclinical animal tumor models are 
now entering the clinic, with the intent of providiyvettng therapeutic efficacy. Improvements on this 
approach involve breaking tolerance to tumor 'self' antigens by inhibiting regulatory cells, boosting T cell 
co-stimulation, and administering combinations of recombinant cytokines and other defined molecules 
with 'immuno-enhancing' activities. Development of these improvements is the primary research 
interest of Dr. Mulé. 
 
 
 
 
Discipline: 
• Cutaneous Oncology 
• Translational Research 
• Radiation Oncology 
• Immunology 
• Melanoma Research Center of Excellence 
• Center for Immunization and Infection Research in Cancer 
 
Fellowship: 
• Fred Hutchinson Cancer Research Center, PhD - Tumor Immunology  
• University of Washington School of Medicine, Postdoctoral Fellow - Surgery 
• National Cancer Institute, Bethesda, Maryland, Fellow - Surgery 
• University of Washington, School of Medicine, MS - Cellular Immunology 
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Warren Jackson (Jack) Pledger, PhD 
Warren Jackson (Jack) Pledger is a molecular cell biologist who is the Associate Director for Research and 
Deputy Director of the Gibbs Cancer Research Institute in Spartanburg, South Carolina. He has held 
academic appointments and tenure at the University of North Carolina School of Medicine (Assistant 
and Associate Professor of Pharmacology and Program Leader of the Cell Biology Program at the 
Lineberger Cancer Center), Vanderbilt University School of Medicine (Professor of Cell Biology) and the 
University of South Florida College of Medicine (Professor of Biochemistry and Oncology.) 
He moved to the Moffitt Cancer Center in 1994 as Associate Center Director for Basic Research and was 
awarded the Cortner-Couch Endowed Chair in Cancer Research. Dr. Pledger was responsible for the 
development, administration and quality of all research programs and cores at Moffitt. He was also 
responsible for recruiting investigators to Moffitt to support the application for a National Cancer 
Institute (NCI) Comprehensive Cancer Center. Moffitt grew into a national research institution during his 
tenure as Associate Center Director for Basic Sciences. He instituted and developed the Moffitt Research 
Institute and was its Founding Director. Moffitt/University of South Florida Ph.D. program in Cancer 
Biology was organized under his leadership, which continues to train students. He also served as the 
Deputy Center Director (2001 to 2013). In addition, he served as the principal investigator at Moffitt’s 
National Functional Genomics Center (NFGC). 
Pledger has received peer-reviewed funding for more than 30 years. He has held numerous National 
Institute of Health (NIH) and NCI grants, participated in three Program Project Grants (PPG) and was the 
principal investigator of one PPG. He has served as the principal investigator on several institutional 
grants including the American Cancer Society (ACS) Institutional Research Grant, the National Genomics 
Center Grant (Department of Defense), and a U56 / U54 partnership grant with the Ponce School of 
Medicine Cancer Center He has over 150 publications in journals, including ScienceNature, Proceedings 
of the National Academy of Sciences, USA, Molecular Cell Biology,[  and Journal of Cell Biology Dr. 
Pledger is also an associate editor for the Journal of Cellular Biochemistry, Critical Reviews in Eukaryotic 
Gene Expression and Cancer Research. He has served as a permanent member on NIH, ACS and VA grant 
review panels and has served on several NIH and NCI ad hoc panels that reviewed Program Project 
Grants and Center Grants.  He was the first recipient of Moffitt Cancer Center's Scientist of the Year 
Award. 
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Nicolas (Nick) C. Porter 
Nick Porter is a senior advisor with the THEO Executive Group who builds strong cultures of excellence 
with senior executives of medical and academic institutions. From 1988 to 2011, Nick was with the 
Moffitt Cancer Center as its chief operating officer and then as its executive vice president for 
institutional advancement and corporate relations. Throughout his tenure, Nick was the primary liaison 
for Moffitt’s board of directors. Prior to joining Moffitt, Nick was chief operating officer of Johns Hopkins 
Hospital. Nick has served on the board of trustees and the finance committee of the National 
Comprehensive Cancer Network; the executive committee of the Alliance of Dedicated Cancer Centers; 
the finance committee of the Association of American Cancer Institutes, and other community boards. 
He holds a B.A. degree from the University of Baltimore and a Master’s of Education from Loyola 
College.  
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John C. Ruckdeschel, MD 
Dr. John C. Ruckdeschel is the Cancer Institute director and Ergon Chair in Cancer Research for the 
University of Mississippi Medical Center. 
Ruckdeschel, who previously served as the director of the Moffitt Cancer Center in Tampa, led that 
institution to National Cancer Institute Comprehensive Cancer Center designation and to become the 
third-largest clinical cancer program in the United States. 
He then moved to the Barbara Ann Karmanos Cancer Center in Detroit, where he re-acquired its NCI 
comprehensive status and completed the process of making Karmanos a free-standing cancer hospital. 
In both settings he built strong clinical networks by working with community physicians and patients, 
developing effective inter-disciplinary clinical teams and creating strong programs across clinical, basic, 
translational and population research. 
As a clinician, Ruckdeschel's career has focused on lung cancer and other thoracic malignancies. He's 
credited with more than 150 peer reviewed manuscripts and co-editorship of the Textbook of Thoracic 
Oncology.  He is currently a North American editor for the Cochrane Lung Cancer Review Group. 
Ruckdeschel completed his undergraduate education in biology at Rensselaer Polytechnic Institute and 
received his medical degree from Albany Medical College in New York.  He went on to an internship at 
Johns Hopkins, residency at the Beth Israel Medical Center in Boston and fellowship at the National 
Cancer Institute's Baltimore Cancer Research Center. 
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Thomas A. Sellers, PhD, MPH 
Dr. Thomas Sellers is center director of Moffitt Cancer Center and executive vice president. Dr. Sellers 
research program seeks to integrate a basic science background in nutrition and genetics with 
observational research methods to try to understand questions such as, why do less than 20 percent of 
cigarette smokers develop lung cancer and why is a proven effective cancer treatment beneficial to only 
a subset of patients? His studies are based on genetic analysis of germline DNA and the increasing 
incorporation of acquired (somatic) events.  
The primary focus of his research is ovarian cancer, which is a devastating disease with no clear warning 
signs and high mortality rates. Dr. Sellers also has active collaborations that involve cancers of the 
breast, lung and prostate. The underlying theme is identifying inter-individual differences in cancer 
susceptibility and using that to inform approaches to cancer prevention, early detection and precision 
medicine to enhance outcomes after diagnosis. 
Critical to the success of this effort is team science, necessitating collaborations with geneticists, 
pathologists, biostatisticians, biomedical informaticists and clinicians. The Moffitt environment enables 
that to happen naturally. 
Dr. Sellers earned his Master of Public Health from Tulane University School of Public Health and 
Tropical Medicine and his Ph.D. in Epidemiology from Tulane. He was a postdoctoral fellow in genetic 
epidemiology at Louisiana State University Medical Center.) 
 
 
 
Education & Training: 
• Postdoctoral Fellow, Louisiana State University Medical Center, 1989 - Genetic Epidemiology 
• PhD, Tulane University, 1988 – Epidemiology 
• MPH, Tulane University, School of Public Health and Tropical Medicine, 1984 – Epidemiology 
• BS, University of California at Davis, 1982 - Community Nutrition 
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Yvette Tremonti, CPA, MBA 
Yvette Tremonti is the Chief Financial and Administrative Officer of Moffitt Cancer Center in Tampa, FL 
and is responsible for overseeing the financial operations of the center, Digital Innovation initiatives, 
Information Technology, Construction Planning & Design and the Enterprise Project Management Office 
aligned with Process Excellence. 
In this capacity, Ms. Tremonti also oversees Payor and Partnership Strategy, Strategy and Planning, and 
Human Resources. Ms. Tremonti supports the successful navigation of the organization through a 
dynamic healthcare terrain and ensures that department leaders are aligned with Moffitt’s strategy to 
transform cancer care.  
As part of the senior leadership team, she is responsible for ensuring the development and achievement 
of the long-term strategic and financial goals of superior value, partnership, financial health, research 
and translation and education. She has worked for Moffitt Cancer Center since 1996. Prior to her current 
role, Ms. Tremonti served as Executive Vice President of Strategy and Business Development and as Vice 
President of Human Resources.  
Ms. Tremonti has approximately 22 years of health care finance experience. She spent nine years with 
Ernst & Young in the audit practice focused on for-profit and not-for-profit health care entities. In 
addition, she served as campus coordinator, recruiter and program instructor for Ernst & Young.  
Ms. Tremonti holds a bachelor’s degree in Business Administration from the University of South Florida 
and a Masters of Business Administration from Auburn University. She is a member of the American and 
Florida Institute of Certified Public Accountants, the Healthcare Financial Management Association and 
the Society for Human Resource Management.  
She places a high priority on the cancer center’s community involvement, encouraging Moffitt’s 
leadership and her own direct reports to be involved in organizations and activities that help to enhance 
the Tampa Bay community. She has taken an active role on the board of directors of the Greater Tampa 
Chamber of Commerce, the Hillsborough Education Foundation, and the National Comprehensive 
Cancer Network (NCCN) Board of Directors. She currently is the treasurer of the Hillsborough Education 
Foundation. 
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The Hon. William (Will) W. Weatherboard 
Speaker Weatherford was the 84th Speaker of the Florida House of Representatives, serving from 2012-
2014, during which time he was the youngest Speaker in America. Throughout his four consecutive 
terms in office, Will was a strong advocate for social upward mobility through free enterprise and 
education reform. He was also a thought leader on other pro-growth solutions including lower taxes, 
pension reform, and free market health care. 
Will is the Managing Partner of Weatherford Capital, a firm with deep roots in Florida and a strong 
global network that partners with owners and management teams of high integrity to build great 
businesses through the provision of capital and strategic business advisory services. 
Will serves on the board of Sunshine Bankcorp, the National Coalition for Capital, the U.S. Global 
Leadership Collation, the Republican State Leadership Committee, Take Stock in Children and Jobs for 
America’s Graduates. Will also served as a Rodel Fellow at the Aspen Institute. 
Will spent six years as a board director at Florida Traditions Bank prior to its sale to Home BancShares in 
July 2014. Will is the Founder of Red Eagle Group, a boutique investment and business consulting firm.  
Will Weatherford attended Jacksonville University, where he received a degree in business in 2002. 
After graduation, Weatherford worked in commercial real estate but was recruited by Allan Bense, his 
father-in-law and the Speaker of the Florida House of Representatives, to join state government. 
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CONSTITUTION  
OF THE 
STATE OF FLORIDA 
 
 
ARTICLE III 
LEGISLATURE 
SECTION 1. Composition.—The legislative power of the state shall be vested in a legislature of the State of 
Florida, consisting of a senate composed of one senator elected from each senatorial district and a house of 
representatives composed of one member elected from each representative district. 
SECTION 2. Members; officers.—Each house shall be the sole judge of the qualifications, elections, and 
returns of its members, and shall biennially choose its officers, including a permanent presiding officer selected 
from its membership, who shall be designated in the senate as President of the Senate, and in the house as 
Speaker of the House of Representatives. The senate shall designate a Secretary to serve at its pleasure, and the 
house of representatives shall designate a Clerk to serve at its pleasure. The legislature shall appoint an auditor to 
serve at its pleasure who shall audit public records and perform related duties as prescribed by law or concurrent 
resolution. 
SECTION 3. Sessions of the legislature.— 
(a) ORGANIZATION SESSIONS. On the fourteenth day following each general election the legislature shall 
convene for the exclusive purpose of organization and selection of officers. 
(b) REGULAR SESSIONS. A regular session of the legislature shall convene on the first Tuesday after the first 
Monday in March of each odd-numbered year, and on the first Tuesday after the first Monday in March, or such 
other date as may be fixed by law, of each even-numbered year. 
(c) SPECIAL SESSIONS. 
(1) The governor, by proclamation stating the purpose, may convene the legislature in special session during 
which only such legislative business may be transacted as is within the purview of the proclamation, or of a 
communication from the governor, or is introduced by consent of two-thirds of the membership of each house. 
(2) A special session of the legislature may be convened as provided by law. 
(d) LENGTH OF SESSIONS. A regular session of the legislature shall not exceed sixty consecutive days, and a 
special session shall not exceed twenty consecutive days, unless extended beyond such limit by a three-fifths vote 
of each house. During such an extension no new business may be taken up in either house without the consent of 
two-thirds of its membership. 
(e) ADJOURNMENT. Neither house shall adjourn for more than seventy-two consecutive hours except 
pursuant to concurrent resolution. 
(f) ADJOURNMENT BY GOVERNOR. If, during any regular or special session, the two houses cannot agree 
upon a time for adjournment, the governor may adjourn the session sine die or to any date within the period 
authorized for such session; provided that, at least twenty-four hours before adjourning the session, and while 
neither house is in recess, each house shall be given formal written notice of the governor’s intention to do so, and 
agreement reached within that period by both houses on a time for adjournment shall prevail. 
History.—Am. C.S. for S.J.R. 380, 1989; adopted 1990; Am. S.J.R. 2606, 1994; adopted 1994; Am. proposed by 
Constitution Revision Commission, Revision No. 13, 1998, filed with the Secretary of State May 5, 1998; adopted 
1998.  
 
Source: The Florida Legislature, The Florida Constitution. Retrieved on October 27, 2018 from: 
http://www.leg.state.fl.us/statutes/index.cfm?submenu=3#A3S01 
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Summary Table of Themes – 1990 Legislation 
Source Quote(s) Context/topic  
Nick Porter It’s a freestanding cancer center, meaning it’s not part of an academic institution. 
 
The Moffitt Cancer Center, almost from the beginning, began to understand that in order to completely devote it’s time, 
effort and resources towards the mission of the cancer center, to contribute to the prevention and cure of cancer, it could 
not stay with strong links to the University of South Florida. 
 
At the time it was, I think, written into the bylaws that the chair of the Moffitt Board of Directors had to be the president of 
the university. That was later changed. 
Evolution of Moffitt 
 
Discussion of board make-
up and relationship with 
USF 
 
Evolution of Moffitt 
Sen. Connie 
Mack 
…somewhere along the line, someone told Lee how important it was for the institution to be independent, free-standing, 
which allowed for decisions to be made and actions taken in a very short period of time. Very little bureaucracy.  
Question regarding MCC’s 
reputation 
Dr. Bill Dalton 
 
I think creating an instrumentality of the state, which creates an incredible ability and opportunity to work with anybody and 
still be independent is phenomenal and it’s key.  
How Moffitt achieved its 
position 
Ed Droste Because it’s cancer only. Because it’s not necessarily under the governance of another educational institution... Decisions 
Dr. Alan List There’s certain milestones, I would say, or paradigm shifts that I think are very important.  
 
We are an instrumentality of the state with a mission for the state. 
Decisions 
 
Post interview addition 
Dr. Jack Pledger …the biggest one was the development of the cancer center and then…becoming completely independent from USF. Decisions 
Ted Couch …the structure of Moffitt…the existence of Moffitt statutorily, the support that Moffitt gets from the state, the fact that we 
are independent of the medical school or a university system gives us some advantage…in being nimble in our decisions. 
How Moffitt achieved its 
position 
Dr. Jim Mule’ I think local and state governments play a crucial role in Moffitt’s success… Role of Moffitt 
 We’ve got to be entrepreneurial and we’ve got to set up a system which takes advantage of the research and clinical 
efforts…not only on paper but certainly in Tallahassee and elsewhere… 
Recalling a conversation, 
quoting Moffitt. Decisions. 
Dr. Tom Sellers One of the things he learned from MD Anderson was to associate with a university but don’t be married into a single 
institution. MD Anderson will always be part of the University of Texas system. We don’t have that restriction and I know 
there was a time in our history where that was helpful in giving us more flexibility to achieve our mission. I think that was the 
most important one. 
Decisions 
 
 
